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Summary 
Biological indicators for neurotransmitter activity are of great interest for a better understanding of 
the pathophysiology of psychiatric disorders. The monoaminergic neurotransmitter serotonin, in 
particular, plays an important role in the aetiology of many mental disorders. Serotonin has homeo-
static effects on brain functioning by regulating the general excitability of neurons, and thus plays a 
role in modulating perception and behaviour. The loudness dependence of auditory evoked potentials 
(LDAEP) is a measure of the excitability of neurons in the auditory cortex during the processing of 
tones of different intensities. Due to a strong serotonergic innervation of the primary auditory cortex 
it is assumed that serotonin has modulatory effects on these brain areas. A strong LDAEP is thought 
to reflect a weak serotonergic activity and vice versa. 
The LDAEP has been successfully applied in several fields of research. One of its most promising 
applications is the prediction of treatment responses. However, the LDAEPs validity has been 
challenged. Particularly, research on some clinical diagnoses is constrained by an inherent heteroge-
neous symptom constellation within clinical diagnoses based on ICD-10 or DSM-V. It is therefore 
necessary to assess the symptoms with dimensional measures in order to give evidence to the 
underlying biological abnormalities. On the other hand, no standardized protocols exist for the 
application and analysis of the LDAEP. Basically, in order to measure the electrophysiological 
response of the auditory cortex, dipole source analysis, distributed imaging methods (LORETA) and 
single electrode estimation have been applied. However, results obtained with different approaches 
show major inconsistencies. 
The aim of the present thesis was to progress in the search of biomarkers suitable for a daily clinical 
use. So far, findings in schizophrenia research using LDAEP are inconsistent and lack comparability 
due to the above-mentioned methodological issues. Study I conducted within this thesis investigated 
patients with schizophrenia by means of LDAEP taking dimensional measures of the symptoms into 
account. Patients showed higher LDAEP values compared to healthy controls, indicating a lower 
serotonergic activity. Moreover, predominant negative symptoms were associated with the LDAEP. 
These findings are in line with other studies, which showed a dysfunctional serotonergic neurotrans-
mission in the genesis of negative symptoms. Study II examined the underlying neural generators 
during loudness processing using magnetoencephalography (MEG). Magnetic field tomography 
analysis revealed additional activation of brain regions outside of the auditory cortex. Time course 
analysis further specified that tones with high intensities were processed within hundreds of millisec-
onds from the primary auditory cortex as well as the primary somatosensory cortex via the posterior 
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cingulate cortex into the premotor cortex. These findings have strong implications on the compara-
bility of the different analysis approaches.  
In summary, in search of clinical biomarkers it is important to shed light on possible influences of 
methodological factors in order to improve their reliability and validity. Their application in daily 
clinical practice would lead to more precise diagnoses and improve treatment strategies by enabling a 
better prediction of therapeutic outcome. 
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Zusammenfassung 
In der psychiatrischen Forschung sind biologische Indikatoren für die Neurotransmitter-Aktivität im 
Gehirn von grossem Interesse. Insbesondere Serotonin, ein monoaminer Neurotransmitter, spielt in 
der Ätiologie vieler psychischer Erkrankungen eine wichtige Rolle. Serotonin wird eine regulierende 
Funktion im Gehirn zugeschrieben, indem es das Erregungsniveau von Nervenzellen mit der 
Wahrnehmung und dem Verhalten des Organismus abstimmt. Die Lautstärkeabhängigkeit Akustisch 
Evozierter Potentiale (LAAEP) ist ein Mass für die Reagibilität der Neurone im auditorischen Kortex 
bei der Verarbeitung unterschiedlich lauter Töne. Angesichts einer starken serotonergen Innervation 
des primären auditorischen Kortex wird vermutet, dass Serotonin einen modulierenden Einfluss auf 
die Aktivität dieses Kortexareals hat. Es wird angenommen, dass eine starke LAAEP eine schwache 
serotonerge Aktivität wiederspiegelt und vice versa. 
Trotz eines beachtlichen Erfolges der LAAEP in verschiedenen Bereichen der neurowissenschaftli-
chen Forschung in der Psychiatrie, ist dieser Indikator noch nicht genügend validiert, um im klini-
schen Alltag verwendet werden zu können. Ausserdem sind derartige Biomarker bei Untersuchungen 
an psychiatrischen Stichproben mit heterogenen Symptomkonstellationen nicht uneingeschränkt 
anwendbar. Symptome, die unter derselben klinischen Diagnose subsumiert sind, unterliegen 
möglicherweise unterschiedlichen biologischen Ursachen. Im Kontext solcher Forschung ist es daher 
erforderlich, dimensionale Beschreibungen der Symptome zu berücksichtigen und mit der LAAEP 
zu assoziieren. Zum anderen existieren bis anhin keine standardisierten Protokolle für die Applikati-
on und Auswertung der LAAEP. Um Potentialveränderungen im auditorischen Kortex zu erfassen, 
wurden einerseits Dipolquellenmodelle sowie verteilte Quellenmodelle (LORETA) und andererseits 
Ableitungen an einzelnen Elektroden vorgenommen. Untersuchungen zeigen, dass die Ergebnisse 
zwischen diesen Auswertungsansätzen inkohärent sind. 
Ziel der vorliegenden Arbeit war es, diesen Limitationen Rechnung zu tragen um die Etablierung der 
LAAEP voranzubringen. Erkenntnisse zur LAAEP bei schizophrenen Patienten sind uneinheitlich 
und aus methodischen Gründen schwer miteinander zu vergleichen. In der Studie I wurden Patienten 
mit Schizophrenie mittels LAAEP und unter Berücksichtigung des Schweregrads unterschiedlicher 
Symptomcluster, namentlich Negativ- und Positivsymptome, untersucht. Patienten zeigten eine 
signifikant höhere LAAEP im Vergleich zur gesunden Kontrollgruppe, beziehungsweise eine 
erniedrigte serotonerge Aktivität. Darüberhinaus war die Ausprägung der Negativsymptomatik stark 
mit der LAAEP assoziiert. Dies ist in Übereinstimmung mit früherer Literatur, die eine Dysfunktion 
des serotonergen Systems in der Genese von Negativsymptomen hypothetisierte. In der Studie II 
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wurden die der LAAEP zugrundeliegenden Generatoren im Gehirn näher untersucht. Mithilfe von 
Magnetoencephalographie (MEG) und eines verteilten Imaging Verfahrens wurde ermittelt, dass 
nebst dem auditorischen Kortex auch andere Hirnregionen involviert sind. Eine Analyse der Zeitver-
läufe ergab eine sequenzielle Verarbeitung von den sensorischen Arealen über den posterioren 
cingulären Cortex zum Prämotor-Cortex im Millisekundenbereich. Diese zusätzlichen Aktivierungen 
dürften eine Auswirkung auf die Vergleichbarkeit der unterschiedlichen Auswertungsmethoden 
haben. 
Zusammenfassend ist es von grosser Bedeutung, den Einfluss möglicher methodologischer Faktoren 
auf die LAAEP zu untersuchen um die Reliabilität und Validität dieses klinischen Biomarkers zu 
verbessern. Der Einsatz im klinischen Alltag würde eine präzisere Diagnostik und eine bessere 
Therapieprädiktion begünstigen und so die Behandlung von Patienten massgeblich verbessern. 
 
 v 
Abbreviations 
5-HT 5-hydroxytrypamine, serotonin 
5-HTTLPR serotonin-transporter-linked promoter region 
AEP auditory evoked potential 
AIC akaike’s information criterion 
ASF amplitude-stimulus function 
BA brodmann area 
BDNF brain derived neurotrophic factor 
BESA brain electric source analysis 
BET brain extraction tool 
BIC bayesian information criterion 
BRMS Bech-Rafaelsen melancholia scale 
CDSS Calgary depression rating scale for schizophrenia 
COMT Catechol-O-Methyltransferase 
CPZ chlorpromazine 
CSF cerebrospinal fluid 
DAT dopamine transporter 
dB decibel 
DC direct current 
DSA dipol source analysis 
DSM-V Diagnostic and Statistical Manual of Mental Disorders (5th edition) 
EEG electroencephalography 
EPSP excitatory postsynaptic potential 
ERP event-related potential 
FDG fluorodeoxyglucose 
fMRI functional magnetic resonance imaging 
FWE family-wise error 
GABA gamma-aminobutyric acid 
GFP global field power 
GLM generalized linear models 
HAMD Hamilton depression rating scale 
HL normal hearing threshold 
Hz hertz 
ICA independent component analysis 
 vi 
ICD-10 International Statistical Classification of Diseases (10th revision) 
IPSP inhibiotry postsynaptic potential 
ISI interstimulus interval 
LAAEP Lautstärkeabhängigkeit akustisch evozierter Potentiale 
LDAEP loudness dependence of auditory evoked potentials 
LORETA low resolution electromagnetic tomography 
MEG magnetoencephalography 
MFT magnetic field tomography 
MINI Mini international neuropsychiatry interview 
MN minimum norm 
MNI Montreal Neurological Institute 
MRS magnetic resonance spectroscopy 
NIfTI Neuroimaging Informatics Technology Initiative 
NOS nitric oxide synthase 
PAC primary auditory cortex 
PANSS Positive and Negative Syndrome Scale 
PCA principal component analysis 
PCC posterior cingulate cortex 
PET positron emission tomography 
PMC premotor cortex 
pT pico tesla 
RMS root mean squared 
ROI region of interest 
SANS Scale for Assessment of Negative Symptoms 
SERT serotonin transporter 
SL sensation level; individual’s hearing level 
SNP single nucleotide polymorphism 
SNR signal-to-noise ratio 
SPECT single photon emission computed tomography 
SPL sound pressure level 
SSRI selective serotonin reuptake inhibitor 
STG superior temporal gyrus 
TFCE threshold-free cluster enhancement 
 
Introduction 
1 
1. Introduction  
1.1 In search of clinical biomarkers in psychiatry 
The World Health Organization reported in 2004 that about one person in four will develop one or 
more mental or behavioural disorders during their lifetime. Mental disorders represent an immense 
psychological, social and economic burden (Beaglehole & Irwin, 2004). Diagnostic tools in psychia-
try have always been based on subjective clinical parameters with high variability that describe 
symptoms, mental state examinations, and clinical behavioural observations (Hyman, 2007). 
However, the rising discontent with current diagnostic tools in psychiatry (DSM-V, American 
Psychiatric Association, 2013; ICD-10, World Health Organization, 1993) refers to the considerable 
divergency in the aetiology and pathophysiology underlying psychiatric disorders (First, 2010). 
Patients with the same apparent diagnosis may suffer from a variety of symptoms, conceivably 
caused by different biological processes, and as a consequence some of them may get treated 
inappropriately (Linden, 2012). Thus, to improve the quality of diagnoses and the effectiveness of 
treatment of psychiatric disorders, there is a quest for identifiable biological foundations to psychiat-
ric diagnoses in order to set an objective alternative to the current clinical parameters (Cook, 2008; 
Leiser, Dunlop, Bowlby, & Devilbiss, 2011; Linden, 2012; Luck et al., 2011; McLoughlin, Makeig, 
& Tsuang, 2013; I. Singh & Rose, 2009). A promising alternative is provided by bio-markers, which 
have been defined as having the ‘characteristic that is objectively measured and evaluated as an 
indicator of normal biological processes, pathogenic processes or pharmacologic responses to a 
therapeutic intervention’ (Biomarkers Definitions Working Group, 2001, p. 91). In other words, in 
the context of psychiatric disorders, an ideal biological marker presents high diagnostic specificity 
and sensitivity and is qualified for prognosticating the course of an illness (including the detection of 
individuals at-risk) and for predicting and monitoring response to treatment (I. Singh & Rose, 2009). 
These efforts will be useful for guiding tailored individualized therapy in clinical practice. 
Several potential biomarkers have been proposed in psychiatric research, for example specific 
molecules and metabolites in cerebrospinal fluid (CSF) and urine, sleep states, and physiochemical 
responses (Cook, 2008). Currently, however, genetic testing and neuroimaging are the main tech-
niques for identifying biomarkers in psychiatry (I. Singh & Rose, 2009). Within neuroscience, 
neurobiological, neuroanatomical or neurophysiological findings can define an imaging biomarker 
(Linden, 2012), for instance [F-18]-fluorodeoxyglucose (FDG) positron emission tomography (PET) 
has been used in alzheimer research (Herholz et al., 2002), cortical grey matter density measures 
were proposed in psychosis (Sun et al., 2009), and stages of sleep/wakefulness characterized with 
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electroencephalography (EEG) in depression (Steiger & Kimura, 2010). In the context of a neurosci-
entific approach to defineing a biomarker it is critical that the measure is independent of individual 
influences by the observer or environmental influences, as well as the thoughts and attitudes of the 
subject (Kraemer, Schultz, & Arndt, 2002). Furthermore, the concept of endophenotypes has gained 
great attention in unravelling significant heterogeneity which is intrinsic to some psychiatric disor-
ders (Tandon, Nasrallah, & Keshavan, 2009). Endophenotypes are disease-associated neurobiologi-
cal correlates that represent intermediate traits in the causal connection between genotypes and 
phenotypes1, whereby the main advantage is that they are exposed to less complex genetic determi-
nation than clinical phenotypes (Gottesman & Gould, 2003; Hyman, 2007; Kawohl & Hoff, 2010). 
Moreover, the dysfunctional correlates are heritable traits that occur even in unaffected relatives of 
patients and help to identify the genetic factors underlying susceptibility to mental illnesses.  
However, numerous challenges exist that researchers and clinicians are confronted with in the quest 
for sensitive and reliable imaging biomarkers in psychiatry (Linden, 2012; Luck et al., 2011; I. Singh 
& Rose, 2009). The above-mentioned problem of heterogeneity of symptoms within a given clinical 
diagnosis provides on the one hand the motivation to promote biomarker research, and on the other 
hand creates a serious pitfall in applying neuroimaging biomarkers. Referring to the latter, this is 
mainly because biomarkers are still related to diagnoses based on the DSM-V or ICD-10 that underly 
complex pathogenic biological processes. A possible solution to overcome the diagnostic uncertain-
ties of phenotypic definition is the use of dimensional measures of mental functions and their 
underlying neural circuits to classify disorders (Insel et al., 2010; Miller, 2010). The main goal in 
biomarker research is to move beyond current diagnostic definitions of psychopathologies by 
identifying the underlying processes of significant cognitive, affective and social processes that are 
associated with particular mental disorders (Hyman, 2007). Furthermore, in order to be widely useful 
as biomarkers, measures require the power to distinguish patients with a particular psychiatric 
disorder both from controls and from patients with different disorders, and at best to characterize 
individuals within a group (Linden, 2012). However, their sensitivity, specificity and ability to make 
predictions should be specified (Cook, 2008). 
A complete understanding of the psychometric properties (i.e. quantifiable attributes as for example 
validity and reliability that relate to the potency of the measurement) of a biological marker is 
                                                   
 
 
1 Phenotypes are attributable to observable characteristics of traits that are produced by the interaction of genetic 
expression and environmental influences (Birbaumer & Schmidt, 2005). 
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therefore required (Luck et al., 2011). The biomarker’s validity and reliability must be examined in 
nonclinical samples before it can be implemented in routine clinical practice. Reliability is a measure 
of the precision of scientific measurements and the extent to which they reflect the true variance of a 
signal not contaminated by random error (Hensch, Herold, Diers, Armbruster, & Brocke, 2008; 
Schmidt, Le, & Ilies, 2003). That means that optimally re-testing under the same conditions should 
lead to identical results, reflecting high consistency on each repetition. The evaluation of the validity 
of a biomarker is more complex and requires sufficient reliability. Essentially, construct validity 
states the degree to which a biomarker truly tests what it intends to test (i.e. the accuracy of the 
measurement) and to what extent it can explain the underlying biological phenomenon (Clark & 
Watson, 1995).  
Considering all these caveats, standardized acquisition and analysis procedures should be elaborated 
upon to assure quality. The great variability of the biomarkers’ corresponding parameters (for some 
examples see chapter 2.2) that is inherent in most neuroimaging approaches may limit the compara-
bility of findings and conceivably weaken the validity of the biomarker.  
Furthermore, for successful implementation in daily clinical use, additional consideration has to be 
given to cost and ease of the pipeline of the biomarker handling. EEG is a powerful tool that does not 
need expensive equipment and is relatively easy to apply in psychiatric institutions with no access to 
high-end neuroimaging laboratories (McLoughlin et al., 2013). EEG is particularly applicative in 
large-sample studies, which are generally required in genetic imaging. Moreover, the non-invasive 
nature of EEG allows for a relatively comfortable measurement of children and anxious or suspicious 
patients who are not suitable to undergo noisy, highly motion-susceptible (functional magnetic 
resonance imaging; fMRI) or invasive (PET) neuroimaging measurements (McLoughlin et al., 2013). 
EEG is generally easy to translate from animal models to human, as the underlying neural processes 
that are directly measured through EEG are similar between species (Woodman, 2012). The straight-
forwardness of pharmacological manipulations and genetic modification in rodents and primates can 
help to assess EEG measures as a potential biomarker (Luck et al., 2011).  
The aim of this dissertation is to shed light on the loudness dependence of auditory evoked potential 
(LDAEP), a potential EEG-based biomarker proposed to reflect neurotransmitter activity in the 
brain. Pertaining to the challenges for biomarkers that have to be overcome before they can be 
implemented in clinical practice, as described above, this work refers to specific problems regarding 
the LDAEP as a biomarker. 
First, the concept of the LDAEP is elaborated (chapter 2.1), followed by an overview of current 
methodological variables that are applied when setting up an experiment with LDAEP (chapter 2.2). 
In addition, a description of what is currently known about the underlying sources involved in 
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LDAEP (chapter 2.3) is given. Furthermore, in the example of schizophrenia and LDAEP, the 
problem of relying on diagnostic tools in research is illustrated (chapter 2.4). In chapter 3 the main 
aims of this dissertation are summarized, followed by a short description of the methods applied in 
the experiments (chapter 4). Given the tremendous heterogeneity that characterizes schizophrenia 
and its related difficulty in the validation of the biomarker, study I (chapter 5.1) addresses the 
heterogeneous phenotypes within schizophrenia by studying the biological correlates within symp-
tom clusters of this disorder, namely negative and positive symptoms. With the objective of improv-
ing the reliability and validity of the LDAEP, study II identifies the neural correlates of intensity 
perception (chapter 5.2). These findings help to better understand which processes are involved 
during the processing of LDAEP and therefore improve the validity of this potential biomarker. 
Additionally, the findings provide suggestions for standardized analytical methods, which will 
increase the reliability of the LDAEP. Chapter 6 highlights the main limitations and conclusions that 
can be drawn from these studies. 
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2. Theoretical background 
2.1 Loudness dependence of the auditory evoked potential (LDAEP) 
2.1.1 Parameterization of the LDAEP 
The loudness dependence of auditory evoked potentials (LDAEP) represents an increase in the 
neuronal response in the auditory cortices with an increase in sound level (Juckel, 2005). This is 
reflected in a variation in amplitude (Fig. 1, panel B) that is considered to show the amount of 
reactivity of the generating cortical neuronal networks in relation to the intensity of the presented 
tones. This reactivity is dependent on the organism’s protection mechanism from sensory overstimu-
lation (Buchsbaum & Silverman, 1968; Hegerl & Juckel, 1993). The terminology to describe the 
LDAEP varies in the extant literature. Some authors use the term IAEP for intensity dependence of 
the auditory evoked potentials (e.g. Hensch et al., 2006). However, the term LDAEP is most widely 
used (e.g. Gallinat et al., 2007; Juckel, Gudlowski, et al., 2008; Ostermann, Uhl, Köhler, Juckel, & 
Norra, 2012; Park, 2014). Notably, the activation upon auditory processing reflects the subjective 
perception (loudness) rather than a physical entity (intensity) (Uppenkamp & Roehl, 2013). In this 
thesis the term LDAEP is therefore used, as in previous publications of our group. In the 60s and 70s 
the observed phenomenon of augmenting/reducing was the focus of attention, precursory to the 
LDAEP paradigm. In their concept of augmenting/reducing, Buchsbaum and Silverman (1968) 
hypothesized that the individual’s enduring mode of ‘stimulus intensity control’ can be assigned into 
two classes: augmenters show increased responses to increasing stimuli, whereas reducers show 
reduced responses. However, methodological criticism (e.g. intensity site, electrode recording and 
stimulus modality) have led to a reformulation of the concept of augmenting/reducing (Carrillo-de-
la-Pena, 1992; Connolly & Gruzelier, 1982) and in its place the LDAEP paradigm moved up (Hegerl 
& Juckel, 1993). The pioniering idea was to determine the loudness intensity effect directly for the 
auditory cortex through the use of dipole source analysis (Hegerl, Gallinat, & Mrowinski, 1994). 
Moreover, due to advanced parameterization of the LDAEP, the dichotomy of the former concept 
was replaced by a continuous variable for which any value is possible within a range. Such a variable 
generally shows improved reliability.  
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Fig. 1.  
A) Neurobiological model of serotonergic modulation of the loudness dependence of auditory evoked 
potentials (LDAEP) in the primary auditory cortex (PAC). The PAC is highly innervated by sero-
tonergic (5-HT) neurons that are located in the raphe nucleus situated in the reticular formation of the 
brain stem. Serotonergic activity from the raphe dorsalis has a modulatory effect on the PAC, mainly 
via the primary modulatory pathway. The 5-HT inhibits indirectly, i.e. via GABAergic interneurons 
the pyramidal cells of the PAC. Alternatively, there is a direct modulatory effect on the pyramidal 
cells both via 5-HT2 (excitatory) and 5-HT1A (inhibitory) presynaptic receptors. This secondary path-
way allows for the fine-tuning of the 5-HT influence. Consequentially, these 5-HT modulatory effects 
prime the reagibility of the pyramidal cells during the processing of an acoustic signal and in turn 
influence the excitatory- and inhibitory postsynaptic potentials (EPSP/IPSP). Adapted from Serotonin 
und akustisch evozierte Potentiale (p. 147), by G. Juckel, 2005, Darmstadt: Steinkopff Verlag. Copy-
right 2005 by Steinkopff Verlag Darmstadt. Adapted with permission. 
B) Example of loudness dependence of auditory evoked activity following auditory stimulation with 
different sound pressure levels of 60, 80, and 100 dB SPL (sound pressure level). The N1/P2 ampli-
tude at Cz increases with rising sound level.  
C) The inverse relationship between 5-HT activity and LDAEP is illustrated. A high firing rate of the 
serotonergic neurons in the raphe nuclei results in a weak LDAEP (i.e. a small increase in N1/P2 
amplitude with increasing intensity, illustrated in bold type) and a low firing rate results in a strong 
LDAEP (i.e. a large increase in N1/P2 amplitude, illustrated in light type). The LDAEP slope can also 
be respectively interpreted as weak or strong reagibility of the PAC in accordance with panel A.  
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Ever since, the LDAEP has been investigated in a large number of studies of humans and animals 
(for some examples refer to 2.1.2). However, great variability exists in the auditory evoked potential 
(AEP)-components used to calculate the LDAEP on the one hand and in the calculation of the 
amplitude-stimulus intensity function (ASF) itself on the other hand. Regarding the former, Hegerl 
and Juckel (1993) originally focused on the N1/P2 peak-to-peak amplitude because of its high 
reliability in comparison to N1 or P2 (Beauducel, Debener, Brocke, & Kayser, 2000) and because of 
its lower sensitivity to latency shifts (Connolly & Gruzelier, 1982) (different components are 
illustrated in Fig. 1, panel B). The N1/P2 magnitude can be calculated in several different ways: 
effective amplitude, peak-to-peak amplitude or as the root mean squared effective amplitude over the 
epoch of the Nl/P2-component (for a definition see Scherg & Von Cramon, 1990). Referring to the 
latter, the slope of the ASF function can be calculated either as the line of best fit, by using the least-
square technique (linear slope), or from the median of all possible lines between any two intensities 
(median slope) (Hegerl & Juckel, 1993). The median slope is presumed to better cope with the 
extreme values of intensity (Connolly & Gruzelier, 1982). Overall, the steeper the line, the higher the 
degree of loudness dependency, irrespective of which slope is used. 
Moreover, the LDAEP occurs with high inter-individual (Buchsbaum, 1971) and low intra-individual 
variability (Carrillo-de-la-Pena, 2001; Hegerl et al., 1994; Hensch et al., 2008). A genetic back-
ground is thought to play an important role, as similiarity of LDAEP within family is far more 
pronounced than between genetically unrelated pairs (Sándor, Áfra, Proietti-Cecchini, Albert, & 
Schoenen, 1999). 
2.1.2 A biomarker for central serotonergic activity  
A growing body of evidence from human and animal studies suggests that the physiological proper-
ties of the auditory cortex in relation to intensity variation of a tone are directly associated with the 
serotonin (5-HT; 5-hydroxytrypamine) released at the synapses in the primary auditory cortex 
(PAC). An inverse relationship is assumed, whereby a weak LDAEP indicates high serotonergic 
activity, and vice versa (Fig. 1, panel C). For a detailed description of the serotonin modulation 
theory please refer to Fig. 1, panel A and C and to Hegerl et al. (1994); Hegerl and Juckel (1993).  
The serotonin system plays an important role in the pathophysiology of major psychiatric disorders 
such as depression, schizophrenia, anxiety disorders, posttraumatic stress disorder, chronic pain 
syndrome and substance related disorders, and thus is a target of pharmacotherapeutic interventions 
(Hegerl & Juckel, 2000). Reliable indicators of this system are urgently needed for clinical and 
scientific interest. Peripheral measurements of precursors and metabolites of serotonin in serum and 
CSF only reflect the brains serotonergic activity indirectly and their relevance to functional aspects 
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of the neurotransmitter system remain unclear (Bell, Abrams, & Nutt, 2001; Murphy, 1990). There is 
no gold standard for measuring brain serotonergic activity directly in humans. However, a strong 
evidence exists for the serotonin hypothesis and the LDAEP owing to data from animal studies 
(O'Neill, Croft, & Nathan, 2008).  
Several studies in mammals used epidural (i.e. for intraoperative monitoring of evoked potentials) 
electrode placement while challenging the serotonergic system (Juckel, Hegerl, Molnar, Csepe, & 
Karmos, 1999; Juckel, Molnar, Hegerl, Csepe, & Karmos, 1997; Manjarrez, Hernandez, Robles, & 
Hernandez, 2005; Wutzler et al., 2008). These studies show an inverse relationship between the 
serotonergic system and evoked potentials in the PAC by intravenous administration or direct 
microinjection into the dorsal raphe nucleus of 5-HT agonists and antagonists. Importantly, the 
neural pathways involved in the processing of loudness intensity variation in animals share anatomi-
cal and functional similarities to humans and thus the results from these studies are translatable 
(Juckel, Csépe, Molnár, Hegerl, & Karmos, 1996). 
Investigations on patients suffering from psychiatric disorders that underlie aberrant serotonergic 
neurotransmission, genetic polymorphisms of serotonin and direct pharmacological challenge studies 
in humans all serve to strengthen the assumption of an inverse relationship between LDAEP and 
serotonin (consider O’Neill, Croft, et al., 2008 and Park, Lee, Kim, & Bae, 2010 for a detailed 
review).  
Most promising are studies that predict the treatment response to specific pharmacological interven-
tions. LDAEP values that reflect the level of serotonergic activity are collected prior to treatment 
and, in turn, indicate whether the patient would be a good or bad responder to treatment. In affective 
disorders strong LDAEP (i.e. low serotonergic level) is proposed to reflect a favourable response to 
selective serotonin reuptake inhibitors (SSRI) and preventive lithium treatment (Hegerl, Gallinat, & 
Juckel, 2001; Leuchter, Cook, Hunter, & Korb, 2009; Park & Lee, 2013).  
Even though these studies are encouraging, particularly in improving antidepressant medication, the 
effect on the LDAEP after SSRI treatment is contradictory (Gallinat et al., 2000; Guille et al., 2008; 
Juckel et al., 2003; Linka, Sartory, Wiltfang, & Mueller, 2009; Norra et al., 2008; Oliva et al., 2010; 
Segrave, Croft, Illic, Phan, & Nathan, 2006; Simmons, Nathan, Berger, & Allen, 2011; Uhl et al., 
2006). Simmons, Nathan, Berger, & Allen (2011) and O’Neill et al. (2008) argue that a chronic 
manipulation of the serotonergic system might have a stronger impact on the LDAEP than acute 
changes. This statement is based on the fact that acute manipulations of the serotonergic system have 
often failed to change the LDAEP (Guille et al., 2008; Norra et al., 2008; Oliva et al., 2010; Uhl et 
al., 2006) and variables representing a trait, such as genotypes (Hensch et al., 2006), vulnerability to 
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psychiatric disorders (Gudlowski et al., 2009) or characteristics of long-term ecstasy-users (Wan, 
Baldridge, Colby, & Stanford, 2009), show stronger associations with the LDAEP.  
The identification of individuals at risk for psychiatric disorders (or at least before full-blown illness) 
is of current interest. Early detection allows for early intervention, which is of high importance, as 
timely interventions could prevent the manifestation of the illness. Many patients with affective 
disorders experience recurrent thoughts of death and hopelessness that are associated with an 
elevated risk of suicide attempts. For clinicians, it would be most helpful to have a measure that 
reliably predicts which individual will show suicidal behaviour and which will not. It is hypothesized 
that a strong LDAEP, indicating low serotonergic activity, is associated with acute suicidal ideation, 
alongside a history of suicide attempts (T. J. Chen et al., 2005; D.-H. Kim & Park, 2013; Park & Lee, 
2014). A closer investigation into the process underlying suicidal attempts reveals that directly after a 
suicide attempt, high fluctuations of serotonergic levels are apparent, beginning at higher levels and 
falling to lower levels about one week later (Uhl et al., 2012). Another crucial observation is that 
individuals at risk for psychosis with characteristic prodromal symptoms already exhibit enhanced 
serotonin levels, measured by means of LDAEP, before the onset of psychosis (Gudlowski et al., 
2009). In the further course of the illness the aberrant serotonergic level remains high (Juckel, 
Gudlowski, et al., 2008). This substantiates a strong rationale of LDAEP being a marker for vulnera-
bility rather than for expression of illness itself. Altogether, the results in studies into prediction of 
progression of suicidal ideations potentially leading to suicidal behaviour and early detection of 
psychotic disorders lead to the hypothesis that dysregulated serotonergic neurotransmission reflects a 
trait marker of these illnesses that is already present before the onset of the disease or behaviour. In 
this manner the LDAEP holds promising characteristics for use as a biomarker (Luck et al., 2011). 
Psychiatric disorders underlie very complex etiological and pathogenetical mechanisms, though it 
will be very difficult to identify the risk by a single measure. A model combining genetic and 
biological features may be developed to refine the predictability of this risk. 
LDAEP is a promising endophenotype in human serotonin research with the potential to associate 
the causal pathway from genetic variation to the phenotypes (Hensch et al., 2006). Several psychiat-
ric disorders that are characterized by the presence of a dysfunctional serotonergic activity are linked 
to single nucleotide polymorphisms (SNPs) of the serotonergic system (Strobel et al., 2003) and 
therefore a potential association between LDAEP and genetic variants of the serotonergic system is 
of great interest. So far, SNPs of the 5-HT1B receptor (Juckel, Hegerl, et al., 2008) and the serotonin-
transporter-linked promoter region (5-HTTLPR) (e.g. Gallinat et al., 2007; Hensch et al., 2006; 
Juckel, Hegerl, et al., 2007; Strobel et al., 2003) have been associated with the LDAEP, but with 
contradictory findings. This is probably due to limited effect sizes and methodological variations 
(Hitz, Wyss, Hengartner, & Kawohl, in preparation). However, further candidate genes, such as the 
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Catechol-O-Methyltransferase (COMT)-gene (Juckel, Kawohl, et al., 2008), the nitric oxide synthase 
(NOS1, NOS3)-genes (Kawohl, Giegling, et al., 2008) that are linked with the dopaminergic system 
and the brain derived neurotrophic factor (BDNF)-gene (Juckel et al., 2010) have been investigated 
in association with the LDAEP. These genetic studies point out that the LDAEP may also underlie 
influences by other changes in neurotransmission. For further discussion of this issue refer to chapter 6.3. 
2.2 Overview of methodologies used in LDAEP research 
The variety of the methodologies applied in LDAEP research is manifold. This limits the compara-
bility of the stated results across the field and leads to inconsistent findings. Furthermore, to be 
applied as a biomarker in future clinical use, it is mandatory to define optimal parameters best used 
in the implementation and analysis of LDAEP studies, thereby enhancing the reliability of the 
LDAEP. Variety in the LDAEP methodology emerges with respect to stimulus properties, demo-
graphic and habitual characteristics, and parameters of LDAEP. The following section gives an 
overview of potential pitfalls to consider when planning an experiment. 
In terms of stimulus properties, differences between studies can be mainly observed in the different 
use of stimulus intensity, initial intensity level, number of intensity levels, interstimulus interval 
(ISI), order of stimuli presentation and frequency of the tones. Beauducel et al. (2000) investigated 
the reliability of the LDAEP and proposed that stimulus intensity should vary between 60 and 95 dB 
sound pressure level (SPL) with at least five different intensity levels. However, the range of 
intensities used in LDAEP studies varies between two and six different intensities. Another group 
found increased reliability with higher intensity levels, but they pointed out that it is unclear whether 
the results would remain stable if one high intense tone were to be repeatedly presented or the same 
tone embedded in a range of other intensities (Hensch et al., 2008). The optimal sweeps, i.e. aver-
aged epoches per intensity, should be around 100 to achieve sufficient signal-to-noise ratio (SNR), 
but time-on-task effects such as increasing slowdown, habituation, boredom and fatigue must be 
considered and could vary between patient samples (Hensch et al., 2008). For a more detailed 
description of EEG methodology please refer to chapter 4.1. There is evidence that the initial 
intensity level (30 or 70 dB SPL) affects the growth in N1 amplitude with increasing intensity (Uhl et 
al., 2011). Moreover, the reference level of the presented stimuli varies in LDAEP studies and 
individual’s hearing thresholds are mostly disregarded. Besides the most commonly used physical 
reference, referred to as sound pressure level (SPL), there exist audiometric references relative to 
normal hearing threshold (HL) or to the individual’s hearing level (SL) (Picton et al., 2000). Some 
studies reported that when the stimulation rate is increased (ISI>4s), further generators, presumably 
in modality unspecific areas underlying the N1 component, are represented in the recorded waveform 
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(Budd, Barry, Gordon, Rennie, & Michie, 1998; Hari, Kaila, Katila, Tuomisto, & Varpula, 1982; 
Näätänen & Picton, 1987). These additional sources could contribute to the scalp derived potentials 
and may mislead interpretation of what is measured (for further information refer to chapter 5.2). 
Furthermore, it must be considered that the order of presentation of the tones (randomised, pseudo-
randomised or in a block) may have an influence on the subject’s perception, for instance by 
enhancing attention to a specific tone that is out of range and this may lead to a pronounced response 
(Carrillo-de-la-Pena, 1999; Zacharias, Konig, & Heil, 2012). Soeta and Nakagawa (2001; 2011) 
investigated the effects of different stimulus frequencies (250 Hz, 1000 Hz, >1000 Hz) on the 
loudness dependent slope of a continuous tone (1000 ms) and reported a lower increase in amplitude 
with higher frequencies. 
Regarding demographic and habitual characteristics, most studies on the LDAEP included both 
men and women in the sample and gender was not considered a confounding influence. However, a 
gender effect has been observed in recent studies indicating a stronger LDAEP in healthy females 
than males (Oliva et al., 2011), which is in line with findings of reduced mean rates of serotonin 
synthesis in females (Nishizawa et al., 1997). Hormonal fluctuations across the menstrual cycle or 
due to contraceptive use may have additional influences on auditory evoked potentials (Walpurger, 
Pietrowsky, Kirschbaum, & Wolf, 2004). These results are in line with the findings of another study, 
where lower variances in the LDAEP values were reported for men (Hensch et al., 2008). Another 
factor that has to be accounted for is nicotine use, as it was demonstrated to have an effect on sensory 
response in mice (Metzger, Maxwell, Liang, & Siegel, 2007) and also on the LDAEP (Gallinat et al., 
2005). However, nicotine use was not associated with genetic traits and is thought rather to be a state 
dependent factor.  
The parameterization of the LDAEP varies highly between the studies. On the one hand, there are 
several ways to calculate the ASF as well as to choose the AEP-components (for a description of the 
different possibilities of doing so, refer to chapter 2.1.1). On the other hand, some studies reported 
scalp potentials from mostly midline electrodes (Fz, Cz), whereas others implemented source 
analysis of the PAC. In the following section these analysis methodologies are shortly summarized 
with regard to reliabilities. 
In single electrode estimation, features such as amplitude or latency are analysed only at electrode 
channels of interest or channels at which the feature is maximally expressed. This method is most 
commonly used in LDAEP research, which might be due to its ease of use, as single electrode 
estimation is the simplest and most rapidly completed procedure (Carrillo-de-la-Pena, 1999; Hensch 
et al., 2008).  
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The problem which occurs with scalp-recorded data is that the true brain sources are unknown and 
only a mixture of activity from different generators including non-cerebral (e.g muscle or ocular) 
artefacts is represented on the scalp (McLoughlin et al., 2013). Hensch et al. (2008) focussed on the 
reliability of these parameters in LDAEP and reported satisfying retest, odd-even and split-half 
reliabilities after three weeks for Cz, C3 and C4 electrodes (r = .60-.90). The highest reliabilites were 
reported at Cz with linear slopes (females r = .88, males r = .82). Accordingly, using principal 
component analysis (PCA) to accurately identify the independent event-related potentials (ERP) 
components, the N1/P2 slopes and the P2 slope compared to P1, N1 and P1/N1 slopes reached high 
temporal stability (Beauducel et al., 2000). These findings are in line with reliability measurements 
over one year that reached good reliabilities (r = .60-.80) for the N1/P2 slopes at Fz and Cz (Carrillo-
de-la-Pena, 2001). What makes comparisons difficult is that studies in LDAEP research evaluated 
different components, namely P1, N1, or P1-P2 (e.g. Gudlowski et al., 2009; Linka, Sartory, Gastpar, 
Scherbaum, & Müller, 2009). 
The initial theory of LDAEP by Hegerl and Juckel (1993) suggests that the ideal methodological 
assessment strategy is to assess the loudness dependence in the PAC (for a detailed argumentation 
see Hegerl et al, 1994)  . Comparable to scalp channel measures, the retest-reliabilities (after three 
weeks and one year) of N1/P2 slopes for dipoles obtained with brain electric source analysis (BESA) 
are excellent, especially for tangential dipoles (r = .88), which are thought to reflect activity in the 
PAC. Individual differences in skull thickness or cortical folding may account for the variability of 
the brain signal measured at the scalp. Thus source localisation could be used to counteract these 
influences (Luck et al., 2011). Source analysis techniques such as BESA and low resolution electro-
magnetic tomography (LORETA) are ideal tools for this purpose (for a description see chapter 4.2).  
2.3 Underlying sources in loudness perception 
In the quest for an informative biomarker, it is inevitable to improve the validity of the candidate 
marker. In order to specify whether the LDAEP measures what it claims to measure, the underlying 
mechanisms must be elucidated and integrated into existing knowledge about sensory processing and 
cognitive functions. Especially when analysing single electrode sites or setting dipoles to represent 
the brain sources a priori, extensive knowledge of the brain regions which are involved in loudness 
perception is necessary. Additionally, the generators activated may depend on the context the stimuli 
are presented in (e.g. ISI, intensity level) (see chapter 2.2). The involvement of the supratemporal 
plane in the generation of LDAEP as proven by EEG, fMRI and magentoecenphalography (MEG) is 
beyond controversy (Jäncke, Shah, Posse, Grosse-Ryuken, & Müller-Gärtner, 1998; Mulert et al., 
2005; Neukirch et al., 2002; Wood et al., 1984). Moreover, it has been reported that subcortical areas 
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are involved in auditory processing and show sensitivity to different intensity levels (W. T. Roth, 
Horvath, Pfefferbaum, & Kopell, 1980). Although the N1 and P2 components are exogenous 
components (thought to be modulated only by physical characteristics of the stimulus) an unspecific 
component is assumed to contribute to the measured signal. It is ambiguous whether this unspecific 
component is related to higher cognitive functions such as orientation of attention linked to the 
execution of motor response (Hari et al., 1982; Näätänen & Picton, 1987). 
2.4 Schizophrenia: Uncertainties about phenotypic definition in psychiatry 
Schizophrenia is a chronic mental illness characterized by disturbances in thought, perception, affect, 
behavior, and communication. About one percent of the world’s population is affected during their 
lifetime (Perala et al., 2007) and their symptoms often lead to impaired functional outcome, resulting 
in poor success in social and professional life (Rössler, Salize, van Os, & Riecher-Rössler, 2005). 
The current diagnostic system (DSM-V; American Psychiatric Association, 2013) contains a broad 
spectrum of symptoms required for schizophrenia, which can be roughly categorized as positive and 
negative symptoms (Andreasen et al., 1994). Positive symptoms are core features of the illness and 
include hallucinations, delusions and formal thought disturbances. They are most often accompanied 
by negative symptoms that indicate a deficit in normal mental functions and consist of affective 
flattening, alogia (impoverishment of the language), avoliation (reduced emotional expression), 
anhedonia (inability to experience pleasure) and attentional impairment (Andreasen & Black, 2001). 
Supposedly, negative symptoms have a more stable developmental course than positive symptoms 
and appear to be present at the prodromal as well as the residual state of the disease (Davidson & 
McGlashan, 1997). Primary negative symptoms are directly related to the disease process itself and 
secondary negative symptoms occur as a result of the illness or because of medication side effects 
(Kirkpatrick, Fenton, Carpenter Jr., & Marder, 2006). Importantly, with contemporary measurements 
of psychopathology, it is not possible to distinguish primary from secondary negative symptoms 
(Lindenmayer, Harvey, Khan, & Kirkpatrick, 2007).  
It is still a matter of debate whether the current diagnostic criteria for schizophrenia are useful for 
neuroscientific research (Hyman, 2007). First, the inherently heterogeneous symptom presentation of 
schizophrenia leads to different symptom constellations subsumed under the same diagnosis, hence 
the biological processes may also differ substantially. Second, the traditional diagnostic system only 
allows categorizing of the disorders in entities being either ill or healthy, not allowing for the 
characterization of gradations of disease severity within a category (McLoughlin et al., 2013). A 
wide community of researchers propose a dimensional approach based on symptom clusters to 
provide a better perspective on phenomenology of psychopathology, because it considers symptom 
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patterns that share neurobiological, genetic and developmental features (e.g. negative symptoms or 
disorganized speech) (Barch et al., 2013). In schizophrenia research, however, some symptoms, 
namely delusions and hallucinations have been observed in a continously distributed fashion in the 
general population (Rössler et al., 2007). Nonetheless, in the currently released 5th edition of the 
DSM, a dimensional approach was not considered (American Psychiatric Association, 2013).  
Concomittant to these shortcomings, it is not surprising that the exact pathophysiology of schizo-
phrenia still remains fragmented (Tandon, Keshavan, & Nasrallah, 2008). The dopamine model is the 
predominant approach to explaining the prevalent symptoms as an imbalance of dopaminergic 
neurotransmission. It is supposed that an excess activation of subcortical dopamine D2-receptors is 
responsible for positive symptoms, whereas a hypoactivation of cortical dopamine D1-receptors leads 
to negative and cognitive symptoms (K. L. Davis, Kahn, Ko, & Davidson, 1991; Knable & 
Weinberger, 1997). The fact that atypical neuroleptics develop their pharmacologic effects via the 
dopaminergic and serotonergic system likewise, lead to the extension of the dopamine hypothesis 
(Meltzer, 1999). Serotonin ought to reinforce the imbalance in the mesolimbic-mesocortical path-
way. The probable involvement of several neurotransmitter systems in the pathophysiology of 
schizophrenia strengthens the assumption of multiple underlying aetiologies in this clinical diagno-
sis. Moreover, it has been reported that the administration of ad-on SSRIs to a subgroup of patients 
suffering predominantly from negative symptoms leads to a relief of symptoms (Sepehry, Potvin, 
Elie, & Stip, 2007).  
A potential clinical value of the LDAEP as a biomarker for serotonergic activity would be that 
subgroups of patients could be identified and treatment decisions could be adapted (Fitzgerald et al., 
2009; Linka, Sartory, Gastpar, et al., 2009). So far, only a few studies have assessed the LDAEP in a 
schizophrenic sample, and most have focused on diagnostic categories. Patients with a diagnosis of 
schizophrenia (Juckel et al., 2003; Juckel, Gudlowski, et al., 2008; Park et al., 2010) or at-risk for 
schizophrenia (Gudlowski et al., 2009) showed weaker LDAEP values than healthy subjects, 
supporting the hypothesis of higher serotonergic levels in schizophrenia. Furthermore, the LDAEP 
normalized to levels found in healthy subjects after a 4-week treatment with 5-HT2 antagonists 
clozapine or olanzapine (Juckel, Gudlowski, et al., 2008). One study by Ostermann et al. (2012) did 
not find any significant group differences between patients with schizophrenia and healthy subjects 
regarding LDAEP. Only by considering the symptom dimensions, did patients with schizophrenia 
spectrum disorders show positive correlations of LDAEP with depression, paranoid ideation, and 
psychoticism (Ostermann et al., 2012). 
Therefore, study I (chapter 5.1) focused on LDAEP and its relationship to the symptom dimension, 
specifically in patients with chronic schizophrenia suffering mainly negative symptoms.  
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3. Aims and research questions 
The primary aim of this dissertation was to increase our understanding of the problems related to the 
validation of the LDAEP as a proposed biomarker for central serotonergic activity.  
The motivation for this aim is based on previous research focusing on strategies and suggestions to 
yield clinically relevant biomarkers. Although the LDAEP has been proposed to be a valid marker 
with predictable power for the serotonin neurotransmitter system, the review of the pertinent research 
literature identified the following research gaps. 
On the one hand, the validation of the LDAEP is compromised when applied to currently used 
diagnostic categories because they subsume clinical entities of very different aetiologies and 
pathophysiologies under the same heading. As a result, previous research investigating the LDAEP 
across patient samples with the same psychiatric diagnosis showed partially contradictory findings. 
In schizophrenia, both increased and equal serotonergic levels compared to healthy subjects were 
found (Juckel, Gudlowski, et al., 2008; Ostermann et al., 2012; Park et al., 2010). This could be due 
to differential biological processes underlying schizophrenia that manifest in positive and negative 
symptoms and can be explained by a dysfunctional dopaminergic as well as serotonergic system. 
However, the LDAEP as a biomarker can be used as a powerful tool to represent the biological 
pathways of brain function and disentangle subsamples of psychiatric disorders more sensitively and 
specifically than the clinical phenotype. But this problem has to be accounted for by the use of 
dimensional measures of psychopathology or on measures that record the individual symptoms. In 
the first study, we therefore applied the LDAEP paradigm to a psychiatric sample suffering from 
schizophrenia, in due consideration of defined subgroups of negative and positive symptoms within 
this diagnostic group. 
On the other hand, the neurobiological mechanisms of the LDAEP are not fully elucidated. It is 
particularly unclear which neural generators contribute to the EEG waveforms elicited at the scalp 
during the auditory N1/P2 component. In order to correctly apply the analysis methods such as 
dipole source analysis or single electrode estimation, the sources underlying loudness perception 
must be known. Only then can the main claim to what’s being measured be satisfactorily met. 
Moreover, the variety of methodologies used in LDAEP analysis complicates the interpretation and 
comparability of the results. Thus, the second study focused on the investigation of the temporal 
activation patterns of the generators involved in loudness perception by means of a distributed source 
model using MEG. The findings of this study may clarify the underlying mechanisms of the LDAEP 
and potentially improve the accuracy, i.e. validity of the LDAEP. 
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4. Methods 
The following sections give a brief introduction into the methods used in the two studies presented in 
this thesis investigating the LDAEP, namely electroencephalography (EEG) and magnetoenceph-
alography (MEG). These electrophysiological measures are ideal for examining the function of the 
auditory cortex, because they do not emit acoustic noise themselves, as would be the case in fMRI 
for example. EEG and MEG directly reflect the brief, transient changes in neural activity generated 
through postsynaptic potentials, whereas fMRI measures the hemodynamic response that can only be 
viewed as an indirect measure of neural activity. Another favourable advantage is its excellent time 
resolution in the range of milliseconds, providing insight into the temporal dynamics of brain 
processes (Hansen, Kringelbach, & Salmelin, 2010; Jäncke, 2005).  
4.1 Electroencephalography (EEG) 
EEG recordings of electrical activity of the human brain are traditionally acquired with electrodes 
placed on the scalp. These electrodes record the summation of tens of thousands nerve cell potentials 
in large populations of neurons spreading passively throughout the brain, as well as cerebrospinal 
fluids, skull and the scalp. The oscillations of brain electric potentials result from chemical processes 
that trigger charges in the membranes. During the transmission of a signal from one neuron to 
another, neurotransmitters are released in the synaptic cleft to exhibit or inhibit the target neuron. 
Glutamate and gamma-aminobutyric acid (GABA) are the main neurotransmitters involved in the 
generation of excitatory - and inhibitory postsynaptic potentials (EPSP/IPSP), whereas serotonin, 
dopamine, and acetylcholine have a regulative effect on the reagibility of these neurons (Kandel, 
Schwartz, & Jessell, 2000). The resulting shift of electrical charges along the cell membranes causes 
a sink-source configuration in the extracellular medium around the neuron (called passive ohmic 
current or volume current) that acts as a small dipole, which is derived on the cortical surface. Since 
the current of a single nerve cell would be too small to be detected at the surface of the scalp, an 
EEG signal reflects the activation of synchronized assemblies of parallel-organized cortical pyrami-
dal cells (Jäncke, 2005; Michel, 2009).  
A powerful tool in neuroscience consists of ERPs, which are derived from on-going EEG activity, 
averaged over a series of trials, triggered by the same event (such as the presentation of an auditory 
stimulus) (Walter, Cooper, Aldridge, McCallum, & Winter, 1964). The on-going EEG reflects a 
wide-range of neural activity that simultaneously regulates sensory and cognitive functions, but also 
physiological processes. The response of a single sensory stimulus is not visible in the EEG record-
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ing, because it is intermixed with noise (background brain activity) and overlaid by stronger physio-
logical signals. By means of averaging several epochs that are time-locked to the stimulus, any 
random fluctuations will cancel each other out and an increased SNR for the signal of interest can be 
achieved (Fabiani, Gratton, & Coles, 2000). This is the traditional view to explain the generation of 
ERPs. An alternative hypothesis claims that ERPs depend on spatial synchronization of underlying 
neural activity (Makeig et al., 2002; Musall, von Pföstl, Rauch, Logothetis, & Whittingstall, 2014; 
Sauseng et al., 2007). At rest, the on-going oscillation activity produces signals that are out of phase. 
During stimuli presentation the phases of this on-going activity are resetted by the stimuli, resulting 
in a phase-coherent rhythm that can be detected in an ERP (Makeig et al., 2002).  
Only the ERPs relevant to this thesis will be discussed, namely the long latency auditory evoked 
potentials. The most common N1 and P2 components appear approximately 100 ms and 200 ms, 
respectively, after the presentation of a stimulus (see Fig. 1, panel B). According to a traditional 
definition they are called exogenous components and are presumed to primarily reflect basic 
processing, dependent upon characteristics of the external stimulus (e.g. intensity level). However, 
they are also called transient exogenous components, similar to endogenous components, because 
internal cognitive processing (e.g. attention) influences their amplitude (Fabiani et al., 2000; Jäncke, 
2005). 
Although the time resolution capabilities of EEG, in comparison to PET or fMRI, are exceptional, 
there is a basic limitation regarding the determination of the sources generating neural activity. The 
exact reconstruction of the location and distribution of neural generators is not conclusive, and this is 
commonly referred to as the inverse problem (Jäncke, 2005). Theoretically, an infinite number of 
solutions may result from inferring the generating sources of the known scalp distribution. Only the 
introduction of constraints on the possible solutions can solve this problem. In order to improve the 
source estimations, mathematical advances during the last decades have been used to develop some 
models with appropriate assumptions. These inverse solution algorithms range from dipole source 
analysis to distributed source models that allow a three-dimensional map of the brain (Michel et al., 
2004). 
4.2 Source imaging 
This section describes some of the currently available source localization approaches in EEG and 
MEG. Dipole source analysis is most commonly used to measure the LDAEP and was applied in 
study I included in this thesis (see chapter 5.1). The LORETA approach is also adopted in LDAEP 
research, albeit less commonly (Jaworska, Blier, Fusee, & Knott, 2012; Jaworska et al., 2013; 
Mulert, Juckel, Augustin, & Hegerl, 2002; Mulert et al., 2007; Park, Kim, Kim, Im, & Lee, 2011). 
Methods 
18 
Finally, magnetic field tomography (MFT) is a distributed source analysis with minimal priors and 
most appropriate for exploring the underlying sources in loudness perception. Therfore, the MFT was 
applied in study II (see chapter 5.2). 
4.2.1 Dipole source analysis (DSA) 
The main principal of DSA is to specify a small number of sources in a model and test if the result-
ing scalp potential fits the original measurements. The analysis uses an iterative process to find the 
best-fitting location of the dipoles that contribute to the scalp potentials that are actually measured, 
with the lowest residual variance. The projection of neuronal activity from the sources to the surface 
that reverts to physical assumptions is straightforward (the so-called forward model) (Michel et al., 
2004; Scherg, 1990). Because the electric signal travels through the whole brain, the different 
conductivities of the tissues (brain, CSF, skull and scalp) must be included in the model. Besides 
some simplified head models that approximate the head with a sphere of homogeneous conductivity 
or with several spherical shells with different conductivities, more realistic models from individual 
MRT-scans are used (Jäncke, 2005). The brain electrical source analysis (BESA) software developed 
by Scherg and Von Cramon (1986) is based on spatiotemporal multiple dipole modelling of discrete 
sources that can be modelled over a period of time rather than just at one instant. Additionally, this 
approach considers the orientation of the source (tangential or radial) and allows disentanglement of 
the overlap inherent in scalp potential waveforms. This is especially advantageous in separating the 
primary and secondary auditory cortex when analysing the LDAEP (Hegerl & Juckel, 1993). A 
crucial issue when using dipole models is to assume the correct number of sources. This is mainly 
based on physiological knowledge. In LDAEP research, for example, two dipoles are set in the 
auditory cortex of each hemisphere representing the primary and secondary auditory cortex (for an 
explanation of the detailed procedure refer to Hegerl et al. (1994)). However, a third contributing 
source is assumed to improve the residual variance of the model (Bruneau, Roux, Garreau, & Lelord, 
1985; Näätänen & Picton, 1987) and was implemented in the BESAs tutorial on “AEP experiment on 
intensity dependence” by Scherg and Hoechstetter (2009). In study I presented in this thesis the 
expanded dipole model with three dipoles was applied and in study II the physiological basis for 
these assumptions was explicitly treated. 
4.2.2 Low resolution electromagnetic tomography (LORETA) 
Although the following source analysis was not applied in the studies presented in this thesis, but 
was implemented in some studies examining the LDAEP, a short description of its main assumptions 
is given in the following sections. 
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LORETA (Pascual-Marqui, Michel, & Lehmann, 1994) is a distributed source model that has the 
advantage of not being dependent on a priori assumptions about the underlying sources. This means 
that the solution is minimally biased by the experimenter and each point in a 3D grid is considered as 
a possible location of a current source. In principle, the inverse solution can be calculated for each 
voxel in the brain millisecond by millisecond. Unfortunately, according to the inverse problem 
different constellations of solution points can lead to the same distribution of electrical potentials at 
the scalp. Indeed, the LORETA approach implements mathematical constraints based on physiologi-
cal principles that state that the activity of neightbouring neurons is similar. An exact description of 
the mathematical algorithm can be found in Pascual-Marqui (1999). Studies that investigated the 
LDAEP by means of the LORETA approach in order to directly obtain the activity in the PAC 
implemented the probabilistic maps by Penhune, Zattore, MacDonald, & Evans (1996) to define their 
regions of interests.  
4.2.3 Magnetic field tomography (MFT) 
Similar to LORETA, the magnetic field tomography (MFT) is based on the minimum norm (MN) 
algorithm originally proposed by Hämäläinen and Illmoniemi (1994). MFT is able to identify 
multiple sources at a time, and provides probabilistic estimates for the primary current density within 
the subject’s brain for each time slice independently (Dammers & Ioannides, 2000; Ioannides, 
Bolton, & Clarke, 1990). Notably, the MFT allows the detection of superficial as well as deeper 
generators in the brain without fixing the number of generators a priori. The capability of reproduc-
ing sources from deeper structures is possible because in contrast to the MN approach, the MFT 
additionally uses a non-linear weighting function that favours the solution that was initially found. 
Further, the reconstruction of these initial values improves due to an iterative process. The detailed 
mathematical algorithm is described in Ioannides et al. (1995). Moreover, MFT results can easily be 
assigned to anatomical structures when combined with MRI anatomical scans. The resulting 4D 
spatio-temporal profiles can then be entered in statistical analyses similar to the ones proposed for 
fMRI. In our case we used Monte Carlo permutation testing, implemented in FSL (FMRIB's Soft-
ware Library, www.fmrib.ox.ac.uk/fsl). This test is a subset of non-parametric statistics and assumes 
no parametric distribution. The standard approach to permutation tests is to exchange the units of the 
observed data points to obtain the distribution of the test statistic under the null hypothesis. The 
randomized samples can then be fitted to a general linear model to test the linear combination of 
explanatory variables (e.g. 4D responses to presented auditory stimuli). In order to assess the 
neuronal activity between different experimental conditions, i.e. intensity levels, a t-statistic can be 
calculated. A further advantage of permutation testing is that it allows an exact control of the family-
wise error (FWE) rate. This is very important in multiple comparisons because when using a 
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conventional alpha threshold (typically 5%) in a data set containing thousands of voxels, the proba-
bility of false positives will increase enormously (Nichols & Holmes, 2002; Pantazis & Leahy, 
2010).  
4.3 Comparison of EEG and MEG 
In principle, EEG and MEG measurements result from the same type of brain activity. The magnetic 
field recorded in MEG is evoked by the electrical activity of the postsynaptic intracellular and 
extracellular currents in pyramidal cells, whereas in EEG mainly extracellular currents contribute to 
the signal (Hämäläinen, Hari, Ilmoniemi, Knuutila, & Lounasmaa, 1993). Compared to EEG, the 
spatial resolution of MEG is superior, because the cerebral and extracerebral tissues are transparent 
to magnetism and thus the attenuation of the signal is merely minimal (Dammers & Ioannides, 2000). 
Furthermore, no reference point is needed in MEG analysis, whereas in EEG the choice of a refer-
ence electrode is essential. In contrast to EEG that is sensitive to tangentially and radially oriented 
sources, MEG is mostly sensitive to tangentially oriented dipoles (Ahlfors, Han, Belliveau, & 
Hämäläinen, 2010). In other words, sources that are oriented perpendicular (radial) to the overlying 
skull (e.g. the top of a gyrus) evoke a magnetic field that is parallel to the sensors and which is not 
detectable (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Schema of a part of the cortex showing a sulcus and two gyri. Sources at the top of a gyrus cause 
radial components evoking a radial magenetic field that are not detectable by MEG. Adapted from An 
introduction to the event-related potential technique (p. 30), by S. J. Luck, 2005, Cambridge, MA: MIT 
press. Copyright 2005 by Massachusetts Institute of Technology.  
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However, when superficial and tangential sources (e.g. within a sulcus) are targeted, the sources can 
be localized with more accuracy than with EEG, because the signal is contaminated less by disturb-
ing signals. As all primary sensory areas are located on the wall of a sulcus, MEG has been widely 
used to study processes in the somatosensory and auditory systems (Hämäläinen et al., 1993). 
Besides these inherent difficulties, the costs of maintenance and the facility to run an MEG are rather 
high. However, technological advances promise some cost-effective alternatives, for example by 
replacing the liquid helium, used for cooling the sensors, with liquid nitrogen (Dammers et al., 
2014). 
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5.1.1 Abstract 
Besides the influence of dopaminergic neurotransmission on negative symptoms in schizophrenia, 
there is evidence that alterations of 5-HT system functioning also play a crucial role in the patho-
physiology of these disabling symptoms. From post mortem and genetic studies on patients with 
negative symptoms a 5-HT dysfunction is documented. In addition atypical neuroleptics and some 
antidepressants improve negative symptoms via serotonergic action. So far no research has been 
done to directly clarify the association between the serotonergic functioning and the extent of 
negative symptoms. Therefore, we examined the status of brain 5-HT level in negative symptoms in 
schizophrenia by means of the loudness dependence of auditory evoked potentials (LDAEP). The 
LDAEP provides a well established and non-invasive in vivo marker of the central 5-HT activity. We 
investigated 13 patients with schizophrenia with predominant negative symptoms treated with 
atypical neuroleptics and 13 healthy age and gender matched controls with a 32-channel EEG. The 
LDAEP of the N1/P2 component was evaluated by dipole source analysis and single electrode 
estimation at Cz. Psychopathological parameters, nicotine use and medication were assessed to 
control for additional influencing factors. Schizophrenic patients showed significantly higher 
LDAEP in both hemispheres than controls. Furthermore, the LDAEP in the right hemisphere in 
patients was related to higher scores in scales assessing negative symptoms. A relationship with 
positive symptoms was not found. These data might suggest a diminished central serotonergic 
neurotransmission in patients with predominant negative symptoms.  
5.1.2 Introduction 
Negative symptoms are core features of schizophrenia and are generally considered in psychiatric 
scales (Andreasen, 1989) and diagnostic classification, e.g. in the DSM-IV-TR (American 
Psychiatric Association, 2000). These symptoms describe a deficit or an absence of normal mental 
functions and have traditionally been considered to consist of affective flattening, alogia, avolition, 
anhedonia and attentional impairment (Andreasen, 1982). Research in this field has characterised 
negative symptoms to occur as accompanying symptoms of positive symptoms (e.g. hallucinations, 
delusion and formal thought disturbances) and both in the prodromal and residual state of the 
disease. They are named primary negative symptoms if directly related to the disease process itself 
and not resulted in a secondary action from other psychiatric symptoms or medication side effects 
(Kirkpatrick et al., 2006). Negative symptoms often lead to social impairment, resulting in poor 
success in social and professional life and account for much of the long-term morbidity and poor 
functional outcome of patients with schizophrenia (Häfner, Löffler, Maurer, Hambrecht, & an der 
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Heiden, 1999; Rössler et al., 2005). Despite that, the pathophysiology of negative symptoms has 
been widely unknown so far. 
Schizophrenia research on biochemical functions has largely focused on the dopamine neurotrans-
mitter system. The dopamine-hypothesis based on imaging studies proposes an imbalance of cortical 
and subcortical preponderance of dopaminergic neurotransmission, where a subcortical hyperstimu-
lation of dopamine D2-receptors leads to positive symptoms, and a hypoactivation of cortical 
dopamine D1-receptors leads to negative and cognitive symptoms (K. L. Davis et al., 1991; Grace, 
1991; Knable & Weinberger, 1997; Weinberger, 1987). However, the theory of a serotonin (5-HT) 
and dopamine interaction as the mechanism behind schizophrenia has gained more acceptance. 
Moreover, there is evidence that the serotonin system inhibits dopamine function in frontal cortex 
and reinforces the imbalance in the mesolimbic-mesocortical pathway of the dopaminergic system 
(Abi-Dargham, 2007; Breier, 1995; Kapur & Remington, 1996; Meltzer, 1989; B. Roth & Meltzer, 
2000). The involvement of the serotonergic system in this theory is due to the fact that atypical 
neuroleptics (J. M. Davis, Chen, & Glick, 2003; Leucht, Heres, Kissling, & Davis, 2011; Miyamoto, 
Duncan, Marx, & Lieberman, 2004) and antidepressants (Rummel-Kluge, Kissling, & Leucht, 2006; 
Silver, 2004; S. P. Singh, Singh, Kar, & Chan, 2010), which act via the serotonergic system, show 
remarkable potency for the treatment of negative symptoms. Meltzer (1999) specifies that 5-HT2A 
receptor antagonism and 5-HT1A partial agonism together with weak dopamine D2 receptor antago-
nism are responsible for the principal pharmacologic effects of atypical neuroleptics on negative 
symptoms. An addendum to the former concept was that this new hypothesis allows explaining the 
heterogeneity of schizophrenia even better. Since a single type of abnormality of the neurotransmitter 
systems is unlikely to emerge as characteristic of all patients with schizophrenia. To sum up, there is 
evidence that the serotonergic system is a key component in the pathogenesis of negative symptoms. 
The serotonin system plays an important role in pathophysiology of the major psychiatric disorders 
and provides a target of pharmacotherapeutic interventions. Therefore reliable indicators of this 
system are in urgent need for clinical and scientific interest (Hegerl & Juckel, 2000). Such indicators 
could be used after overcoming some challenges concerning the implementation in daily clinical use 
to identify patients with serotonergic dysfunctions and thus serve as therapy predictors (Hegerl et al., 
2001; Juckel, Pogarell, et al., 2007). In fact, common indicators of the serotonin system are mainly 
indirect peripheral parameters that only give an approximate indication of the central serotonergic 
system. Such methods as neuroendocrinological challenge tests, measuring concentrations of 
serotonin metabolites in cerebrospinal fluid and tryptophan depletion test have not been proven to be 
sufficiently valid (Juckel, 2005). Furthermore, the use of imaging techniques that allow to reflect the 
availability of binding potentials of serotonin transporter (SERT) or 5-HT receptors, such as positron 
emission tomography (PET) (Quednow et al., 2012) and single photon emission computed tomogra-
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phy (SPECT), are not appropriate for daily clinical use because of their invasive properties (B. Roth 
& Meltzer, 2000). 
In the continuing search for biological correlates of psychiatric disorders, evoked potentials now 
constitute a prime target of investigation. In particular, the loudness dependence of auditory evoked 
potentials (LDAEP) has been widely reported to be a valid measure of central serotonergic activity in 
humans (Hegerl et al., 2001; Hegerl & Juckel, 1993, 1994; Kawohl, Hegerl, Müller-Oerlinghausen, 
& Juckel, 2008; I. H. Lee et al., 2011; O'Neill, Croft, et al., 2008). This measure represents a growth 
of the amplitude in primary auditory cortices, measured from the peak of the N1 to the peak of the P2 
component along with an increase in sound pressure level (Fig. 3A). A pronounced LDAEP suppos-
edly reflects a low central serotonergic neurotransmission and vice versa. Some other reports have 
suggested that the interpretation may be more complex and the LDAEP’s specificity as a marker of 
serotonin function has been challenged (Hitz et al., 2011; Juckel, Kawohl, et al., 2008; Kawohl, 
Giegling, et al., 2008; O'Neill et al., 2007). 
 
 
              
Fig. 3. A) Example of loudness dependence of auditory evoked potential (LDAEP). Auditory evoked 
activity of the tangential dipole in the right hemisphere following auditory stimulation of a 1000 Hz tone 
with different sound pressure levels (60 to 100 dB SPL) over all subjects (n=26). B) Dipole sources of 
auditory evoked potentials localized in primary auditory cortex. 
 
A significant body of research documents a weaker LDAEP in patients with schizophrenia compared 
to healthy controls, thus indicating increased serotonergic activity in patients (Gudlowski et al., 
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2009; Juckel et al., 2003; Juckel, Gudlowski, et al., 2008; Park et al., 2010). But this research to date 
has tended to focus on the diagnosis of schizophrenia, neglecting the clinical heterogeneity. Howev-
er, it is of great interest to investigate schizophrenia on the psychopathological symptom level. Thus, 
the aim of the current study is to scrutinize the putative role of serotonergic neurotransmission of 
negative symptoms in schizophrenia.  
5.1.3 Methods  
5.1.3.1 Subjects 
The sample included 26 male subjects (13 patients, 13 controls) who underwent electrophysiological 
recording. Subjects with psychiatric comorbidity, drug or alcohol abuse, benzodiazepine consump-
tion for more than 10 days before examination or a lifetime history of neurological diseases were 
excluded. Thirteen patients with predominant negative symptoms recruited from the Department of 
General and Social Psychiatry at the Psychiatric University Hospital Zurich met the diagnostic 
criteria for chronic paranoid schizophrenia in accordance to ICD-10 (World Health Organization, 
1993). The psychopathological state of all patients was rated based on the Positive and Negative 
Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987) and the Scale for Assessment of Negative 
Symptoms (SANS; Andreasen, 1989). To differentiate depressive symptoms from negative symp-
toms, Hamilton Depression Rating Scale (HAMD; Hamilton, 1960), Bech-Rafaelsen Melancholia 
Scale (BRMS; Bech & Rafaelsen, 1980) and Calgary Depression Rating Scale for Schizophrenia 
(CDSS-G; Addington, Addington, & Schissel, 1990) were applied. All patients were using atypical 
antipsychotics during the test period. Dosages were transformed into chlorpromazine (CPZ) equiva-
lent values for comparative reasons (Möller, Müller, & Bandelow, 2001). Thirteen healthy, age- and 
gender-matched volunteers recruited from medical staff and students served as the control group. 
Controls with a lifetime history of any psychiatric disorder were excluded.  
5.1.3.2 Ethics statement 
The study was approved by the special subcommission for psychiatry of the ethics committee of the 
canton of Zurich (“SPUK ZH Psychiatrie”) under the title "Die Rolle der zentralen serotonergen 
Aktivität bei Negativsymptomen" (Ref.-Nr.: E-19/2006) and was carried out in accordance with the 
Declaration of Helsinki. All subjects have given written informed consent. Only participants with 
uncompromised capacity to consent were approached. The capacity to give consent had been 
established by the senior consultant psychiatrists responsible for the treatment of the patients.  
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5.1.3.3 Electrophysiological assessment  
Subjects were seated with their eyes open in a quiet room adjacent to the recording apparatus and 
were asked to avoid facial muscle movements throughout the auditory stimulus presentation se-
quence and the recording. As attention to the auditory stimuli has been shown to modulate the 
auditory evoked potentials (Schechter & Buchsbaum, 1973) and therefore also the LDAEP (Baribeau 
& Laurent, 1987), a silent movie was shown to them for distraction and the stimuli were presented in 
randomized orders and points in time that precluded preparatory state. Auditory evoked potential 
(AEP)-recording was performed with 32 electrodes referenced to FCz (BrainCap-MR 32 standard, 32 
channels, Easycap, Herrsching-Breitbrunn) in accordance with the international 10-20 System 
(Jasper, 1958). Scalp electrode impedances were kept below 10 kΩ. Sinus tones (1 000 Hz, 40 ms 
duration with 10 ms rise and fall time, ISI randomized between 1 800 and 2 240 ms) of five intensi-
ties (60, 70, 80, 90, 100 dB sound pressure level, generated by a PC-stimulator) were presented 
binaurally in a pseudo-randomized order over headphones using Presentation software (Neurobehav-
ioral Systems, Inc. San Pablo, CA). Data were collected with a sampling rate of 250 Hz and a band 
pass filter (0.5-70 Hz). Continuous EEG files for each subject were loaded into Brain Electrical 
Source Analysis software (BESA, version 5.3, MEGIS, Gräfelfing, Germany) and filtered digitally 
with a high bandpassfilter of 0.16-30 Hz (6/12 dB octave). Before averaging, the first responses of 
each of the five intensities were excluded in order to reduce short-term habituation effects. For 
artefact suppression, all trials were automatically excluded from averaging when the voltage exceed-
ed ±50 µV in any of the 32 channels at any point during the averaging period. Data with a 100 ms pre 
stimulus and a 300 ms post stimulus baseline interval were then inspected visually. On average 63 % 
(± 5.228) artefact-free sweeps per intensity were averaged separately for each participant, which 
should lead to an appropriate signal-to-noise ratio. 
5.1.3.4 Dipole source analysis (DSA) and single electrode estimation 
Dipole source localization of the N1/P2-component of AEPs was computed by means of the inverse 
solution as implemented in BESA, using a spherical head model. DSA provides an important 
methodological advance, because overlapping subcomponents of the N1/P2-component in the 
primary as well as secondary auditory cortex can be studied separately (Scherg, Vajsar, & Picton, 
1989). This is a pivotal point, as primary auditory cortex is highly innervated by serotonin compared 
to secondary auditory cortex (Hegerl et al., 1994). Similar studies reveal a high spatio-temporal 
accuracy with DSA (Kawohl et al., 2007; Waberski, Gobbele, Kawohl, Cordes, & Buchner, 2003). 
Based on the grand average over all subjects a dipole model was computed for the 60 dB and 70 dB 
intensities with two regional sources (one for each hemisphere, Fig. 3B). Several authors suppose a 
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frontal protective mechanism being activated during presentation of high tone intensities (Bruneau et 
al., 1985; Yamaguchi & Knight, 1990). Therefore a third regional source was added to the frontal 
region for the high intensity dipole model computed for the 90 and 100 dB intensities. These two 
models were applied to the individual data sets (low intensity model to 60-70 dB, high intensity 
model to 80-100 dB) in order to obtain the spatio-temporal information of the brain activation. The 
methods have been published in detail elsewhere (Hegerl et al., 1994; Hegerl & Juckel, 1993, 1994). 
Because the majority of studies on the LDAEP focused on the N1/P2 component, which seems to be 
more internally consistent and test-retest reliable than slopes based on other components (Beauducel 
et al., 2000; Hegerl, Prochno, Ulrich, & Müller-Oerlinghausen, 1988), the peak-to-peak N1/P2 
amplitudes were used to quantify differences in the responses to the different tone intensities. 
Additionally to the DSA approach we analysed the data with a scalp method, as recommended by our 
group (Hagenmuller, Hitz, Darvas, & Kawohl, 2011), to facilitate across-study comparisons. N1/P2 
amplitudes were determined at the Cz electrode and were re-referenced to linked mastoids. The 
LDAEP was determined by the median of all slopes of each possible connection between the five 
different N1/P2 amplitudes corresponding to the five different intensities (Hegerl & Juckel, 1994) for 
tangential dipole activity of both hemispheres and Cz-electrode estimation derived amplitudes. These 
values were used as the main variables for statistical evaluation.  
5.1.3.5 Statistical analysis 
Comparison of age and smoking status in patients and controls was conducted with a t-test for 
independent samples and cross-tabulation with χ2 test, respectively. To test the association between 
LDAEP values and the group factor (control group vs. schizophrenic patients) we conducted a series 
of generalized linear models (GLM) (Hoffman, 2004). GLM was chosen because it allows for 
variables that are not normally distributed in comparison to familiar used methods as ANOVA or 
linear regression analysis. LDAEP of the left and right hemisphere and from Cz-estimation were 
entered as the dependent variables. The covariates age and nicotine use were tested separately in 
bivariate analyses against LDAEP using DSA. Distribution and link-function of the LDAEP varia-
bles were chosen according to their graph and the goodness of model fit indices. For this purpose we 
compared the Akaike’s information criterion (AIC) and the Bayesian information criterion (BIC) for 
the different distributions and link-functions. The best fit to the data was finally obtained with a 
gamma distribution (right skewed distribution) and log link-function. In all GLM a robust estimator 
was used to reduce the effects of outliers and influential observations. Group effects on LDAEP were 
displayed with mean differences, whereas associations between continuous measures and LDAEP 
were depicted with unstandardized regression coefficients (B). In order to provide comparability 
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among predictors all continuous covariates were standardized using the z-transformation. Wilcoxon-
test was used to test if the medians between left and right LDAEP differed significantly. Analyses 
were carried out with SPSS version 20 for Windows.  
5.1.4 Results  
Demographics and psychopathology data for both groups are summarised in Table 1. Although 
antipsychotic medication estimated by CPZ-equivalent dose had a medium to strong effect on 
psychopathological scales, the correlations did not reach the level of statistical significance (PANSS 
general score; r = -0.698, P = .08; other scales r = -0.31 - 0.44, P > .10).  
 
Table 1. Demographic and clinical data of the sample. 
 Patients  Controls t / χ2 P 
N 13 13   
Age (years) 35.0 (8.13) 35.4 (8.17) t =0.120, df=24 .905 
Medication (CPZ) 707.0 (597.62) - - - 
Smoking (yes/no) 69; 31 23; 77 χ2=5.571, df=1 .018 * 
PANSS positive 15.46 (4.93) - - - 
PANSS negative 18.39 (6.25) - - - 
SANS composite score 31.31 (15.39) - - - 
BRMS  6.31 (3.77) - - - 
HAMD 17 8.69 (4.07) - - - 
CDSS-G 3.15 (3.11) - - - 
Data presented as % or mean ± SD. Abbreviations: CPZ, Chlorpromazine Dose Equivalence Ratios; 
PANSS, Positive and Negative Syndrome Scale; SANS, Scale for Assessment of Negative Symptoms; 
BRMS, Bech-Rafaelsen Melancholia Scale; HAMD, Hamilton Depression Rating Scale, CDSS-G, 
Calgary Depression Rating Scale for Schizophrenia. * P < .05. 
 
The LDAEP using DSA was significantly associated with the group membership in both hemi-
spheres (right: Wald = 10.094, df = 1, P = .001; left: Wald = 7.791, df = 1, P = .005). Patients with 
schizophrenia showed a significantly higher LDAEP than the control group (Table 2, Fig. 4). Results 
were adjusted for age and nicotine use. The magnitude of the group effect on LDAEP on both 
hemispheres was remarkably large, as indicated through the standardized mean difference Cohen’s d 
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= 1.04 (left) and d = 1.20 (right) (benchmarks are as follows: d = 0.3 depicts a small effect, d = 0.5 a 
medium effect and d = 0.8 a large effect). No significant differences in the LDAEP between the 
groups were found using single electrode estimation at Cz (Wald = 0.057, df = 1, P = .811). No 
significant differences between left and right LDAEP were found, neither among the whole sample 
(Z = -1.283, P = .200), nor among schizophrenic patients (Z = -1.153, P = .249) or the control group 
(Z = -.524, P = .600). 
 
Fig. 4. Overall distribution of the loudness dependence of auditory evoked potentials (LDAEP) values 
between healthy controls and patients with schizophrenia. The boxplots represent medians, quartiles and 
extreme values of the LDAEP variable in the left and right hemisphere across both groups. 
 
 
Table 2. LDAEP mean values in left and right hemisphere and Cz electrode across groups.  
Hemisphere Group Mean 95% CI Wald χ2 (df) Sig 
Left Controls 1.060 0.894-1.258 7.791 (1) .005 * 
 Patients 1.450 1.230-1.710   
Right Controls 0.905 0.781-1.050 10.094 (1) .001 * 
 Patients 1.234 1.073-1.420   
Cz Controls 0.150 0.116-0.194 0.057 (1) .811 
 Patients 0.142 0.105-0.192   
Results are adjusted for age and nicotine use. * p < .01. 
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Moreover, we observed a significant positive relationship between the SANS subscales “affective 
flattening” (beta = 0.207, P = .000), “anhedonia” (beta = 0.155, P = .016) and “attentional impair-
ment” (beta = 0.189, P = .015) and the LDAEP in the right hemisphere in patients. SANS composite 
score (the sum of scores for all items), which reflects severity of negative symptoms, was also 
positively correlated with the right LDAEP (beta = 0.153, P = .035) (Table 3, Fig. 5A). In figure 5 
the association between LDAEP and the severity of negative as well as positive symptoms are 
illustrated. Depressive symptoms (BRMS and CDSS G scale) (beta = -0.372, P = .000; beta = -0.305, 
P = .000) as well as PANSS general score (beta = -0.159, P = .026) were associated with the left 
LDAEP. Patients with higher scores on these scales showed lower LDAEP (Table 4). As shown in 
Table 3 and 4 all other psychopathological scales were not significant. LDAEP on both hemispheres 
were positively associated with medication by means of CPZ-equivalent dose (beta = 0.162, P = .001 
and beta = 0.173, P = .030 for right and left hemisphere). 
 
Table 3. Associations between right-hemispheric LDAEP values and clinical characteristics among patients. 
Measures B 95%-CI Wald χ2 (df) Sig 
CPZ 0.162 0.069; 0.254 11.593 (1) .001 * 
PANSS positive −0.014 −0.154; 0.125 0.041 (1) .840 
PANSS negative 0.103 −0.036; 0.243 2.114 (1) .146 
PANSS composite score −0.086 −0.241; 0.070 1.170 (1) .279 
PANSS general −0.174 −0.354; 0.006 3.574 (1) .059 
SANS Affect 0.207 0.094; 0.321 12.908 (1) .000 * 
SANS Alogia −0.015 −0.151; 0.121 0.047 (1) .829 
SANS Avolition −0.101 −0.228; 0.026 2.416 (1) .120 
SANS Anhedonia 0.155 0.029; 0.282 5.779 (1) .016 * 
SANS Attention 0.189 0.036; 0.341 5.906 (1) .015 * 
SANS composite score 0.153 0.011; 0.296 4.451 (1) .035 * 
BRMS  0.054 −0.129; 0.237 0.331 (1) .565 
HAMD 17 −0.049 −0.204; 0.106 0.391 (1) .532 
CDSS G −0.055 −0.184; 0.074 0.695 (1) .404 
Abbreviations: CPZ, Chlorpromazine Dose Equivalence Ratios; PANSS, Positive and Negative Syn-
drome Scale; SANS, Scale for Assessment of Negative Symptoms; BRMS, Bech-Rafaelsen Melancholia 
Scale; HAMD, Hamilton Depression Rating Scale, CDSS-G, Calgary Depression Rating Scale for 
Schizophrenia. B, unstandardized regression coefficient. * P < .05.  
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Fig. 5. A) LDAEP of the right hemisphere correlates with severity of negative symptoms in schizophrenic 
patients (p < .05). B) No correlation with positive symptoms was found. 
 
Table 4. Associations between left-hemispheric LDAEP values and clinical characteristics among patients. 
Measures B 95%-CI Wald χ2 (df) Sig 
CPZ 0.173 0.160; 0.331 4.681 (1) .030 * 
PANSS positive −0.091 −0.219; 0.037 1.935 (1) .164 
PANSS negative −0.061 −0.275; 0.152 0.320 (1) .572 
PANSS composite score −0.007 −0.237; 0.223 0.004 (1) .950 
PANSS general −0.159 −0.299; −0.019 4.962 (1) .026 * 
SANS Affect −0.073 −0.256; 0.110 0.607 (1) .436 
SANS Alogia −0.048 −0.319; 0.224 0.118 (1) .731 
SANS Avolition −0.120 −0.329; 0.089 1.263 (1) .261 
SANS Anhedonia −0.219 −0.367; −0.071 8.406 (1) .004 * 
SANS Attention −0.028 −0.276; 0.221 0.047 (1) .828 
SANS composite score −0.137 −0.294; 0.019 2.970 (1) .085 
BRMS  −0.372 −0.493; −0.250 36.082 (1) .000 * 
HAMD 17 −0.075 −0.294; 0.143 0.457 (1) .499 
CDSS G −0.305 −0.409; −0.202 33.331 (1) .000 * 
Abbreviations: CPZ, Chlorpromazine Dose Equivalence Ratios; PANSS, Positive and Negative Syn-
drome Scale; SANS, Scale for Assessment of Negative Symptoms; BRMS, Bech-Rafaelsen Melancholia 
Scale; HAMD, Hamilton Depression Rating Scale, CDSS-G, Calgary Depression Rating Scale for 
Schizophrenia. B, unstandardized regression coefficient. * P < .05. 
* * * * 
* 
*
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5.1.5 Discussion  
The present study was designed to investigate the role of serotonergic neurotransmission estimated 
by the LDAEP for the psychopathology of negative symptoms in schizophrenia. Due to the hetero-
geneity of the clinical concept of schizophrenia and its limitations as a valid object for scientific 
investigation (Cook, 2008), the level of psychopathological symptoms was chosen. We hypothesized 
that the LDAEP in patients with predominant negative symptoms would deviate from that of patients 
with predominant positive symptoms and healthy controls, indicating a difference in serotonergic 
neurotransmission. The results of this study provide new evidence in schizophrenia research. We 
would like to emphasize two remarkable findings. First, patients with schizophrenia showed a 
significantly stronger LDAEP than the control group. Based on the presumptions of the inverse 
relationship between LDAEP and 5-HT, this may indicate a difference in serotonergic neurotrans-
mission. Moreover, the stronger LDAEP in patients with schizophrenia is highly associated with 
negative symptoms. Second, only the increased LDAEP in the right hemisphere was associated with 
negative symptoms, underscoring the effects of laterality in brain functions and brain activity in 
schizophrenia. The single electrode estimation at Cz did not show any significant differences 
between the groups, which may derive from additional frontal source activation involved in high 
intensities. This has also been reported by Hagenmuller et al. (2011).  
Our findings contrast with those of previous studies, which showed that patients with schizophrenia 
had a weaker LDAEP than healthy controls (Gudlowski et al., 2009; Juckel et al., 2003; Juckel, 
Gudlowski, et al., 2008; Park et al., 2010). However, those studies were not designed to control for 
LDAEP differences between positive and negative symptoms. They focused on schizophrenic 
patients as a self-contained group. Nevertheless, Juckel, Gudlowski, et al. (2008) reported a tendency 
toward a positive relationship between PANSS negative score and LDAEP whereas Gudlowski et al. 
(2009) found a negative relationship between those scores. Our findings are contrary to the results of 
Gudlowski et al. (2009). One explanation for inconsistent findings could be due to a difference in 
methodology as sampling biases, gender effects, intensity of stimuli and methods of estimation (DSA 
vs. single-electrode) (O'Neill, Croft, et al., 2008). In particular, our data were analysed with DSA 
method, whereas Gudlowski et al. (2009) used single-electrode estimation for LDAEP. According to 
Hagenmuller et al. (2011), studies using different methods are difficult if not impossible to compare. 
Furthermore, the sample in Gudlowski’s study included females and males. Even though some 
studies reported no gender effects (Hegerl & Juckel, 1994; Park et al., 2010; Simmons et al., 2011), 
others have documented some effects on the LDAEP (Hensch et al., 2008; Jaworska et al., 2012; 
Oliva et al., 2011). The study by Juckel, Gudlowski, et al. (2008) used comparable methodology to 
the present study and some results are in line with our findings, showing strong LDAEP in patients 
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with negative symptoms among schizophrenic patients. Compared to healthy controls, they reported 
weaker LDAEP in the left hemisphere in patients, which states a contrary result to our findings.  
Nonetheless, our results are consistent with those of previous research on neurotransmitter alterations 
in negative symptoms and suggest the role of an impaired serotonergic system (Breier, 1995). 
Although many studies on the direct involvement of the serotonin system in schizophrenia exist, here 
we focus on results concerning negative symptoms. Direct evidence is provided from a post-mortem 
study, which reported a decreased 5-HT2 receptor density in frontal cortex in patients with chronic 
schizophrenia (Hashimoto et al., 1993). Furthermore, a PET study showed lower availability of 5-
HT1A receptors in patients with schizophrenia compared to healthy controls and receptor binding was 
negatively associated with negative symptoms, estimated by the PANSS scale (Yasuno et al., 2004). 
Moreover, a genetic study by Reynolds, Yao, Zhang, Sun, & Zhang (2005) gives support to an 
involvement of the serotonergic system in the pathogenesis of negative symptoms, since the 5-HT2C 
receptor promoter polymorphism is associated with negative symptoms. From studies on the 
mechanism of action of atypical neuroleptics in negative symptoms an indirect evidence for sero-
tonergic involvement is provided. In this context, it remains unclear why serotonin antagonists as 
well as agonists have an impact on the serotonergic system and improve the outcome of negative 
symptoms. Silver (2004) suggests that these pharmacologically distinct treatments may share 
common final mechanism. This paradoxical finding needs further investigation. Moreover, one has to 
consider that different 5-HT receptors have opposite effects on the function of neurons by means of 
inhibition and excitation (B. Roth & Meltzer, 2000). Further research is needed to clarify, if negative 
symptoms are caused directly by a primary abnormality in serotonergic transmission or in a second-
ary way via modulation of dopamine release (Abi-Dargham, 2007; Goff & Evins, 1998; Winograd-
Gurvich, Fitzgerald, Georgiou-Karistianis, Bradshaw, & White, 2006). 
With regard to the laterality effect, the present results showed a positive association between LDAEP 
and negative symptoms (SANS subscale affective flattening, anhedonia and attentional impairment, 
SANS composite score) in the right hemisphere, and a negative association between LDAEP and 
depressive symptoms (BRMS and CDSS G scale) in the left hemisphere in schizophrenic patients. A 
possible explanation could be that the LDAEPs in patients with high scores on depressive scales 
converge towards the LDAEP values of healthy controls (weaker LDAEP). This conclusion is in line 
with the literature about LDAEP in depressive patients, where no significant effect on the LDAEP 
has been shown (Jaworska et al., 2012; Linka, Müller, Bender, & Sartory, 2004; Park et al., 2010). 
Our results could also be due to serotonergic interhemispheric asymmetry, respectively to a reduced 
leftward asymmetry of brain structures of the auditory cortex in schizophrenia as observed by 
Salisbury, Kuroki, Kasai, Shenton, & McCarley (2007) and Shenton, Dickey, Frumin, & McCarley 
(2001). At that juncture, that the role of the laterality effect in schizophrenia and in particular in 
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negative symptoms is not known, interpretation is limited. 
Nevertheless, our study is not without limitations: The sample size was relatively small, which had 
an effect on the statistical power. Furthermore, the effects of education were not considered. With 
regard to the influence of attention to the LDAEP (Baribeau & Laurent, 1987) and given that patients 
with negative symptoms often show an attention deficit during auditory performances (Bozikas, 
Kosmidis, Kioperlidou, & Karavatos, 2004), an objective procedure controlling attention would have 
been necessary to add further consistency to our findings. A biased effect of medication is plausible 
since all patients were treated with atypical neuroleptics. There was an association with CPZ-
equivalent dose and LDAEP found in both hemispheres in this study, indicating an elevated LDAEP 
(and lower serotonergic activity) with higher medication use. Furthermore, general symptoms rated 
on PANSS scale were negatively related to medication in that they displayed a statistical trend 
(p=0.08). In a study by Juckel et al. (2003) an increased LDAEP after a treatment with atypical 
neuroleptics compared to baseline was observed. Moreover, in a PET study, a trend toward a 
decreased 5-HT2 receptor binding in prefrontal cortex was found in neuroleptic treated patients, 
whereas neuroleptic naive patients showed similar results as healthy controls (Okubo et al., 2000). 
As negative symptoms also occur as pharmacological side effects (secondary negative symptoms) it 
is debatable if the found relationship between LDAEP and negative symptoms is an effect of 
secondary negative symptoms. A distinction between primary and secondary negative symptoms is 
not possible with contemporary measurements of psychopathology (Flaum & Andreasen, 1995; 
Lindenmayer et al., 2007). On the other hand, a study design including unmedicated chronic schizo-
phrenic patients is hardly realistic both for ethical reasons and practicability. Further studies with 
more focus on the effect of medication are therefore needed. 
Another limitation is the possible influence of other neurotransmitters on the LDAEP. There are 
genetic association studies and challenge trials on possible influences of dopamine, glycine, and 
nitric oxide (Hitz et al., 2011; Juckel, Kawohl, et al., 2008; Kawohl, Giegling, et al., 2008; O'Neill et 
al., 2007). As these studies point to a sensitivity of the LDAEP also to neurotransmitter systems other 
than 5-HT, the LDAEP’s specificity as a marker of serotonergic function is challenged (O'Neill, 
Croft, et al., 2008). This has to be taken into account in the interpretation of this study. Nevertheless, 
also these results are in part heterogeneous, e.g. an association of the LDAEP with the dopaminergic 
system by means of the COMT Val158Met-polymorphism (Juckel, Kawohl, et al., 2008) could not 
be reflected in a dopaminergic challenge trial (Hitz et al., 2011). 
In conclusion, the aim of the present study was to investigate the LDAEP as an indicator of serotonin 
functioning within the schizophrenic spectrum. In particular, we took account of the heterogeneity of 
clinical diagnosis by examining the accurate psychopathological symptoms. The results showed an 
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association between the serotonergic function estimated by the LDAEP and the extent of negative 
symptoms directly. Our findings support the idea of differential clinical features of schizophrenia and 
contribute to the clarification of the aetiology of negative symptoms. 
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5.2.1 Abstract 
Loudness dependence of auditory evoked potentials (LDAEP) evaluates loudness processing in the 
human auditory system and is often altered in patients with psychiatric disorders. Previous research 
has suggested that this measure may be used as an indicator of the central serotonergic system 
through the highly serotonergic innervation of the auditory cortex. However, differences among the 
commonly used analysis approaches (such as source analysis and single electrode estimation) may 
lead to different results. Putatively due to discrepancies of the underlying structures being measured. 
Therefore, it is important to learn more about how and where in the brain loudness variation is 
processed. We conducted a detailed investigation of the LDAEP generators and their temporal 
dynamics by means of multichannel magnetoencephalography (MEG). Evoked responses to brief 
tones of six different intensities were recorded from 19 healthy participants. We used magnetic field 
tomography in order to appropriately localize superficial as well as deep source generators of which 
we conducted a time series analysis. The results showed that apart from the auditory cortex other 
cortical sources exhibited activation during the N1/P2 time window. Analysis of time courses in the 
regions of interest revealed a sequential cortical activation from primary sensory areas, particularly 
the auditory and somatosensory cortex to posterior cingulate cortex (PCC) and to premotor cortex 
(PMC). The additional activation within the PCC and PMC has implications on the analysis ap-
proaches used in LDAEP research. 
5.2.2 Introduction 
The loudness dependence of the N1/P2 auditory evoked potentials (LDAEP) constitutes a prime 
object of investigation in the continuing search for biological correlates of psychiatric disorders 
(Kenemans & Kähkönen, 2011). Due to feasibility reasons the LDAEP is mostly recorded by 
electroencephalography (EEG). Nonetheless, the loudness dependence can also be measured from 
changes in magnetic fields (LDAEF) using magnetoencephalography (MEG). LDAEP has been 
reported to be a valid measure of central serotonergic neurotransmission both in animals and humans 
(Hegerl & Juckel, 1993; O'Neill, Croft, et al., 2008). The basic concept of LDAEP is that sero-
tonergic neurotransmission has a homeostatic function and modulates the responsiveness and 
sensitivity of cortical neurons in the primary auditory cortex (PAC) (Jacobs & Azmitia, 1992). A 
pronounced LDAEP supposedly reflects low central serotonergic neurotransmission, whereas a weak 
LDAEP reflects high serotonergic activity (Hegerl & Juckel, 1993; Kawohl, Hegerl, et al., 2008; 
Wutzler et al., 2008). The measure of the auditory evoked response to increasing sound pressure 
levels is referred to as loudness dependence and is inter-individually different (Buchsbaum, 1971). 
The LDAEP has been widely applied in psychiatric samples (Ostermann et al., 2012; Park et al., 
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2010; Wyss et al., 2013), in studies with pharmaceutical challenge (Hitz et al., 2011; Kähkönen, 
Jääskeläinen, Pennanen, Liesivuori, & Ahveninen, 2002), in relation with the prediction of treatment 
outcome (Juckel, Pogarell, et al., 2007; Linka et al., 2004) and in genetic association studies (Gallinat 
et al., 2003; Juckel, Kawohl, et al., 2008; Kawohl, Giegling, et al., 2008).  
Nonetheless, further improvement of the sensitivity and specificity of the LDAEP analysis is 
required to qualify it as a diagnostic marker. This could facilitate the clinical applicability of the 
parameter. Thus far the LDAEP has been analyzed in several different ways. The most common 
strategies used in EEG rely on single-electrode estimation (e.g. Debener et al., 2002), dipole source 
analysis (DSA; e.g. Wyss et al., 2013) and current source density analysis using low resolution brain 
electromagnetic tomography (LORETA; e.g. Jaworska et al., 2013). A general restriction of source 
localisation in EEG and MEG is the existence of the inverse problem (Michel et al., 2004). This 
indicates that from the signal measured at the scalp, the location of the underlying generators is not 
uniquely determined. One should keep in mind that different source configurations can produce the 
same potentials on the scalp. 
By using the EEG single-electrode estimation at the Cz electrode or the Fz electrode – by far the 
most used strategy to define the LDAEP – we have to account for following limitations: first, it is for 
sure that a single electrode cannot adequately represent source activity generated by the underlying 
brain area due to the superposition effect and the poor conductance of the skull. Secondly, using a 
single channel only is not possible to set apart the overlapping generators in both the primary and 
secondary auditory cortices with this approach. This differentiation is important because the seroto-
nin concentration is highest in the primary sensory areas (Azmitia & Gannon, 1986; Juckel et al., 
1997; Lewis, Campbell, Foote, & Morrison, 1986). Positron emission tomography (PET) and 
autoradiography analysis showed a high mean density of serotonin transmitter receptors in the PAC 
(Fink et al., 2009; Zilles et al., 2002). Moreover, a functional magnetic resonance imaging (fMRI) 
study on LDAEP using individual landmarks for the separation of primary and secondary auditory 
cortices indicated different loudness dependencies in these areas (Brechmann, Baumgart, & Scheich, 
2002). Thus, the primary auditory cortex plays a pivotal role in the analysis of the LDAEP and the 
consequential interpretations.  
Fortunately, advances in source reconstruction allow for the isolation of the signal from the PAC in a 
relatively straightforward fashion. Both dipole source analysis (Hegerl & Juckel, 1993; Scherg & 
Picton, 1991) and LORETA (Mulert et al., 2002) showed to be capable of separating the sources in 
the auditory cortex and are used to determine the LDAEP. One problem with DSA is that the 
investigator has to define the number of dipoles that better explains the variances of contributing 
sources a priori. In the standard N1/P2 dipole model for the analysis of the LDAEP two dipoles are 
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set in each hemisphere, one tangential dipole representing the PAC and one radial representing the 
secondary auditory cortex (Scherg & Von Cramon, 1985). 
However, little effort has been made to specify if significant additional generators contribute to the 
scalp potential or account for an improvement of the residual variance in the dipole model. Electro-
physiological studies conducted in the 1980s and 1990s already pointed out that the auditory N1 
wave does not arise from a unitary source (i.e. auditory cortices) but reflects a superposition of 
sources with different functional significances (Giard et al., 1994; Knight, Hillyard, Woods, & 
Neville, 1980; Näätänen & Picton, 1987; Picton et al., 1999). Those studies were mostly based on 
derived sources from the scalp potentials or limited by a priori dipole models. Since then not much 
research has been done on the underlying mechanism of auditory processing during the N1/P2 time 
window, even though the methodology has improved significantly. For instance, better resolution in 
space and time can be achieved by using a few hundreds of highly sensitive magnetometer sensors in 
MEG or by utilizing a hybrid fMRI/EEG system which provides both, high spatial and temporal 
resolutions (Neuner et al., 2014).  
Evidence from the recent studies comparing the diverging analysis methods in LDAEP research is in 
line with the assumptions that additional sources are activated. Hagenmuller et al. (2011) compared 
DSA analysis with single-electrode estimation within the same sample and found a significant 
difference between scores obtained with both methods. The authors assumed that a third source was 
additionally activated and contributed to the scalp signal captured by a single electrode. Actually, 
some studies used a third regional source in the dipole model in the frontal region, especially for high 
intensities in order to improve the residual variance between the modeled and the true signal record-
ed at the scalp (Hitz et al., 2011; Wyss et al., 2013). Surprisingly, a study by Mulert et al. (2002)    
compared DSA and LORETA for source localisation and did not find a significant correlation 
between the results of the two techniques. This dissociation could be explained because distinct types 
of source analysis methods were compared. DSA in contrast to LORETA is a discrete source 
analysis that requires a priori assumptions about the exact number of dipole sources based on 
physiological knowledge. In this study the authors used a two-dipole model instead of setting a third 
dipole. This could have led to a contamination of the true signal resulting from the tangential dipole 
activity representing the primary auditory cortex.  
The present study aims at improving the analysis strategy of LDAEP investigations by taking into 
account all generators involved in loudness dependence by means of MEG analysis. We used 
wholehead MEG combined with a distributed source model approach which allows an exploratory 
analysis – without fixing the number of generators a priori – of the spatio-temporal profiles of the 
activated brain regions with excellent time resolution (Attal, Maess, Friederici, & David, 2012; 
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Ioannides, 2006; Ioannides, Poghosyan, Dammers, & Streit, 2004). The use of high-density record-
ing by means of MEG/EEG has never been applied in the analysis of LDAEP thus far and the 
increased number of channels used in this study tends to result in a satisfactory disentanglement of 
the overlapping components in the brain (Dammers et al., 2007; Michel et al., 2004). We hypothesize 
that besides the auditory cortex additional sources contribute to late auditory evoked responses as 
observed from scalp recordings in the timeframe of N1m/P2m. We suppose that this interfering 
source activity is mostly apparent after high intensity tones due to the following reasons: First, while 
using dipole source models in the analysis of LDAEP an involvement of a third neuronal source was 
supposed to be present at particularly high intensities (Hitz et al., 2011; Wyss et al., 2013). Second, 
Näätänen and Picton (1987) already reported that an additional component was most easily observed 
at high intensities. 
Our findings promise to be valuable in improving basic physiological knowledge of the involved 
processes in order to define prior assumptions in discrete source analysis, for instance to create an 
adequate dipole model (Scherg & Berg, 1991). Moreover, we intend to further elucidate the compa-
rability of the various methodological approaches.  
5.2.3 Methods 
5.2.3.1 Subjects 
Nineteen healthy male right-handed subjects participated in the study (mean age 26.5 ± 4.0 years). 
All volunteers were recruited from the staff of the Forschungszentrum Jülich and from a volunteer 
mailing list. Subjects that met the following criteria were excluded: current or prior history of 
neuropsychiatric disorders as assessed by the Mini International Neuropsychiatry Interview 
(M.I.N.I.) (De Pascalis, Cozzuto, & Russo, 2012); first-degree relatives with psychiatric disorders; 
drug or alcohol abuse; and smoking or a lifetime history of metabolic disorders. Subjects were 
instructed to consume neither alcohol nor any pharmaceuticals 48 h before or caffeine 12 h before 
measurements. Handedness was assessed by the Edinburgh Handedness Inventory (Oldfield, 1971). 
All subjects gave written informed consent. The study was approved by the Ethics Committee of the 
Medicine Faculty of the Rheinisch-Westfälischen Technischen Hochschule Aachen (RWTH Aachen 
University) and was carried out in accordance with the Declaration of Helsinki. One subject was 
excluded as not suitable for analysis because of poor signal quality from the MEG measurements 
which was most likely due to external noise. 
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5.2.3.2 Experimental procedure 
Neuromagnetic field changes in response to auditory stimulation were recorded in a magnetically 
shielded room with a whole-head 248 magnetometer system (Magnes3600, 4D-Neuroimaging, San 
Diego, USA). Recordings were performed in a supine position with the subjects lay with their eyes 
open. During the passive listening of the auditory stimulation all subjects were asked to stay relaxed 
and to avoid movements. As attention to the auditory stimuli has been shown to modulate the 
auditory evoked potentials (Schechter & Buchsbaum, 1973), and therefore also the LDAEP 
(Baribeau & Laurent, 1987), a silent movie was shown to the subjects for the purposes of distraction 
and they were told not to pay attention to the auditory stimuli. The sinusoidal tones (1000 Hz, 40 ms 
duration with 10 ms rise and fall time) were generated by a digital signal processor (Multi I/O 
Processor RX8, TDT System 3, Tucker-Davis Technologies, Alachua, USA) and were presented 
binaurally through earphones with plastic tubes and ear plugs inserted into the outer ear canals. Two 
programmable attenuators for the left and right ear (PA5, TDT System 3, Tucker-Davis Technolo-
gies, Alachua, USA) were used to present the tones at 10, 20, 30, 40, 50 and 60 dB sensation level 
(SL) in a pseudo-randomized order with not more than two equal levels following each other and 
pseudo-random stimulus onset asynchrony between 2 and 3 s in steps of 17 ms. Individual hearing 
thresholds were determined prior to each experiment and calibrated over five times. The mean 
threshold across all subjects was approximately 20 dB sound pressure level (SPL) and was just above 
the level of system noise of 20 dB SPL (at octave-band around 1000 Hz) that means that the present-
ed stimuli were in the range of 30 to 80 dB SPL. The individual threshold was examined to guarantee 
an equal perception of the tones at both ears and to control the variability due to differences in the 
stimulation settings. Moreover, it is important to dissociate between perceived loudness and physical 
sound intensity, as it is supposed that the activation in auditory cortex rather reflects the subjective 
perception (Langers, van Dijk, Schoenmaker, & Backes, 2007). A system specific constant time 
delay of 20 ms respective to the stimulus onset was taken into account and later subtracted for 
analysis. 
5.2.3.3 MEG recording 
The neuromagnetic activity was continuously recorded with a sampling rate of 678.17 Hz in a 
frequency range from DC up to 200 Hz. Prior to the MEG measurement, 5 head location coils were 
attached to subject’s head. The position of the coils and the head itself was digitized using a 3D 
digitizer (Polhemus, 3space/Fastrack, Colchester, USA). Before and after each recording block, 
subject’s head position was monitored by the head location coils, whereby a maximum difference of 
5 mm for each experiment was accepted for further analysis. Eye movement and heart beats were 
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monitored simultaneously using electrocardiography and electrooculography, respectively (Brain 
Vision BrainAmp ExG MR, Brain Products, Gilching, Germany). 
5.2.3.4 Individual anatomical MRIs 
For the co-registration of the MEG coordinate frame with the individual brain anatomy, high-
resolution T1-weighted MR-images were acquired for each subject with a voxel size of 1 x 1 x 1 
mm3 (3T, Trio, Siemens, Erlangen, Germany). The rendered head shape was matched to the surface 
of the scalp by means of customized software, providing an affine transformation matrix for co-
registering the MEG head coordinate and the MRI coordinate system (Dammers et al., 2007). For 
MEG source space preparation the individual anatomical brain was extracted using Brain Extraction 
Tool (BET) as implemented in FSL (Version 5.0.4, FMRIB's Software Library, 
www.fmrib.ox.ac.uk/fsl) and a source space of approximately 10000-12000 nodes using an isometric 
5 mm grid was defined prior to source analysis. 
5.2.3.5 MEG signal processing 
After acquisition, all data were band-pass filtered with a blackman windowed sinc filter (S. W. 
Smith, 1997) in the range of 1-200 Hz including notch filters at the power line frequency (50 Hz and 
the harmonics). Noisy MEG channels were excluded by visual inspection. Artifact rejection was 
automatically performed using the independent component analysis (ICA) as described in Dammers 
et al. (2008)  . Artifact free epochs were extracted for each stimulus in a time window of ranging 
from -200 ms to +650 ms before and after stimulus onset, respectively. The epoch onsets were 
corrected for the time delay between generating and presenting the stimuli to the subject ears. A 
baseline correction was calculated from the pre-stimulus interval -200 ms to -50 ms. The first five 
epochs of each condition were excluded in order to reduce short-term habituation effects and epochs 
with threshold level above 3 pT were excluded by default. Within one subject, only the minimum 
number of accepted epochs (min. 70) was averaged according to the six conditions. Across subjects 
on average 73.8 (SD 1.3) out of 80 epochs were accepted for each condition and guaranteed an 
almost constant signal-to-noise ratio. Global field power (GFP) was calculated independently for 
each subject and condition and was normalized by dividing through the standard deviation of the 
baseline (Lehmann & Skrandies, 1980). 
5.2.3.6 MEG source analysis 
Magnetic field tomography (MFT; Ioannides et al., 1990) is a distributed source reconstruction 
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method for the localization of the primary current density as recorded by MEG. MFT belongs to the 
family of weighted minimum norm solver (Ioannides, 2006; Ioannides et al., 1995; Taylor, 
Ioannides, & Muller-Gartner, 1999). A detailed description of the algorithmic steps is described in 
(Ioannides, 1995). In short: Let mi be the output of the ith magnetometer. Then the measurement mi 
can be expressed as a linear functional of the primary current density ! !  with the vector-valued 
lead field ϕ!(!) describing the sensitivity profile of the ith sensor: 
!! = ϕ!(!)! ∙ ! ! ∙ !!!     (1) 
For estimating the current density !(!) MFT is based on a probabilistic treatment of the inverse 
problem where the estimated current density is expressed as a linear combination of expansion 
functions: 
! ! = !! ∙ !! ! ∙ !(!)!!     (2) 
with N being the number of detectors, !(!) is a probability weighting function defined throughout 
the source space, incorporating any a priori information about source location, and !! are expansion 
coefficients that can be determined from the measurement data. In contrast to the well-known MN 
approach, MFT uses a non-linear weighting function ! !  that allows the weights to depend on the 
strength of the first solution ||!! ! ||! (with ! = 1) of the primary current density (Taylor et al., 
1999). The initial values for the weighting function in MFT is determined by training the algorithm 
using computer generated data before MFT is applied to the real data (Ioannides et al., 1990). During 
inversion the weight update !! = ! ∙ !! ! ∙ !!!!(!) ! is used to sharpen up the reconstruction 
within an iterative process, with !! being the initial weight and ! being a constant to ensure that the 
sum of weights equals 1. In other words, the result of the first application is used to enhance the a 
priori probability weight in regions where the activity has been identified. The difference to MN 
estimation is that in MN based solver no iteration is involved (with ! = 0) and ! ! = ! = 1. 
Moreover, the regularization parameter in MN solvers is estimated only once (typically from the 
noise covariance matrix), while in MFT the parameter is adapted for each inversion (Ioannides et al., 
1990). In this way MFT is computationally more demanding, but is able to reconstruct shallow as 
well as deep sources at a time (Y.-H. Chen et al., 2009; Dammers & Ioannides, 2000; Weidner, 
Boers, Mathiak, Dammers, & Fink, 2010). 
Lead fields used (cf. Eq. 1) for the MFT analysis were computed from each individual subject with 
respect to a spherical head model. Current density source reconstruction was estimated based on the 
averaged MEG data. We used the modulus (strength) of the current density activation for further 
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analysis. The mean of the baseline was subtracted for baseline correction in each subject individual-
ly. Because we were only interested in calculating the root mean squared (RMS) values out of 
positive activations, negative values possibly resulting from baseline correction were set to zero. 
RMS values were calculated voxel-wise for these data for each subject in a sliding window of 50 ms 
latency with 25 ms overlap between 0 and 650 ms. In this way, full 3D reconstructions across time 
are provided with respect to the GFP distribution and the time characteristics of the auditory evoked 
components (Woods, 1995). These 4D spatio-temporal profiles (MFTrms values) were transformed 
into the Neuroimaging Informatics Technology Initiative (NIfTI) format using an interpolated 
common isometric voxel size of 2 mm3 for both the MFTrms reconstruction and the MRI anatomical 
scans in order to combine the MFT solution with the FSL software. Each NIfTI-volume was then 
aligned to the MNI standard space (Montreal Neurological Institute, MNI152 2mm brain) using the 
non-linear registration algorithm (FNIRT, Non-linear Image Registration Tool; FSL). Finally, the 
standard space volumes were used for statistical analysis throughout. 
5.2.3.7 Statistical analysis 
For group analysis, the transformed MFTrms volumes for each sound pressure level and time 
window were entered into second-level statistical group analysis using the generalized linear model 
included in FSL. Monte Carlo Permutation was applied as a non-parametric measure with minimal 
need of assumptions about the data. Due to our particular interest in the highest sound levels, we 
performed one-sample permutation t-tests with 5000 permutations to assess brain activity differences 
in the processing of the highest (60 dB) vs. lowest (10 dB) sensation levels (Nichols & Holmes, 
2002). The voxel-wise maps were thresholded using threshold-free cluster enhancement (TFCE; 
Smith and Nichols, 2009) at P < .001 at cluster-level for T = 3.73 and all significance values were 
family-wise error (FWE) corrected for multiple comparisons. Variance smoothing was applied using 
a Gaussian kernel of width 3 mm in order to increase the power of the test. Anatomical regions were 
defined by means of the Jülich Histological Atlas (JHA; Eickhoff, Heim, Zilles, & Amunts, 2006) at 
highest t-values and maximum probabilities of each anatomical label. For the regions that have not 
yet been defined in a cytoarchitectonic map, we used the macroscopic probabilistic Harvard-Oxford 
cortical structural atlas, provided with FSL. We performed a time-course analysis within the anatom-
ical regions significantly activated in the t-test during the N1m time window for each condition to 
elucidate the temporal dynamics across regions. Based on the 4D spatio-temporal profiles of the 
MFT analysis we calculated RMS values in space by taking into account all voxels in each of these 
regions-of-interest (ROI) for each time point. The data was normalized by the maximum value found 
across all conditions in time for each subject respectively, thus providing comparisons between 
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subjects and conditions. In order to statistically evaluate the best fit lines (linear or quadratic) of the 
slopes generated from mean RMS activations versus intensity levels (Fig. 8) across the ROIs, we 
used hierarchical linear regression analysis (SPSS version 22 for Mac) using RMS values as the 
dependent measure.  
5.2.4 Results 
5.2.4.1 Source analysis  
Figure 6 shows the GFP over 248 magnetometers of the averaged auditory evoked field calculated 
across all sound pressure levels. Based on these latency peaks we concentrated on the activity in the 
following time windows 75–125 ms for N1m and 175–225 ms for P2m.  
 
Fig. 6. Group averages (n=19) of global field power (GFP) after auditory stimuli presentation (10-60 dB 
SL). The N1m peak occurred between 75-125 ms, the P2m peak between 175-225 ms. MFT analysis 
were conducted within these time windows. Reference level of intensity is SL. 
 
In the N1m time window we found significant neural activations in the primary auditory cortex 
(PAC), the posterior cingulate cortex (PCC), the premotor cortex (PMC) and the primary somatosen-
sory cortex (Fig. 7A). Moreover, activation was found in the paracingulate cortex. In the time 
window of P2m significant activations were shown in the PAC, the primary and secondary visual 
cortices extending into the precuneus and the PMC (Fig. 7C). Table 5 provides the t-contrast values 
and MNI coordinates. 
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Fig. 7. MEG activation for the contrast analysis between the highest and the lowest intensity in the time 
window of N1m (A) and P2m (C) (N = 19, thresholded below P < .001 at cluster level for T = 3.73, 
FWE-corrected). Time course analysis between 0 and 300 ms poststimulus in each ROI (B). Vertical 
dotted line indicates the latency of N1. L: left hemisphere; R: right hemisphere. RMS values for time 
courses were low pass filtered at 30 Hz for graphical reasons. Reference level of intensity is SL. 
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Table 5. Anatomical locations of all significant T-contrast activations in MEG magnetic field tomogra-
phy in the time window of N1m and P2m. 
N = 19, thresholded below P < .001 at cluster level for T = 3.73, FWE-corrected. To keep apart the 
different clusters, local maxima within 10 mm of each other in each cluster were defined. L: left hemi-
sphere; R: right hemisphere; k: cluster size; MNI: Montreal Neurological Institute (mm). 
 
5.2.4.2 Time course analysis of the activation in a ROI 
The results of the time course analysis revealed different activation pattern among the ROIs between 
0 and 300 ms (Fig. 7B). In the sensory cortices a saturation effect of the N1m could be observed that 
means that the highest sound level did not evoke a higher mean MFTrms value. According to 
latencies, the N1m component peaked between 88 and 133 ms across all intensity levels in the 
sensory cortices (auditory and somatosensory) and the PCC (Table 6). The time courses of the mean 
MFTrms values in the PMC did not show accentuated peaks. However, a loudness dependency is 
still obvious and a maximum value at 119 ms for the 60 dB condition was reached. 
Relating to the P2m component a distinct peak with the highest sound level is shown in the PCC. In 
the remaining ROIs the peaks were rather broad and flat, nevertheless showing an increase around 
220 ms in the sensory areas whereas no clear peak was observed in the PMC. 
The temporal sequence of activations for the highest sound pressure levels determined from the N1-
peak latencies was from PAC and primary somatosensory cortex to PCC and finally to PMC (Fig. 
7B, Table 6). The left and the right PAC were activated simultaneously. 
 
    
MNI coordi-
nates 
 Region  L/R k t-value x y z 
 60−10dB  
N1m Primary auditory cortex/Planum temporale  R 2173 5.58 50 −26 6 
 Primary auditory cortex/Middle temporal gyrus L 800 4.58 −50 −22 8 
 Posterior cingulate cortex L 2173 5.7 −6 −50 28 
 Posterior cingulate cortex/Precuneus R 2173 5.4 4 −48 30 
 Premotor cortex/Primary somatosensory cortex R 368 5.16 48 −6 50 
 Paracingulate cortex L 95 4.46 −4 20 44 
P2m Primary auditory cortex R 1651 6.42 52 −16 2 
 Primary auditory cortex/Middle temporal gyrus L 385 4.34 −52 −10 −6 
 Visual Cortex V1 and V2/Precuneus R 212 3.85 8 −56 14 
 Premotor Cortex L 117 4.59 −28 −20 66 
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Table 6. N1-peak latencies for each sound pressure level within ROIs. 
L: left hemisphere; R: right hemisphere. 
 
5.2.4.3 LDAEP slope differences among the ROIs 
A supplemental research question arose during our analysis based on the observation of the satura-
tion effect. Therefore, the slope of the loudness dependence of the RMS activation across all 
intensities was generated at the previously defined time window of N1m (75-125 ms) within each ROI. 
 
 
 
 
 
 
Fig. 8: ROI analysis of average current densities at N1m over all intensities. L: left hemisphere; R: right 
hemisphere. 
 
 dB SL 
Region  L/R 10 20 30 40 50 60 
    ms 
Primary auditory cortex/Planum temporale  R 114 107 96 96 92 89 
Primary auditory cortex/Middle temporal gyrus L 111 101 98 96 92 90 
Posterior cingulate cortex/Precuneus L/R 117 111 117 96 104 99 
Premotor cortex R 88 172 200 121 96 119 
Primary somatosensory cortex R 133 120 95 92 93 88 
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Figure 8 shows that the mean MFTrms value in the PAC increases steadily with lower intensities but 
decreases with the highest intensity in both hemispheres. A similar trend was observed for the 
activation in the primary somatosensory cortex. On the other hand, the activation in the PCC and the 
PMC steadily increases with sound pressure level.  
These characteristics were confirmed by hierarchical linear regression analysis. Analysis revealed 
that a quadratic model was able to account for an additional amount of total variance of a linear 
model alone in the left and right PAC (left: ΔR2 = .096, P = .000; right: ΔR2 = .083, P = 0.000). No 
additional variances were explained for the quadratic model in the PCC (ΔR2 = .003, P = .531), PMC 
(ΔR2 = .006, P = .378) and in the primary somatosensory cortex (ΔR2 = .018, P = .122).  
5.2.5 Discussion 
This study assessed the neuroanatomical correlates of the N1m/P2m-complex evoked by the presen-
tation of brief tones of different intensities. In addition to prior studies, multichannel MEG was used 
and source reconstruction was performed using a data-driven approach. Brain activation during the 
processing of the tones presented with the highest sound pressure levels compared to those with the 
lowest sound pressure levels was computed. However, the waveforms of both the N1m and P2m are 
not generated by a single region, but they rather reflect the sum of several relatively independent 
latent components generated by a distributed network involving PAC, primary somatosensory cortex, 
motor cortex and the PCC.  
5.2.5.1 Sources in and near the auditory cortex  
A large number of studies examined brain activity generated by loudness variation of auditory 
stimulation with EEG (Hegerl et al., 1994; Neukirch et al., 2002), MEG (Ioannides, 2006; Vasama, 
Mäkelä, Tissari, & Hämäläinen, 1995) or fMRI (Jäncke et al., 1998; Mulert et al., 2005; Wood et al., 
1984). They have consistently found sources in and in the vicinity of the auditory cortex and further 
investigated the underlying neural mechanisms (i.e. increased responses or spatial extent of activated 
cortex volume) by intensity change. In line with these studies we found activation in the primary 
auditory cortex and specifically as shown in other MEG studies (Godey, Schwartz, De Graaf, 
Chauvel, & Liegeois-Chauvel, 2001) the activation extended into the planum temporale at the N1m 
time-range (Table 5, Fig. 7). In contrast, the activation showed a slight posterior to anterior shift 
toward the planum polare in the time window of the P2m. 
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5.2.5.2 Contribution of neural activity outside the auditory cortex  
To our knowledge there is very little research reporting on sources outside the auditory cortex 
underlying the LDAEP. It is known that subcortical structures involved in the early processing of 
auditory stimuli such as the superior olive, the inferior colliculus and the medial geniculate body are 
sensitive to noise levels, showing a higher activity to increasing levels (W. T. Roth et al., 1980).  
Nevertheless, references from studies describing the generators of the auditory N1 and P2 compo-
nents are extensive and should be taken into account for the interpretation of our results. Näätänen 
and Picton (1987)   already pointed out that not only one predominant generator but also other 
sources contribute to the scalp recorded N1 peak in auditory processing. These authors proposed a 
third component underlying the N1 wave often referred as the “unspecific component” whose exact 
location is still unknown, but is proposed to lie within the frontal motor cortex and PMC in the 
precentral gyrus. Justification for these assumptions came from the effects of interstimulus intervals 
(ISI) on the scalp topography of the N1, as refractoriness processes become more active during 
increased ISI (>4 s) and thus lead to less specific additional sources near the vertex (Hari et al., 1982; 
Näätänen & Picton, 1987; Velasco & Velasco, 1986). Moreover, intracerebral recordings in monkeys 
supported additional generators of auditory evoked potentials in the PMC and motor cortex (Arezzo, 
Pickoff, & Vaughan, 1975). Since then only few studies have contributed to the clarification of this 
third component by means of scalp current density and dipole analysis. The characteristics of this 
frontal response, however, are still ambiguous. Some authors (Alcaini, Giard, Thevenet, & Pernier, 
1994; Giard et al., 1994; Näätänen & Picton, 1987) described a component with contributions from 
sources outside the auditory cortex with a peak latency of 100 ms, most easily recorded at intensities 
greater than 60dB SPL and with long as well as short ISIs. The sources were described to lie within 
the posterior frontal lobe in the motor cortex (BA4), the supplementary motor area (BA6) or the 
cingulate gyrus. Other authors reported a component generated by the same regions but at later 
latencies (i.e. around. 125 ms; 140 ms) or with a longer refractory period, that is emerging only with 
longer ISIs (Alcaini et al., 1994; Picton et al., 1999).  
Our study is the first using a distributed source model to show an additional significant activation in 
the PMC during the N1m time window. The response remained relatively constant between 60 and 
180 ms and peaked at 119 ms in the condition of the highest intensity (Fig. 7B). These findings are in 
agreement with the findings of the aforementioned previous work. The activation in the PMC might 
be related to the acoustic startle response to a sudden loud noise and is viewed as an aversive 
response to novel and potentially harmful stimuli (De Pascalis et al., 2012; P. J. Lang, Bradley, & 
Cuthbert, 1990). The primary somatosensory cortex that is additionally activated in the present study 
could also play a considerable role in the processing of the startle response (Neuner et al., 2010). 
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Other authors pointed out that the supplementary and premotor areas may be related to the orienting 
response, an orientation of attention to a change in the environment and linked to the planning and 
execution of motor responses even though the subjects had no such task to perform (Hari et al., 1982; 
Y. H. Kim et al., 1999; Näätänen & Picton, 1987).  
Furthermore, the PCC was observed to belong likewise to the network of auditory intensity pro-
cessing. The results show a greater increase in activation with higher sound pressure levels in the 
time window of N1m and P2m. Interestingly, one single LDAEP-study using PET reported activa-
tion in this region (Lockwood et al., 1999), but with maximal activation at lower intensities. The 
authors assigned to this region a significant role in regulating or controlling the magnitude of 
intensity and also mentioned a possible link to the attention system. However, the functional role of 
the PCC is currently not clear and competing theories exist (Leech & Sharp, 2014). According to our 
findings (Fig. 7B) the PCC is activated after the primary sensory areas and may subserve evaluative 
functions such as monitoring sensory events and homeostatic processes (Vogt, Finch, & Olson, 
1992). In fact, the PCC shows no direct innervations to primary sensory and motor areas (Parvizi, 
Van Hoesen, Buckwalter, & Damasio, 2006), but connections to the prefrontal cortex. Interestingly, 
the PCC is modulated by serotonergic neurotransmission (Hahn et al., 2012). Long term treatment 
with SSRIs were reported to have a significant effect on the neuronal structure (Kraus et al., 2014) 
and function (Matthews et al., 2010) of the PCC. Moreover, transmitter receptor fingerprints of the 
cerebral cortex indicate that the mean densities of 5-HT1A and 5-HT2 receptors are comparable 
between PCC and PAC (Zilles et al., 2002). While studies about treatment response prediction are 
promising in LDAEP research, the optimal used analysis method is still debated (Jaworska et al., 
2013; Mulert et al., 2002; Park et al., 2011). However, scalp measured potentials, for instance at Cz, 
might reflect serotonergic modulated responses from both the PAC and the PCC (e.g. Linka et al., 
2004). To our knowledge, there exists no study investigating a modulatory effect of the 5-HT system 
on the PMC.  
Another interesting finding is that the presentation of auditory stimuli activated not only the primary 
auditory cortex but also the primary visual and somatosensory cortex. This is in agreement with the 
theory of multisensory integration that states low level integration in different sensory modalities (i.e. 
auditory, visual and somatosensory) and controverts the traditional assumption that multisensory 
integration is a higher order process (Schroeder & Foxe, 2005).  
By comparing the activation pattern between the time windows of N1m and P2m, we did not find 
any significant differences. Figure 7 reveals that there has been a slight shift of activation from the 
PCC toward the precuneus and the visual cortices.  
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5.2.5.3 LDAEP slope differences among the ROIs 
Our data showed that the characteristics of responses to high intensity levels differ between the 
ROIs. Responses at the highest intensities in the PAC level off, what is commonly called saturation, 
whereas the slope in the PCC and PMC continuously increases along the intensity level (Fig. 8). 
Saturation is particularly susceptible to varying methodological conditions and has been documented 
when stimuli were presented at shorter intervals than 2.5 s or when the intensity was held constant 
within blocks (Näätänen & Picton, 1987). However, this effect is discussed controversially to occur 
in the auditory cortex. While some studies reported saturation effects (Bruneau et al., 1985; 
Lockwood et al., 1999; Neukirch et al., 2002; Reite, Zimmerman, Edrich, & Zimmerman, 1982) 
others did not (Brechmann et al., 2002; Calvert et al., 2001; Hall et al., 2001; Jäncke et al., 1998; 
Langers et al., 2007; Wood et al., 1984). Thus it appears that the mechanism leading to saturation is 
not well understood. The hypothesis of intensity selectivity of neurons contribute to sorting out this 
issue: first, the observation of spatial extend of activated voxels with increasing intensities in fMRI 
leads to the hypothesis of an increase in the number of responding neurons. As a consequence, 
involved neurons spread to auditory association areas when the monotonic neurons in PAC are 
saturated (Jäncke et al., 1998; Uppenkamp & Roehl, 2013). The observed response saturation in PAC 
in our data might be a consequence of this restricted response. Second, it is supposed that neurons in 
the auditory cortex have specific functions related to the decomposition of acoustic information 
(Seifritz et al., 2002). The so called monotonic and non-monotonic intensity tuned neurons differ in 
their response to intensity level to protect the sensory system from overstimulation and are thought to 
be topographically organized without forming a clear intensity map in PAC (Woods et al., 2010). An 
incoming sensory stimulus gets processed in these neurons by a cortical intensity tuning mechanism 
that is based on the basic principle of the canonical microcircuit. This process emphasizes that 
temporal interaction between excitatory thalamic and inhibitory input via interneurons is pivotal for 
intensity tuning (Ojima, 2011; Wu, Tao, & Zhang, 2011). The fact that inhibition is less represented 
than excitation by the BOLD activation in functional imaging (Waldvogel et al., 2000), having in 
mind this interactional process, this could explain why most fMRI studies investigating response 
saturation in PAC did not find a saturation effect.  
Interestingly, the characteristics of the activation found in the PMC in our data is in line with earlier 
observations from our working group: Hagenmuller et al. (2011) revealed that the LDAEP slopes 
(amplitudes plotted against intensity) differentiate between DSA and single-electrode estimation at 
Cz. While the slope induced at the scalp showed a steady rise to increasing intensity levels, the 
potentials within PAC saturated with the highest intensity. This effect is also shown in the present 
data, when activations over intensities in PAC and PMC are compared. Considering the similar 
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LDAEP slopes at Cz and within the PMC, we can suppose that the single-electrode method’s 
sensitivity to potential changes outside the temporal cortex is affected by this frontal source.  
Furthermore, the nature of synchronicity of the activated brain regions plays an important role. 
Huang et al. (2003) reported a varying percentage of explained variance at the Cz electrode from 
bilateral superior temporal gyrus (STG) sources between healthy controls and patients with schizo-
phrenia. The authors attributed this group differences to an additional generator outside the STG that 
is supposed to fire synchronously or asynchronously with the sources in auditory cortex. In the case 
of synchronously firing – as showed in healthy subjects – it is possible that the variances of both 
sources were correlated and therefore not detectable at Cz. Interfering contributions from extra-
auditory areas, for instance from the PCC, could lead to additional variances of the results across 
psychiatric disorders complicating the use of different analysis approaches (Jaworska et al., 2013; 
Park et al., 2011).  
Substantive procedural differences make direct comparisons between studies on LDAEP difficult. As 
discussed by many authors, the stimuli presented to the subject have a crucial impact on the resulting 
signal and its sources. For example there is a big range of intensity levels presented in LDAEP 
studies – varying from two to six sound levels – what implicates differences in initial levels that in 
turn have an impact on the N1m amplitude (Park et al., 2011; Uhl et al., 2011). Moreover, as already 
discussed above the ISI is supposed to have an effect on the appearance of the sources because 
recovery cycles differ between populations of neurons (Coch, Skendzel, & Neville, 2005). It has 
even been demonstrated that the way the intervals are presented (randomized or in a block) influ-
ences the signal (Zacharias et al., 2012). In our study we did not focus on variation in ISI and its 
specific effects on source localisation remain open. Furthermore, an effect of frequency on the 
loudness dependence was reported (Calvert et al., 2001).  
Further research using dipole source analysis that takes this prior knowledge about the generating 
sources into account, will need to be undertaken. Sophisticated Bayesian inversion schemes (Kiebel, 
Daunizeau, Phillips, & Friston, 2008) are useful to objectively compare competing dipole models 
that vary in the numbers of dipoles or other informative priors and decide which theory explains the 
observed data best. 
5.2.5.4 Conclusion 
This study concentrates on the underlying mechanism of activation during the processing of auditory 
evoked fields related to the variation of tone intensities. Our results indicate that apart from the 
auditory cortex and its association areas other regions are activated post stimulus in the time window 
of N1m and P2m. The most striking result to emerge from the data is additional activation in the 
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premotor (PMC) and primary somatosensory areas with the highest intensity levels. Moreover, we 
found loudness dependent activation in the posterior cingulate cortex (PCC). For further investiga-
tion we analyzed time courses of the activity and receptiveness to rising intensity levels in these 
areas. The motor response might originate from a reaction (e.g. attentional, orienting or protective) of 
the organism to exceptional stimuli and is most likely indicated at the scalp level near vertex. As a 
result, source localization and single-electrode estimation do not cover the same sources and we 
suggest that these methods are not directly comparable in the analysis of LDAEP. 
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6. General discussion 
The LDAEP paradigm has been highly influential in psychiatric research as a potential non-invasive 
biomarker for central serotonergic activity (O'Neill, Croft, et al., 2008). Concomitantly, it has been 
used to make predictions of serotonergic drug response in major depression (Hegerl et al., 2001; 
Leuchter et al., 2009; Park & Lee, 2013). The present dissertation aims to investigate the LDAEP 
both in a clinical sample and in healthy subjects with special regard to the problems that exist when 
using imaging biomarkers. It is essential to address present limitations in order to improve the 
validity of the LDAEP and advance its application in clinical practice. 
The research questions raised in this thesis were motivated by the following shortcomings: first, 
when patients with schizophrenia are investigated, they may have only one or two symptoms in 
common, which is why potential alterations in serotonergic levels as assessed by the LDAEP cannot 
be attributed to the same biological roots. Second, although the LDAEP is a strategy that is very 
common in psychiatric research, a standard protocol for its use is missing. Recent studies showed 
that results obtained with different source analysis approaches are not comparable (Hagenmuller et 
al., 2011; Jaworska et al., 2013; Mulert et al., 2002). This inconcistency may result from the use of 
different methodologies that represent the neural activity of distinct underlying neural generators.  
The aim of the first study (chapter 5.1) was to refer the LDAEP to dimensional measures of mental 
functions in order to avoid the problem of heterogeneity that characterizes schizophrenia. We 
therefore examined patients with schizophrenia, who had been scaled with a standardized question-
naire that determined the severity of different syndromes. Serotonergic dysfunction, as measured by 
the LDAEP, was shown to differ within the phenotypic definition. The second study (chapter 5.2) 
used a distributed source analysis method to shed light on the neurobiological mechanisms of 
loudness dependence in healthy subjects. The findings revealed that a distributed network of 
underlying neural generators is involved. Furthermore, there may be a decisive influence on results 
obtained from scalp channel measures.  
In the following, the findings of the two empirical studies will shortly be summarized and discussed 
in a broader context by taking a more overarching perspective than was outlined in the respective 
discussion sections of the particular studies. 
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6.1 LDAEP as a biomarker in schizophrenia research 
Schizophrenia is a complex and multifactorial disorder with a heterogeneous manifestation of 
psychopathological symptoms. The unravelling of its exact neuronal origins is challenging. The 
present study aimed to examine the underlying chemical disturbances in negative symptoms, a 
subgroup of symptoms within the diagnosis of schizophrenia, by using LDAEP.  
Accordant with our hypothesis, patients with predominant negative symptoms showed a significantly 
stronger LDAEP and respectively lower serotonergic activity than controls. Consistent with earlier 
findings in schizophrenia (Schooler, Buchsbaum, & Carpenter Jr, 1976), our results may be inter-
preted as a failure of the sensory system to sufficiently control for stimulus intensity (strong LDAEP) 
in the chronic state of schizophrenia. This may be interpreted as a lack of protection against over-
stimulation. Such a failure in modulation of sensory input might be controlled by both a cortical 
intensity tuning mechanism in the PAC (Wu et al., 2011) and by higher cognitive functions that 
orientate attention or monitor sensory events (Näätänen & Picton, 1987; Wyss et al., 2014). On the 
other hand, based on the assumption of an inverse relationship between LDAEP and 5-HT function-
ing (Juckel, 2005), this finding points to a reduced serotonergic activity. The prevalent theory of the 
aetiology of negative symptoms suggests a decreased serotonergic and dopaminergic activity in the 
mesocortical system (Abi-Dargham, 2007; B. Roth & Meltzer, 2000). Serotonin has a modulating 
effect on the dopaminergic system. However, to date it is not clear whether this regulation is 
excitatory or inhibitory. The modulatory effect probably depends on the specific 5-HT receptor types 
that are involved (Boureau & Dayan, 2010) as well as mediating effects through interneurons (Kapur 
& Remington, 1996). Moreover, this opposing effect is reflected in drug action that improves the 
outcome of negative symptoms in schizophrenia on the one hand via 5-HT2 antagonism (i.e. atypical 
neuroleptics) and on the other hand via enhancing serotonergic levels through serotonin reuptake 
inhibition (i.e. SSRI) (Leucht et al., 2011; Silver, 2004; S. P. Singh et al., 2010). In future studies the 
exact mechanisms underlying the serotonin-dopamine interaction and its relevance to negative 
symptoms as well as the action of pharmacological agents in the treatment of these symptoms have 
still to be elucidated (De Bartolomeis, Buonaguro, & Iasevoli, 2013; B. Roth & Meltzer, 2000).  
Contrary to our findings, the majority of studies reported weaker LDAEP (stronger serotonergic 
activity) in patients with schizophrenia diagnosed on the basis of current diagnostic categories 
(Gudlowski et al., 2009; Juckel et al., 2003; Juckel, Gudlowski, et al., 2008; Park et al., 2010). Some 
of these studies also stated weak correlations between LDAEP values and psychopathological scales, 
but the findings were inconsistent (Gudlowski et al., 2009; Juckel, Gudlowski, et al., 2008; 
Ostermann et al., 2012). However, these results should be treated with caution because reflecting a 
mixture of symptoms based on different underlying biological processes, they may be biased. 
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Additionally, the methodological parameters used in these studies are hardly comparable and beyond 
that, the caveats outlined in chapter 2.2 may have influenced the results (e.g. gender, analysis 
approach).  
Regarding the present findings the following conclusions can be drawn:  
On the one hand, the study supports the LDAEP as valid tool for identifying differential clinical 
features of schizophrenia by reflecting its aetiological factors, i.e. dysfunctional serotonergic activity. 
Due to the pivotal role that serotonin and dopamine play in the generation of negative symptoms in 
schizophrenia, we extracted, supplementary to the present study, deoxyribonucleic acid (DNA) from 
whole blood samples in order to learn more about the genetic causes of the illness. By examining 
fifteen subjects (controls, n=7; patients with schizophrenia, n=8), we focused on the COMT-gene and 
the 5-HTTLPR being a part of the serotonin transporter (SERT)-gene. COMT is the enzymatic 
product of the COMT-gene and influences dopamine levels by degrading of synaptic dopamine and 
the SERT is responsible in the reuptake of serotonin in the presynaptic neuron (Cooper & Roth, 
2003). The results provided a significant association between the COMT polymorphism and the 
LDAEP in accordance with earlier observations (Juckel, Kawohl, et al., 2008). The main conclusion 
of this finding is that neurotransmitters other than serotonin may have an influence on the LDAEP, 
and this is currently a matter of investigation as further discussed in chapter 6.3. However, due to the 
small sample sizes in the defined groups of allele carriers (n=2/13) and genotypes (n=2/8) (see table 
1 and 2 in the appendix) the results should be interpreted with caution. They were therefore not 
published in the enclosed paper. Further research is needed to clarify the aetiology of positive and 
negative symptoms in more detail before the LDAEP can be used as a diagnostic tool in clinical 
work. It is still unresolved which of the neurotransmitters, serotonin or dopamine, is the driving force 
when it comes to a functional abnormality (Abi-Dargham, 2007; Goff & Evins, 1998; Winograd-
Gurvich et al., 2006). 
On the other hand, as outlined in the introduction of this thesis, the aetiological heterogeneity of 
clinical diagnosis is only one of the problems occurring within the scope of clinical biomarkers. 
Another important aspect that should be considered is that contradictory findings may result from 
different methodologies used in the parameterization of the LDAEP (Hagenmuller et al., 2011). In 
this context, an interesting finding from our study was that the LDAEP at Cz revealed no significant 
differences between the groups. Thus, the estimation at a single electrode site was confirmed to be 
not comparable with dipole source analysis. This accords with earlier observations in which both 
methodologies were compared and significantly different results were found (Hagenmuller et al., 
2011). A possible explanation is that an additional source outside the auditory cortex might be active 
during auditory processing and contribute to the electrical potentials measured at the scalp surface 
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(Alcaini et al., 1994; Arezzo et al., 1975; Giard et al., 1994; Näätänen & Picton, 1987; Picton et al., 
1999). Crucially, the activity from such an additional generator might be either synchronized or 
asynchronized with the activity in the auditory cortex depending on the pathological state of the 
sample examined (Huang et al., 2003). In other words, the mixture of activity from different sources 
that is measured at a single electrode, for example Cz, might differ between patients with schizo-
phrenia and healthy individuals. With due consideration of these arguments it may not be surprising 
that studies investigating the LDAEP in schizophrenic patients reported controversial results, as 
different analysis methodologies were used across studies.  
The study has certain limitations. One source of weakness in this study, which could have affected 
the reported results was that all patients were under medical treatment. The increased loudness 
dependency in patients could be caused by the administered antipsychotic therapy (i.e. the EPSP 
might be enhanced by a reduced inhibitory effect through GABAergic interneurons which in turn 
receive a reduced input via 5-HT2A receptors, because they are blocked by atypical neuroleptics) 
(Meltzer, 1999). Such an effect of medication is reflected by a study that investigated patients with 
schizophrenia treated with atypical neuroleptics over four weeks (Juckel et al., 2003). The results 
showed an increased LDAEP after the treatment compared to baseline measurements. More infor-
mation on the relation between chronically modulating effects of the serotonergic system and the 
LDAEP by means of longitudinal studies would help us to clarify this matter (Meltzer & Massey, 
2011).  
Another limitation of this study is that the numbers of patients and controls were relatively small. 
However, it must be mentioned that the effect sizes that quantify the size of the difference between 
two groups were rather large (Cohen’s d between 1.04-1.20). Further studies should compare the 
LDAEP within schizophrenia by reflecting both the negative and positive symptom clusters, however 
a larger sample size is needed to guarantee a broad variance in symptom characteristics. 
An issue that was not addressed in this study was the determination of the individual hearing levels. 
Based on the original research by Hegerl and Juckel (1993), in which they used sound pressure 
levels, most ensuing studies retained this reference. However, the estimated prevalence of hearing 
impairments, implying that the hearing level lies above 35 dB in the better ear, is between 10-12% in 
general population (age > 15 years) (Stevens et al., 2013). Therefore, the presentation of stimuli of 
different intensities should be referenced to an individual’s hearing threshold. In the second study 
presented in this thesis we accounted for this paucity by determining the SL prior to each experiment. 
In addition, because we used plastic tubes in the MEG experiment to deliver the tones, this procedure 
allowed us to control for further variability due to stimulation setting. 
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The questions brought up in study I relating to the lack of comparability of different analysis 
approaches were further investigated in study II. There we aimed to unravel the generators that are 
involved in the LDAEP paradigm, particularly during loudness perception by means of MEG.  
6.2 Generating sources of LDAEP 
The aim of study II was to explore the neural activations in the time course of the LDAEP in order to 
understand why the commonly used analysis strategies (i.e. dipole source analysis and single 
electrode estimation) are not comparable (Hagenmuller et al., 2011). The study yields the possibility 
of giving researchers using LDAEP strong arguments for deciding on an analysis strategy that is the 
most specific for measuring activity in the PAC. Moreover, referring to the problems about the 
validation of biomarkers as outlined in the introduction, the unravelling of the underlying sources 
might improve the construct validity of the LDAEP and support the interpretation of its mechanisms. 
Several studies have been dedicated to investigating the underlying neuronal mechanism of auditory 
intensity processing by means of electrophysiological methods (Alcaini et al., 1994; Budd et al., 
1998; Hari et al., 1982; Näätänen & Picton, 1987; Velasco & Velasco, 1986). So far, only assump-
tions about an additional source being involved have been drawn in the respective studies and the 
results are ambiguous. However, none of these studies used distributed source analysis to explore the 
underlying generators. We therefore investigated 19 healthy male subjects using MEG to shed light 
on the LDAEP’s generators and its dynamics over time. MEG was chosen because of its advantages 
compared to EEG and fMRI as outlined in chapter 4 and 4.3 respectively. Specifically, physiological 
knowledge based on fMRI studies might be problematic when transferred to EEG analysis for setting 
the number of dipoles a priori (Michel et al., 2004), because the hemodynamic response measured 
with fMRI only reflects the underlying neural activity indirectly (Logothetis, Pauls, Augath, Trinath, 
& Oeltermann, 2001). However, we used MEG to specifically address this research question and not 
to present an alternative measurment method to EEG, especially since MEG scanners are very rare 
and the costs are too high for clinical application.  
The results revealed that during the processing of tones with high intensity levels in the time window 
of N1/P2, not only auditory association areas were activated, but also additional brain regions, 
namely the somatosensory cortex, the premotor cortex (PMC) and the posterior cingulate cortex 
(PCC). 
Of special interest is the activation in the PCC, where strong loudness dependence was observed. 
Interestingly, the PCC contains a mean density (i.e. averaged over all cortical layers) of serotonergic 
receptors (5-HT1A and 5-HT2) that is comparable with that in the PAC. This was shown by the 
seminal study of Zilles et al. (2002) that integrated data from different imaging modalities to produce 
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transmitter receptor fingerprints in the human cerebral cortex. A human PET study additionally 
revealed that 5-HT1A receptors were responsible for a modulatory effect on the key region of the 
default mode network (i.e. the PCC is a pivotal hub in the human resting brain with the highest 
number of functional connections) (Hahn et al., 2012). Crucially, the PCCs structure (Kraus et al., 
2014) and function (Matthews et al., 2010) was reported to be altered by chronic SSRI pharma-
cotherapy. It can thus be concluded that by analysing scalp potentials in the context of the LDAEP, 
the contributing signal from the PCC could likewise add a significant input. Under consideration that 
the LDAEP is traditionally computed from the activity either extracted from dipole source analysis 
or measured at scalp electrodes, these findings provide evidence that the comparability between these 
two methodologies is problematic. They may not represent activity from the same sources. 
These conclusions might have important implications for researching treatment response prediction. 
Studies that examined, in a comparative manner, whether the predictions made about favourable 
response to SSRI treatment were relying on the analysis strategy used for the LDAEP showed 
inconsistent findings. One study favoured the use of source analysis (LORETA) compared to scalp 
channel measures to achieve the best scores in discriminating responders from non-responders 
(Jaworska et al., 2013), which may well be true when using dipole source analysis (Mulert et al., 
2002). An other study found that the power of LORETA as an analytical tool is comparable to that of 
scalp measured LDAEP (Park et al., 2011). And some other reports supported satisfying response 
prediction to SSRIs by measurements at single electrodes only (T. W. Lee, Yu, Chen, & Tsai, 2005; 
Linka et al., 2004). However, the sample under investigation varied between patients with major 
depression and anxiety disorder. The involvement of non-specific brain areas, as found in our study, 
may provide an alternative explanation as to why the above-mentioned studies found favourable 
prediction for treatment response by means of scalp channel measures. Moreover, due to the addi-
tional contribution from non-specific brain areas where synchronized activity can have an interactive 
effect on the variation of the result, the findings may also differ across psychiatric disorders (Huang 
et al., 2003). 
Another line of argument that our data indicates is that the characteristic responses to increasing 
intensity, especially responses to the highest intensities, may reflect differences in cortical origin. 
Indeed, when plotting the amplitude against intensity, the slopes differ across the regions of interest. 
The primary auditory cortex showed decreased amplitudes at the highest intensities, in primary 
somatosensory cortex a similar tendency was observed, whereas the PCC and PMC revealed a 
linearly increasing slope. We assumed that these characteristics in the primary sensory areas were 
attributed to a so-called saturation effect, allowing the sensory system to protect itself from over-
stimulation. However, the existence of such an effect in the auditory cortex is discussed with 
controversy across several different imaging methods (Bruneau et al., 1985; Calvert et al., 2001; Hall 
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et al., 2001; Jäncke et al., 1998; Langers et al., 2007; Lockwood et al., 1999; Neukirch et al., 2002; 
Reite et al., 1982). Accordingly, different theories exist about its underlying mechanisms (Jäncke et 
al., 1998; Ojima, 2011; Uppenkamp & Roehl, 2013; Wu et al., 2011). Notwithstanding, these 
observations are of great importance as they focus on improving the analysis strategy in LDAEP 
research, since exactly the same pattern can be recognized when LDAEP slopes are either plotted 
from the Cz electrode or from dipole source analysis displaying the activity of the PAC 
(Hagenmuller et al., 2011). In this respect, activity recorded at Cz may include activity generated in 
the PCC and PMC. Interestingly, in investigating the augmenting/reducing phenomenon it was noted 
that the response patterns differed within the same individuals depending on the placement of the 
electrode (i.e. midline or temporal) (Carrillo-de-la-Pena, 1999; Prescott, Connolly, & Gruzelier, 
1984). As a consequence, the comparability between results obtained with these methods is problem-
atic. Important to note is that the described saturation effect is assumed to be biased by several 
methodological conditions. The ISI and the design of stimuli presentation (randomised or in blocks) 
influences the occurrence of the paradoxical reduction (Näätänen & Picton, 1987). Moreover, the 
loudest tone presented to the subject is important, because an individual with a strong LDAEP might 
reach the point where the signal saturates earlier than one with a weaker LDAEP (Hensch et al., 
2006). In the present study, the intensity levels varied between 10 and 60 dB SL (i.e. 30 and 80 dB 
SPL attested by audiometric measurements) and as such were relatively low. Nevertheless, the MEG 
responses to the lowest and highest tones were surprisingly distinct.  
Finally, a number of important limitations need to be considered. One basic limitation of the present 
study is the fact that MEG is limited in its sensitivity for radially oriented sources (Ahlfors et al., 
2010). On account of that, the extent of activated brain regions found during the N1/P2 time window 
could be restricted. A recent study from our group used simultaneous EEG and fMRI recordings to 
elucidate the underlying generators of the LDAEP (Neuner et al., 2014). In contrast to our study, 
additional activation in the insular cortices with high intensity tones was found here. Because the 
insular cortices are mainly radially oriented, it is likely that no signal was detectable. Furthermore, 
the determination of the auditory threshold was complicated by the background noise in the MEG 
scanner. Audiometric measurements revealed that the white noise level was similar to individual 
thresholds. Fortunately, human brains are specialized to filter out important information by means of 
attention and various acoustic cues (Ebata, 2003) leading to a distinct electrophysiological response. 
6.3 Future directions 
The present work adds important knowledge in the course of advancing the validation of the LDAEP 
as a potential biomarker. By means of referring to dimensional measures of symptoms in schizophre-
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nia (e.g. severity of negative symptoms), the underlying neuronal dysfunctions can be identified 
more reliably than when referring to the phenotypic definition (see chapter 5.1). Additionally, study 
II showed that several other neuronal sources apart from the auditory cortex are involved in loudness 
processing (see chapter 5.2). This information should be included in the analysis of the LDAEP. 
These findings suggest several courses of action for establishing rigorous and standardized protocols 
not only for the acquisition parameters of the LDAEP but also for its analysis. Discrepancies found 
throughout the research literature suggest that numerous variables have a marked influence on the 
results and impair the sensitivity and specificity of the LDAEP for 5-HT function (see chapter 2.3).  
Basically, this easily implemented EEG-based method could be more largely used in practical 
clinical work to support clinicians in complementing their impressions and intuition with a more 
sophisticated approach (Juckel, Pogarell, et al., 2007). However, further research has to account for 
challenges bridging the science-to-service gap in psychiatry in order to advance the implementation 
of this paradigm in routine clinical practice. 
A fruitful avenue would be the combination of different measures either to correlate the same 
construct as the LDAEP (e.g. measurement of 5-HT release capacity using PET (Quednow et al., 
2012); serum BDNF levels (U. E. Lang, Hellweg, & Gallinat, 2005; Park, Lee, Um, & Kim, 2014)) 
or using measures that are linked to the construct (e.g. SSRI response prediction by theta activity in 
anterior cingulate cortex (Pizzagalli et al., 2001)). Furthermore, the specificity and sensitivity in 
individual treatment decisions or diagnostic accuracy of a psychiatric disease could be enhanced by 
the combination of several independent biomarkers in a multivariate analysis approach (e.g. pattern 
recognition) (Linden, 2012). The basic idea behind this approach is to use the combination of 
different parameters, as for example brain activity in different ROIs or connectivity measures, as 
well as imaging functional polymorphisms to separate patients from healthy individuals or to differ 
between diagnostic categories (see Klöppel et al. (2012) or Orrù, Pettersson-Yeo, Marquand, Satori, 
& Mechelli (2012) for a review). 
A further way of improving the validity of biomarker findings in psychiatry lies in identifying the 
multiple genetic variants that contribute to the clinical phenotypes. As outlined in the introduction 
section (chapter 1.1), the LDAEP fulfils the requirements to stand as an endophenotype. However, 
since genetic association studies indicated that the LDAEP may also underlie influences by different 
neurotransmitter systems, the LDAEP’s sensitivity and specificity for serotonin has been challenged 
(Guille et al., 2008; Massey, Marsh, & McAllister-Williams, 2004; Nathan, Segrave, Phan, O'Neill, 
& Croft, 2006; Norra et al., 2008; Proietti-Cecchini, Afra, & Schoenen, 1997; Segrave et al., 2006; 
Uhl et al., 2006). Associations with the dopaminergic system by means of the COMT polymorphism 
(Juckel, Kawohl, et al., 2008) or by dopamine transporter availability (DAT) (I. H. Lee et al., 2011; 
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Pogarell et al., 2004) were reported. Interestingly, short-time manipulations of the dopaminergic 
system as reflected in dopamine depletion (O'Neill, Guille, et al., 2008) and acute dopamine chal-
lenges with either pergolide, bromocriptine (O'Neill et al., 2006) or levodopa (Hitz et al., 2011) had 
no effects on the LDAEP. It is therefore assumed to be only manipulated by trait factors, i.e. genetic 
predisposition or chronic modulation of monoaminergic activity (O'Neill, Croft, et al., 2008; 
Simmons et al., 2011). Moreover, manipulating effects of glycine, a modulator of NMDA receptors, 
on the LDAEP have been found (O'Neill et al., 2007). Furthermore the gaseous molecule with 
neurotransmitter properties nitric oxide (NO) is thought to influence serotonergic-dopaminergic 
transmission. Kawohl, Giegling et al. (2008) found that functional single nucleotide polymorphisms 
(SNPs) of NOS1 and NOS3 were associated with the LDAEP.  
In addition to possible neuromodulation by monoaminergic systems as discussed above these evoked 
potentials are also modulated by the phasic release of excitatory (i.e. glutamate) and inhibitory (i.e. 
GABA) neurotransmitter systems in the cortex (O'Neill, 2008; Simpson & Knight, 1993). Apparent-
ly, there is no clear evidence about the interaction of GABAergic neurotransmission and the genera-
tion of ERPs. In particular, no research has been done on LDAEP and GABA neurotransmitter 
activity (Kenemans & Kähkönen, 2011). Notwithstanding, a recent study reported high neural 
densities of GABA in the primary sensory and motor areas (La Fougere et al., 2011). Therefore, the 
relationship between LDAEP and GABAergic neurotransmission warrants closer investigation. 
We intended to overcome these shortcomings by conducting studies that investigate the LDAEP and 
GABAergic neurotransmission in healthy humans. In the first study, we combined EEG with 
magnetic resonance spectroscopy (MRS) to measure the amount of free GABA and examined the 
relationship between this neurotransmitter and the neural processing of auditory stimuli in EEG. 
MRS is a very sensitive, non-invasive MRI technique, which allows the in vivo detection of endoge-
nous metabolites in the human brain. However, we did not find any significant correlation between 
the amount of GABA in the auditory cortex and the LDAEP. Moreover, the variances of the effects 
were too high to guarantee a sufficient statistical power. There is evidence that the evoked gamma 
band response is highly correlated with resting GABA concentration (Muthukumaraswamy, Edden, 
Jones, Swettenham, & Singh, 2009) and in addition is modulated by sound intensity (Schadow et al., 
2007). Therefore, the association between GABA levels and gamma-band oscillatory activity in the 
auditory cortex is currently under investigation. To our knowledge, this is the first study that 
measured GABA in the auditory cortex by means of MRS. In a second study we aim to investigate 
the LDAEP and GABAergic neurotransmission in healthy humans simultaneously. We therefore 
planned a study in a hybrid 3T MR-PET scanner (Herzog et al., 2011) with simultaneous EEG 
measurements that will be conducted during the next months. By using radiopharmaceutical com-
pounds, for instance [11C]-flumazenil, PET can reveal the distribution of GABAA receptors in 
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human brain (Miederer et al., 2009). The combination of EEG, PET and MRI imaging techniques 
provides the unique opportunity to simultaneously measuring molecular and functional parameters 
that vary over time. 
6.4 Conclusion 
The present work extends previous research investigating the neurochemical aetiology of negative 
symptoms in schizophrenia by means of LDAEP. Our results revealed that serotonergic activity 
might be reduced in patients with predominantly negative symptoms. This is in accordance with 
medication strategies using atypical neuroleptic medication and antidepressants to enhance sero-
tonergic neurotransmission in this subgroup of patients (Leucht et al., 2011; Silver, 2004). The 
LDAEP is therefore a valid instrument to clarify the underlying pathologies of symptom clusters in a 
heterogeneous diagnosis, such as schizophrenia, and may support individual treatment decisions. 
However, methodological factors which may have influenced the results must be considered and 
need further investigation. In particular the analysis strategies used for the LDAEP must be noted. 
Several studies confirmed that dipole source analysis and single electrode estimation lead to different 
findings and hence are not comparable (Hagenmuller et al., 2011; Jaworska et al., 2013). We 
therefore used source localization procedures by means of magnetic field tomography in MEG in 
order to provide a better estimation of the underlying sources involved in the generation of the 
LDAEP. Interestingly, the analysis showed that along with the auditory cortex additional brain areas 
are involved. Moreover, some of these areas such as the PCC are modified by serotonergic neuro-
transmission. This should also have an impact on the most promising utility of the LDAEP as a 
response marker for antidepressant treatment. Future research should employ standardized proce-
dures in the acquisition and analysis of the LDAEP in order to ensure comparability between studies 
and to improve the validity of its qualities as a biomarker (Luck et al., 2011).  
References 
67 
References 
Abi-Dargham, A. (2007). Alterations of serotonin transmission in schizophrenia. International Review of 
Neurobiology 78, 133-164. doi: 10.1016/S0074-7742(06)78005-9 
Addington, D., Addington, J., & Schissel, B. (1990). A depression rating-scale for schizophrenics. 
Schizophrenia Research, 3(4), 247-251.  
Ahlfors, S. P., Han, J., Belliveau, J. W., & Hämäläinen, M. S. (2010). Sensitivity of MEG and EEG to 
source orientation. Brain Topography, 23(3), 227-232.  
Alcaini, M., Giard, M., Thevenet, M., & Pernier, J. (1994). Two separate frontal components in the N1 
wave of the human auditory evoked response. Psychophysiology, 31(6), 611-615.  
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-
IV-TR: Washington: American Psychiatric Association. 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-
V: Washington: American Psychiatric Association. 
Andreasen, N. C. (1982). Negative symptoms in schizophrenia - definition and reliability. Archives of 
General Psychiatry, 39(7), 784-788.  
Andreasen, N. C. (1989). The scale for the assessment of negative symptoms (Sans) - Conceptual and 
theoretical foundations. British Journal of Psychiatry, Supplement, 155(7), 49-52.  
Andreasen, N. C., & Black, D. W. (2001). Introductory textbook of psychiatry (third ed.): Washington, 
DC: American Psychiatric Publishing. 
Andreasen, N. C., Nopoulos, P., Schultz, S., Miller, D., Gupta, S., Swayze, V., & Flaum, M. (1994). 
Positive and negative symptoms of schizophrenia - past, present, and future. Acta Psychiatrica 
Scandinavica, 90, 51-59.  
Arezzo, J., Pickoff, A., & Vaughan, H. G. (1975). The sources and intracerebral distribution of auditory 
evoked potentials in the alert rhesus monkey. Brain Research, 90(1), 57-73. doi: 10.1016/0006-
8993(75)90682-4 
Attal, Y., Maess, B., Friederici, A., & David, O. (2012). Head models and dynamic causal modeling of 
subcortical activity using magnetoencephalographic /electroencephalographic data. Reviews in 
the Neurosciences, 23(1), 85-95. doi: 10.1515/rns.2011.056 
Azmitia, E. C., & Gannon, P. J. (1986). The primate serotonergic system: a review of human and animal 
studies and a report on Macaca fascicularis. Advances in Neurology, 43, 407-468.  
Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Heckers, S., Malaspina, D., . . . Carpenter, W. T. (2013). 
Logic and justification for dimensional assessment of symptoms and related clinical phenomena 
in psychosis: Relevance to DSM-5. Schizophrenia Research, 150(1), 15-20. doi: 
10.1016/j.schres.2013.04.027 
Baribeau, J. C., & Laurent, J. P. (1987). The effect of selective attention on augmenting/intensity function 
of the early negative waves of AEPs. Electroencephalography and Clinical Neurophysiology. 
Supplement, 40, 68-75.  
Beaglehole, R., & Irwin, A. (2004). The world health report, 2004: Changing history: World Health 
Organization. 
Beauducel, A., Debener, S., Brocke, B., & Kayser, J. (2000). On the reliability of augmenting/reducing. 
International Journal of Psychophysiology, 14(4), 226-240.  
Bech, P., & Rafaelsen, O. J. (1980). The use of rating-scales exemplified by a comparison of the hamilton 
and the bech-rafaelsen melancholia scale. [Article]. Acta Psychiatrica Scandinavica, 62, 128-132.  
Bell, C., Abrams, J., & Nutt, D. (2001). Tryptophan depletion and its implications for psychiatry. The 
British Journal of Psychiatry, 178, 399-405.  
Birbaumer, N., & Schmidt, R. F. (2005). Biologische Psychologie.: Berlin: Springer. 
Boureau, Y.-L., & Dayan, P. (2010). Opponency revisited: competition and cooperation between 
dopamine and serotonin. Neuropsychopharmacology, 36(1), 74-97.  
Bozikas, V. P., Kosmidis, M. H., Kioperlidou, K., & Karavatos, A. (2004). Relationship between 
psychopathology and cognitive functioning in schizophrenia. Comprehensive Psychiatry, 45(5), 
392-400.  
References 
68 
Brechmann, A., Baumgart, F., & Scheich, H. (2002). Sound-level-dependent representation of frequency 
modulations in human auditory cortex: A low-noise fMRI study. Journal of Neurophysiology, 
87(1), 423-433.  
Breier, A. (1995). Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia Research, 14(3), 
187-202.  
Bruneau, N., Roux, S., Garreau, B., & Lelord, G. (1985). Frontal auditory evoked potentials and 
augmenting-reducing. Electroencephalography and Clinical Neurophysiology, 62(5), 364-371. 
doi: 10.1016/0168-5597(85)90045-0 
Buchsbaum, M. (1971). Individual differences in stimulus intensity response. Psychophysiology, 8(5), 
600-611. doi: 10.1111/j.1469-8986.1971.tb00496 
Buchsbaum, M., & Silverman, J. (1968). Stimulus intensity control and cortical evoked response. 
[Article]. Psychosomatic Medicine, 30(1), 12-&.  
Budd, T., Barry, R. J., Gordon, E., Rennie, C., & Michie, P. (1998). Decrement of the N1 auditory event-
related potential with stimulus repetition: habituation vs. refractoriness. International Journal of 
Psychophysiology, 31(1), 51-68.  
Calvert, G. A., Hansen, P. C., Iversen, S. D., & Brammer, M. J. (2001). Detection of audio-visual 
integration sites in humans by application of electrophysiological criteria to the BOLD effect. 
Neuroimage, 14(2), 427-438.  
Carrillo-de-la-Pena, M. T. (1992). ERP augmenting/reducing and sensation seeking: A critical review. 
International Journal of Psychophysiology, 12(3), 211-220.  
Carrillo-de-la-Pena, M. T. (1999). Effects of intensity and order of stimuli presentation on AEPs: An 
analysis of the consistency of EP augmenting/reducing in the auditory modality. Clinical 
Neurophysiology, 110(5), 924-932.  
Carrillo-de-la-Pena, M. T. (2001). One-year test-retest reliability of auditory evoked potentials (AEPs) to 
tones of increasing intensity. Psychophysiology, 38(3), 417-424.  
Chen, T. J., Yu, Y. W. Y., Chen, M. C., Wang, S. Y., Tsai, S. J., & Lee, T. W. (2005). Serotonin 
dysfunction and suicide attempts in major depressives: An auditory event-related potential study. 
Neuropsychobiology, 52(1), 28-36. doi: 10.1159/000086175 
Chen, Y.-H., Dammers, J., Boers, F., Leiberg, S., Edgar, J. C., Roberts, T., & Mathiak, K. (2009). The 
temporal dynamics of insula activity to disgust and happy facial expressions: A 
magnetoencephalography study. Neuroimage, 47(4), 1921.  
Clark, L. A., & Watson, D. (1995). Constructing validity: Basic issues in objective scale development. 
Psychological Assessment, 7(3), 309.  
Coch, D., Skendzel, W., & Neville, H. J. (2005). Auditory and visual refractory period effects in children 
and adults: An ERP study. Clinical Neurophysiology, 116(9), 2184-2203. doi: 
10.1016/j.clinph.2005.06.005 
Connolly, J. F., & Gruzelier, J. H. (1982). Amplitude and latency changes in the visual evoked potential 
to different stimulus intensities. Psychophysiology, 19(6), 599-608.  
Cook, I. A. (2008). Biomarkers in psychiatry: potentials, pitfalls, and pragmatics. Primary Psychiatry, 
15(3), 54.  
Cooper, J. R., & Roth, R. H. (2003). The biochemical basis of neuropharmacology: Oxford university 
press. 
Dammers, J., Chocholacs, H., Eich, E., Boers, F., Faley, M., Dunin-Borkowski, R. E., & Shah, N. J. 
(2014). Source localization of brain activity using helium-free interferometer. Applied Physics 
Letters, 104(21), 213705.  
Dammers, J., & Ioannides, A. A. (2000). Neuromagnetic localization of CMV generators using 
incomplete and full-head biomagnetometer. Neuroimage, 11(3), 167-178. doi: 
10.1006/nimg.1999.0524 
Dammers, J., Mohlberg, H., Boers, F., Tass, P., Amunts, K., & Mathiak, K. (2007). A new toolbox for 
combining magnetoencephalographic source analysis and cytoarchitectonic probabilistic data for 
anatomical classification of dynamic brain activity. Neuroimage, 34(4), 1577-1587. doi: 
10.1016/j.neuroimage.2006.09.040 
Dammers, J., Schiek, M., Boers, F., Silex, C., Zvyagintsev, M., Pietrzyk, U., & Mathiak, K. (2008). 
Integration of amplitude and phase statistics for complete artifact removal in independent 
References 
69 
components of neuromagnetic recordings. IEEE Transactions on Biomedical Engineering, 
55(10), 2353-2362.  
Davidson, L., & McGlashan, T. H. (1997). The varied outcomes of schizophrenia. Canadian Journal of 
Psychiatry. Revue Canadienne de Psychiatrie, 42(1), 34-43.  
Davis, J. M., Chen, N., & Glick, I. D. (2003). A meta-analysis of the efficacy of second-generation 
antipsychotics. Archives of General Psychiatry, 60(6), 553-564. doi: 10.1001/archpsyc.60.6.553 
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991). Dopamine in schizophrenia: a review and 
reconceptualization. American Journal of Psychiatry, 148(11), 1474-1486.  
De Bartolomeis, A., Buonaguro, E., & Iasevoli, F. (2013). Serotonin-glutamate and serotonin-dopamine 
reciprocal interactions as putative molecular targets for novel antipsychotic treatments: From 
receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology, 
225(1), 1-19.  
De Pascalis, V., Cozzuto, G., & Russo, E. (2012). Effects of personality trait emotionality on acoustic 
startle response and prepulse inhibition including N100 and P200 event-related potential. Clinical 
Neurophysiology, 124(2), 292-305. doi: 10.1016/j.clinph.2012.07.018 
Debener, S., Strobel, A., Kurschner, K., Kranczioch, C., Hebenstreit, J., Maercker, A., . . . Brocke, B. 
(2002). Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion? 
Biological Psychiatry, 59(2), 121-133. doi: 10.1016/S0301-0511(01)00132-6 
Ebata, M. (2003). Spatial unmasking and attention related to the cocktail party problem. Acoustical 
Science and Technology, 24(5), 208-219.  
Eickhoff, S. B., Heim, S., Zilles, K., & Amunts, K. (2006). Testing anatomically specified hypotheses in 
functional imaging using cytoarchitectonic maps. Neuroimage, 32(2), 570-582. doi: 
10.1016/j.neuroimage.2006.04.204 
Fabiani, M., Gratton, G., & Coles, M. G. (2000). Event-related brain potentials. In J. T. Caciooppo, L. G. 
Tassinary & G. G. Berntson (Eds.), Handbook of psychophysiology (pp. 53-84). Cambridge: 
Cambridge University Press. 
Fink, M., Wadsak, W., Savli, M., Stein, P., Moser, U., Hahn, A., . . . Lanzenberger, R. (2009). 
Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. 
Neuroimage, 45(2), 598-605. doi: 10.1016/j.neuroimage.2008.11.033 
First, M. B. (2010). Paradigm shifts and the development of the diagnostic and statistical manual of 
mental disorders: Past experiences and future aspirations. Canadian Journal of Psychiatry. Revue 
Canadienne de Psychiatrie, 55(11), 692-700.  
Fitzgerald, P. B., Mellow, T. B., Hoy, K. E., Segrave, R., Cooper, N. R., Upton, D. J., & Croft, R. J. 
(2009). A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated 
melancholic and non-melancholic depression. Journal of Affective Disorders, 117(3), 212-216.  
Flaum, M., & Andreasen, N. C. (1995). The reliability of distinguishing primary versus secondary 
negative symptoms. Comprehensive Psychiatry, 36(6), 421-427. doi: 10.1016/s0010-
440x(95)90249-x 
Gallinat, J., Bottlender, R., Juckel, G., Munke-Puchner, A., Stotz, G., Kuss, H. J., . . . Hegerl, U. (2000). 
The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute 
SSRI response in depression. Psychopharmacology, 148(4), 404-411. doi: 
10.1007/s002130050070 
Gallinat, J., Kunz, D., Lang, U. E., Kalus, P., Juckel, G., Eggers, J., . . . Smolka, M. N. (2005). 
Serotonergic effects of smoking are independent from the human serotonin transporter gene 
promoter polymorphism: Evidence from auditory cortical stimulus processing. 
Pharmacopsychiatry, 38(4), 158-160.  
Gallinat, J., Muller, D. J., Bierbrauer, J., Rommelspacher, H., Juckel, G., & Wernicke, C. (2007). 
Functional cortical effects of novel allelic variants of the serotonin transporter gene-linked 
polymorphic region (5-HTTLPR) in humans. Pharmacopsychiatry, 40(5), 191-195. doi: 
10.1055/s-2007-984464 
Gallinat, J., Senkowski, D., Wernicke, C., Juckel, G., Becker, I., Sander, T., . . . Winterer, G. (2003). 
Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene 
is associated with auditory cortical stimulus processing. Neuropsychopharmacology, 28(3), 530-
532. doi: 10.1038/sj.npp.1300042 
References 
70 
Giard, M. H., Perrin, F., Echallier, J. F., Thevenet, M., Froment, J. C., & Pernier, J. (1994). Dissociation 
of temporal and frontal components in the human auditory N1 wave: A scalp current density and 
dipole model analysis. Electroencephalography and Clinical Neurophysiology, 92(3), 238-252. 
doi: 10.1016/0168-5597(94)90067-1 
Godey, B., Schwartz, D., De Graaf, J., Chauvel, P., & Liegeois-Chauvel, C. (2001). Neuromagnetic 
source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of 
data in the same patients. Clinical Neurophysiology, 112(10), 1850-1859. doi: 10.1016/S1388-
2457(01)00636-8 
Goff, D. C., & Evins, A. E. (1998). Negative symptoms in schizophrenia: neurobiological models and 
treatment response. Harvard Review of Psychiatry, 6(2), 59-77.  
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: Etymology and 
strategic intentions. American Journal of Psychiatry, 160(4), 636-645.  
Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system 
responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41(1), 1-24.  
Gudlowski, Y., Ozgurdal, S., Witthaus, H., Gallinat, J., Hauser, M., Winter, C., . . . Juckel, G. (2009). 
Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as 
assessed by the loudness dependence of auditory evoked activity. Schizophrenia Research, 
109(1-3), 141-147. doi: 10.1016/j.schres.2009.02.008 
Guille, V., Croft, R. J., O'Neill, B. V., Illic, S., Phan, K. L., & Nathan, P. J. (2008). An examination of 
acute changes in serotonergic neurotransmission using the loudness dependence measure of 
auditory cortex evoked activity: Effects of citalopram, escitalopram and sertraline. Human 
Psychopharmacology, 23(3), 231-241. doi: 10.1002/hup.922 
Häfner, H., Löffler, W., Maurer, K., Hambrecht, M., & an der Heiden, W. (1999). Depression, negative 
symptoms, social stagnation and social decline in the early course of schizophrenia. Acta 
Psychiatrica Scandinavica, 100(2), 105-118.  
Hagenmuller, F., Hitz, K., Darvas, F., & Kawohl, W. (2011). Determination of the loudness dependence 
of auditory evoked potentials: Single-electrode estimation versus dipole source analysis. Human 
Psychopharmacology-Clinical and Experimental, 26(2), 147-154. doi: 10.1002/hup.1186 
Hahn, A., Wadsak, W., Windischberger, C., Baldinger, P., Höflich, A. S., Losak, J., . . . Kraus, C. (2012). 
Differential modulation of the default mode network via serotonin-1A receptors. Proceedings of 
the National Academy of Sciences, 109(7), 2619-2624. doi: 10.1073/pnas.1117104109 
Hall, D. A., Haggard, M. P., Summerfield, A. Q., Akeroyd, M. A., Palmer, A. R., & Bowtell, R. W. 
(2001). Functional magnetic resonance imaging measurements of sound-level encoding in the 
absence of background scanner noise. Journal of the Acoustical Society of America, 109(4), 
1559-1570. doi: 10.1121/1.1345697 
Hämäläinen, M. S., Hari, R., Ilmoniemi, R. J., Knuutila, J., & Lounasmaa, O. V. (1993). 
Magnetoencephalography - Theory, instrumentation, and applications to noninvasive studies of 
the working human brain. Reviews of modern Physics, 65(2), 413.  
Hämäläinen, M. S., & Ilmoniemi, R. J. (1994). Interpreting magnetic fields of the brain: Minimum norm 
estimates. Medical and Biological Engineering and Computing, 32(1), 35-42.  
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 
23(1), 56-62. doi: 10.1136/jnnp.23.1.56 
Hansen, P. C., Kringelbach, M. L., & Salmelin, R. (2010). MEG. An introduction to methods. New York, 
NY: Oxford university press. 
Hari, R., Kaila, K., Katila, T., Tuomisto, T., & Varpula, T. (1982). Interstimulus interval dependence of 
the auditory vertex response and its magnetic counterpart: implications for their neural 
generation. Electroencephalography and Clinical Neurophysiology, 54(5), 561-569. doi: 
10.1016/0013-4694(82)90041-4 
Hashimoto, T., Kitamura, N., Kajimoto, Y., Shirai, Y., Shirakawa, O., Mita, T., . . . Tanaka, C. (1993). 
Differential changes in serotonin 5-HT 1A and 5-HT 2 receptor binding in patients with chronic 
schizophrenia. Psychopharmacology, 112, 35-39.  
Hegerl, U., Gallinat, J., & Juckel, G. (2001). Event-related potentials: Do they reflect central serotonergic 
neurotransmission and do they predict clinical response to serotonin agonists? Journal of 
Affective Disorders, 62(1-2), 93-100.  
References 
71 
Hegerl, U., Gallinat, J., & Mrowinski, D. (1994). Intensity dependence of auditory evoked dipole source 
activity. International Journal of Psychophysiology, 17(1), 1-13. doi: 10.1016/0167-
8760(94)90050-7 
Hegerl, U., & Juckel, G. (1993). Intensity dependence of auditory evoked potentials as an indicator of 
central serotonergic neurotransmission: A new hypothesis. Biological Psychiatry, 33(3), 173-187. 
doi: 10.1016/0006-3223(93)90137-3 
Hegerl, U., & Juckel, G. (1994). Auditory-evoked dipole source activity - Indicator of central 
serotonergic dysfunction in psychiatric-patients. [Article]. Pharmacopsychiatry, 27(2), 75-78.  
Hegerl, U., & Juckel, G. (2000). Identifying psychiatric patients with serotonergic dysfunctions by event-
related potentials. World Journal of Biological Psychiatry, 1(2), 112-118.  
Hegerl, U., Prochno, I., Ulrich, G., & Müller-Oerlinghausen, B. (1988). Are auditory evoked potentials 
suitable for predicting the response to lithium prophylaxis? A study on the effects of repeated 
measurement, age, gender, and personality on the amplitude/stimulus intensity function in healthy 
volunteers. Pharmacopsychiatry, 21(6), 336-337. doi: 10.1055/s-2007-1017000 
Hensch, T., Herold, U., Diers, K., Armbruster, D., & Brocke, B. (2008). Reliability of intensity 
dependence of auditory-evoked potentials. Clinical Neurophysiology, 119(1), 224-236. doi: 
10.1016/j.clinph.2007.09.127 
Hensch, T., Wargelius, H. L., Herold, U., Lesch, K. P., Oreland, L., & Brocke, B. (2006). Further 
evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked 
potentials. Neuropsychopharmacology, 31(9), 2047-2054.  
Herholz, K., Salmon, E., Perani, D., Baron, J., Holthoff, V., Fröhlich, L., . . . Kalbe, E. (2002). 
Discrimination between alzheimer dementia and controls by automated analysis of multicenter 
FDG PET. Neuroimage, 17(1), 302-316.  
Herzog, H., Langen, K. J., Weirich, C., Kops, E. R., Kaffanke, J., Tellmann, L., . . . Shah, N. J. (2011). 
High resolution BrainPET combined with simultaneous MRI. Nuklearmedizin-Nuclear Medicine, 
50(2), 74-82. doi: 10.3413/Nukmed-0347-10-09 
Hitz, K., Heekeren, K., Obermann, C., Huber, T., Juckel, G., & Kawohl, W. (2011). Examination of the 
effect of acute levodopa administration on the loudness dependence of auditory evoked potentials 
(LDAEP) in humans. Psychopharmacology, 1-8. doi: 10.1007/s00213-011-2586-8 
Hoffman, J. P. (2004). Generalized linear models: an applied approach. Boston, MA: Pearson. 
Huang, M., Edgar, J., Thoma, R., Hanlon, F., Moses, S., Lee, R., . . . Bustillo, J. (2003). Predicting EEG 
responses using MEG sources in superior temporal gyrus reveals source asynchrony in patients 
with schizophrenia. Clinical Neurophysiology, 114(5), 835-850. doi: 10.1016/S1388-
2457(03)00041-5 
Hyman, S. E. (2007). Can neuroscience be integrated into the DSM-V? Nature Reviews Neuroscience, 
8(9), 725-732. doi: 10.1038/nrn2218 
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., . . . Wang, P. (2010). Research 
domain criteria (RDoC): toward a new classification framework for research on mental disorders. 
American Journal of Psychiatry, 167(7), 748-751.  
Ioannides, A. A. (1995). Estimates of 3D brain activity ms by ms from biomagnetic signals: method 
(MFT), results and their significance. In E. Eiselt, U. Zwiener & H. Witte (Eds.), Quantitative 
and topological EEG and MEG analysis (pp. 59-68). Jena, Germany: Universitaetsverlag 
Druchhaus-Maayer GmbH. 
Ioannides, A. A. (2006). Magnetoencephalography as a research tool in neuroscience: state of the art. 
Neuroscientist, 12(6), 524-544. doi: 10.1177/1073858406293696  
Ioannides, A. A., Bolton, J., & Clarke, C. (1990). Continuous probabilistic solutions to the biomagnetic 
inverse problem. Inverse Problems, 6(4), 523.  
Ioannides, A. A., Liu, M., Liu, L., Bamidis, P., Hellstrand, E., & Stephan, K. (1995). Magnetic field 
tomography of cortical and deep processes: Examples of "real-time mapping" of averaged and 
single trial MEG signals. International Journal of Psychophysiology, 20(3), 161-175.  
Ioannides, A. A., Poghosyan, V., Dammers, J., & Streit, M. (2004). Real-time neural activity and 
connectivity in healthy individuals and schizophrenia patients. Neuroimage, 23(2), 473-482. doi: 
10.1016/j.neuroimage.2004.06.023 
Jacobs, B. L., & Azmitia, E. C. (1992). Structure and function of the brain-serotonin system. 
Physiological Reviews, 72(1), 165-229.  
References 
72 
Jäncke, L. (2005). Methoden der Bildgebung in der Psychologie und den kognitiven 
Neurowissenschaften: Stuttgart: Verlag W. Kohlhammer. 
Jäncke, L., Shah, N. J., Posse, S., Grosse-Ryuken, M., & Müller-Gärtner, H. W. (1998). Intensity coding 
of auditory stimuli: An fMRI study. Neuropsychologia, 36(9), 875-883. doi: 10.1016/S0028-
3932(98)00019-0 
Jasper, H. H. (1958). The ten-twenty electrode system of the international federation. 
Electroencephalography and Clinical Neurophysiology, 10, 380-375.  
Jaworska, N., Blier, P., Fusee, W., & Knott, V. (2012). Scalp-and sLORETA-derived loudness 
dependence of auditory evoked potentials (LDAEPs) in unmedicated depressed males and 
females and healthy controls. Clinical Neurophysiology, 123(9), 1769-1778.  
Jaworska, N., Blondeau, C., Tessier, P., Norris, S., Fusee, W., Blier, P., & Knott, V. (2013). Response 
prediction to antidepressants using scalp and source-localized loudness dependence of auditory 
evoked potential (LDAEP) slopes. Progress in Neuro-Psychopharmacology and Biological 
Psychiatry, 44, 100-107. doi: 10.1016/j.pnpbp.2013.01.012 
Juckel, G. (2005). Serotonin und akustisch evozierte Potentiale: Darmstadt: Steinkopff Verlag. 
Juckel, G., Csépe, V., Molnár, M., Hegerl, U., & Karmos, G. (1996). Intensity dependence of auditory 
evoked potentials in behaving cats. Electroencephalography and Clinical Neurophysiology, 
100(6), 527-537.  
Juckel, G., Gallinat, J., Riedel, M., Sokullu, S., Schulz, C., Möller, H. J., . . . Hegerl, U. (2003). 
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of 
primary auditory cortex evoked activity. Schizophrenia Research, 64(2-3), 115-124.  
Juckel, G., Gudlowski, Y., Muller, D., Ozgurdal, S., Brune, M., Gallinat, J., . . . Meisenzahl, E. M. 
(2008). Loudness dependence of the auditory evoked N1/P2 component as an indicator of 
serotonergic dysfunction in patients with schizophrenia - A replication study. Psychiatry 
Research, 158(1), 79-82.  
Juckel, G., Hegerl, U., Giegling, I., Mavrogiorgou, P., Gallinat, J., Augustin, H., . . . Rujescu, D. (2007). 
Loudness dependence of auditory evoked potentials is not associated with polymorphisms or 
haplotypes in the serotonin transporter gene in a community-based sample of German healthy 
volunteers. Psychiatry Research, 153(2), 183-187. doi: 10.1016/j.psychres.2006.12.014 
Juckel, G., Hegerl, U., Giegling, I., Mavrogiorgou, P., Wutzler, A., Schuhmacher, C., . . . Rujescu, D. 
(2008). Association of 5-HT1B receptor polymorphisms with the loudness dependence of 
auditory evoked potentials in a community-based sample of healthy volunteers. American 
Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 147B(4), 454-458. doi: 
10.1002/ajmg.b.30628 
Juckel, G., Hegerl, U., Molnar, M., Csepe, V., & Karmos, G. (1999). Auditory evoked potentials reflect 
serotonergic neuronal activity - A study in behaving cats administered drugs acting on 5-HT1A 
autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology, 21(6), 710-716.  
Juckel, G., Kawohl, W., Giegling, I., Mavrogiorgou, P., Winter, C., Pogarell, O., . . . Rujescu, D. (2008). 
Association of catechol-O-methyltransferase variants with loudness dependence of auditory 
evoked potentials. Human Psychopharmacology, 23(2), 115-120. doi: 10.1002/hup.906 
Juckel, G., Molnar, M., Hegerl, U., Csepe, V., & Karmos, G. (1997). Auditory-evoked potentials as 
indicator of brain serotonergic activity - First evidence in behaving cats. Biological Psychiatry, 
41(12), 1181-1195. doi: 10.1016/S0006-3223(96)00240-5 
Juckel, G., Pogarell, O., Augustin, H., Mulert, C., Müller-Siecheneder, F., Frodl, T., . . . Hegerl, U. 
(2007). Differential prediction of first clinical response to serotonergic and noradrenergic 
antidepressants using the loudness dependence of auditory evoked potentials in patients with 
major depressive disorder. Journal of Clinical Psychiatry, 68(8), 1206-1212.  
Juckel, G., Schumacher, C., Giegling, I., Assion, H. J., Mavrogiorgou, P., Pogarell, O., . . . Rujescu, D. 
(2010). Serotonergic functioning as measured by the loudness dependence of auditory evoked 
potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. Journal 
of Psychiatric Research, 44(8), 541-546.  
Kähkönen, S., Jääskeläinen, I. P., Pennanen, S., Liesivuori, J., & Ahveninen, J. (2002). Acute trytophan 
depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source 
activity. Psychopharmacology, 164(2), 221-227. doi: 10.1007/s00213-002-1194-z 
References 
73 
Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (2000). Principles of neural science (Vol. 4): McGraw-
Hill New York. 
Kapur, S., & Remington, G. (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. 
American Journal of Psychiatry, 153(4), 466-476.  
Kawohl, W., Giegling, I., Mavrogiorgou, P., Pogarell, O., Mulert, C., Moller, H. J., . . . Juckel, G. (2008). 
Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of 
auditory evoked potentials. The International Journal of Neuropsychopharmacology, 11(4), 477-
483.  
Kawohl, W., Hegerl, U., Müller-Oerlinghausen, B., & Juckel, G. (2008). Insights in the central 
serotonergic function in patients with affective disorders. Neuropsychiatry, 22(1), 23.  
Kawohl, W., & Hoff, P. (2010). Neuropsychiatry, psychopathology, and nosology - Symptoms, 
syndromes, and endophenotypes. In Tretter, Gebicke-Haerter, Mendoza & Winterer (Eds.), 
Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical 
Modeling (pp. 113-127). Weinheim: Wiley-Blackwell. 
Kawohl, W., Waberski, T. D., Darvas, F., Norra, C., Gobbel, R., & Buchner, H. (2007). Comparative 
source localization of electrically and pressure-stimulated multichannel somatosensory evoked 
potentials. Journal of Clinical Neurophysiology, 24(3), 257.  
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for 
schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.  
Kenemans, J. L., & Kähkönen, S. (2011). How human electrophysiology informs psychopharmacology: 
From bottom-up driven processing to top-down control. Neuropsychopharmacology, 36(1), 26-
51. doi: 10.1038/npp.2010.157 
Kiebel, S. J., Daunizeau, J., Phillips, C., & Friston, K. J. (2008). Variational Bayesian inversion of the 
equivalent current dipole model in EEG/MEG. Neuroimage, 39(2), 728-741. doi: 
10.1016/j.neuroimage.2007.09.005 
Kim, D.-H., & Park, Y.-M. (2013). The association between suicidality and serotonergic dysfunction in 
depressed patients. Journal of Affective Disorders, 148(1), 72-76. doi: 10.1016/j.jad.2012.11.051 
Kim, Y. H., Gitelman, D. R., Nobre, A. C., Parrish, T. B., LaBar, K. S., & Mesulam, M. M. (1999). The 
large-scale neural network for spatial attention displays multifunctional overlap but differential 
asymmetry. Neuroimage, 9(3), 269-277. doi: 10.1006/nimg.1999.0408 
Kirkpatrick, B., Fenton, W. S., Carpenter Jr., W. T., & Marder, S. R. (2006). The NIMH-MATRICS 
consensus statement on negative symptoms. Schizophrenia Bulletin, 32(2), 214-219.  
Klöppel, S., Abdulkadir, A., Jack Jr, C. R., Koutsouleris, N., Mourão-Miranda, J., & Vemuri, P. (2012). 
Diagnostic neuroimaging across diseases. Neuroimage, 61(2), 457-463.  
Knable, M. B., & Weinberger, D. R. (1997). Dopamine, the prefrontal cortex and schizophrenia. Journal 
of Psychopharmacology, 11(2), 123-131.  
Knight, R. T., Hillyard, S. A., Woods, D. L., & Neville, H. J. (1980). The effects of frontal and temporal-
parietal lesions on the auditory evoked potential in man. Electroencephalography and Clinical 
Neurophysiology, 50(1-2), 112-124. doi: 10.1016/0013-4694(80)90328-4 
Kraemer, H. C., Schultz, S. K., & Arndt, S. (2002). Biomarkers in psychiatry: Methodological issues. The 
American Journal of Geriatric Psychiatry, 10(6), 653-659.  
Kraus, C., Ganger, S., Losak, J., Hahn, A., Savli, M., Kranz, G. S., . . . Lanzenberger, R. (2014). Gray 
matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin 
reuptake inhibitor intake. Neuroimage, 84, 236-244. doi: 10.1016/j.neuroimage.2013.08.036 
La Fougere, C., Grant, S., Kostikov, A., Schirrmacher, R., Gravel, P., Schipper, H. M., . . . Thiel, A. 
(2011). Where in-vivo imaging meets cytoarchitectonics: The relationship between cortical 
thickness and neuronal density measured with high-resolution [(18)F]flumazenil-PET. 
Neuroimage, 56(3), 951-960. doi: 10.1016/j.neuroimage.2010.11.015 
Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (1990). Emotion, attention, and the startle reflex. 
Psychological Review, 97(3), 377. doi: 10.1037/0033-295X.97.3.377 
Lang, U. E., Hellweg, R., & Gallinat, J. (2005). Association of BDNF serum concentrations with central 
serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology, 
30(6), 1148-1153.  
References 
74 
Langers, D. R., van Dijk, P., Schoenmaker, E. S., & Backes, W. H. (2007). fMRI activation in relation to 
sound intensity and loudness. Neuroimage, 35(2), 709-718. doi: 
10.1016/j.neuroimage.2006.12.013 
Lee, I. H., Yang, Y. K., Chen, P. S., Huang, H. C., Yeh, T. L., Lu, R. B., . . . Lin, S. H. (2011). Loudness 
dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine 
transporters and serotonin transporters in healthy volunteers - a two isotopes SPECT study. 
Psychopharmacology, 214(3), 617-624.  
Lee, T. W., Yu, Y. W. Y., Chen, T. J., & Tsai, S. J. (2005). Loudness dependence of the auditory evoked 
potential and response to antidepressants in chinese patients with major depression. Journal of 
Psychiatry and Neuroscience, 30(3), 202-205.  
Leech, R., & Sharp, D. J. (2014). The role of the posterior cingulate cortex in cognition and disease. 
Brain, 137(Pt 1), 12-32. doi: 10.1093/brain/awt162 
Lehmann, D., & Skrandies, W. (1980). Reference-free identification of components of checkerboard-
evoked multichannel potential fields. Electroencephalography and Clinical Neurophysiology, 
48(6), 609-621.  
Leiser, S. C., Dunlop, J., Bowlby, M. R., & Devilbiss, D. M. (2011). Aligning strategies for using EEG as 
a surrogate biomarker: A review of preclinical and clinical research. Biochemical Pharmacology, 
81(12), 1408-1421. doi: 10.1016/j.bcp.2010.10.002 
Leucht, S., Heres, S., Kissling, W., & Davis, J. M. (2011). Evidence-based pharmacotherapy of 
schizophrenia. The International Journal of Neuropsychopharmacology, 14(02), 269-284.  
Leuchter, A. F., Cook, I. A., Hunter, A., & Korb, A. (2009). Use of clinical neurophysiology for the 
selection of medication in the treatment of major depressive disorder: The state of the evidence. 
Clinical EEG and Neuroscience, 40(2), 78-83.  
Lewis, D. A., Campbell, M. J., Foote, S. L., & Morrison, J. H. (1986). The monoaminergic innervation of 
primate neocortex. Human Neurobiology, 5(3), 181-188.  
Linden, D. E. J. (2012). The challenges and promise of neuroimaging in psychiatry. Neuron, 73(1), 8-22.  
Lindenmayer, J. P., Harvey, P. D., Khan, A., & Kirkpatrick, B. (2007). Schizophrenia: Measurements of 
psychopathology. Psychiatric Clinics of North America, 30(3), 339-363.  
Linka, T., Müller, B. W., Bender, S., & Sartory, G. (2004). The intensity dependence of the auditory 
evoked N1 component as a predictor of response to citalopram treatment in patients with major 
depression. Neuroscience Letters, 367(3), 375-378. doi: 10.1016/j.neulet.2004.06.038 
Linka, T., Sartory, G., Gastpar, M., Scherbaum, N., & Müller, B. W. (2009). Clinical symptoms of major 
depression are associated with the intensity dependence of auditory event-related potential 
components. Psychiatry Research, 169(2), 139-143. doi: 10.1016/j.psychres.2008.06.009 
Linka, T., Sartory, G., Wiltfang, J., & Mueller, B. W. (2009). Treatment effects of serotonergic and 
noradrenergic antidepressants on the intensity dependence of auditory ERP components in major 
depression. Neuroscience Letters, 463(1), 26-30. doi: 10.1016/j.neulet.2009.07.038 
Lockwood, A. H., Salvi, R. J., Coad, M. L., Arnold, S. A., Wack, D. S., Murphy, B., & Burkard, R. F. 
(1999). The functional anatomy of the normal human auditory system: Responses to 0.5 and 4.0 
kHz tones at varied intensities. Cerebral Cortex, 9(1), 65-76. doi: 10.1093/cercor/9.1.65 
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001). Neurophysiological 
investigation of the basis of the fMRI signal. Nature, 412(6843), 150-157.  
Luck, S. J. (2005). An introduction to the event-related potential technique. Cambridge, MA: MIT press. 
Luck, S. J., Mathalon, D. H., O'Donnell, B. F., Hämäläinen, M. S., Spencer, K. M., Javitt, D. C., & 
Uhlhaas, P. J. (2011). A roadmap for the development and validation of event-related potential 
biomarkers in schizophrenia research. Biological Psychiatry, 70(1), 28-34.  
Makeig, S., Westerfield, M., Jung, T. P., Enghoff, S., Townsend, J., Courchesne, E., & Sejnowski, T. J. 
(2002). Dynamic brain sources of visual evoked responses. Science, 295(5555), 690-694. doi: 
10.1126/science.1066168 
Manjarrez, G., Hernandez, E., Robles, A., & Hernandez, J. (2005). N1/P2 component of auditory evoked 
potential reflect changes of the brain serotonin biosynthesis in rats. Nutritional Neuroscience, 
8(4), 213-218.  
Massey, A. E., Marsh, V. R., & McAllister-Williams, R. H. (2004). Lack of effect of tryptophan 
depletion on the loudness dependency of auditory event related potentials in healthy volunteers. 
Biological Psychiatry, 65(2), 137-145.  
References 
75 
Matthews, S. C., Simmons, A. N., Strigo, I. A., Arce, E., Stein, M. B., & Paulus, M. P. (2010). 
Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers. 
Psychiatry Research, 182(2), 81-87. doi: 10.1016/j.pscychresns.2010.02.003 
McLoughlin, G., Makeig, S., & Tsuang, M. T. (2013). In search of biomarkers in psychiatry: EEG-based 
measures of brain function. American Journal of Medical Genetics Part B-Neuropsychiatric 
Genetics, 165(2), 111-121.  
Meltzer, H. Y. (1989). Clinical-studies on the mechanism of action of clozapine - the dopamine-serotonin 
hypothesis of schizophrenia. [Article]. Psychopharmacology, 99, 18-27.  
Meltzer, H. Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 
21(2 Suppl), 106-115.  
Meltzer, H. Y., & Massey, B. W. (2011). The role of serotonin receptors in the action of atypical 
antipsychotic drugs. Current Opinion In Pharmacology, 11(1), 59-67. doi: 
10.1016/j.coph.2011.02.007 
Metzger, K. L., Maxwell, C. R., Liang, Y., & Siegel, S. J. (2007). Effects of nicotine vary across two 
auditory evoked potentials in the mouse. Biological Psychiatry, 61(1), 23-30.  
Michel, C. M. (2009). Electrical neuroimaging: Cambridge University Press. 
Michel, C. M., Murray, M. M., Lantz, G., Gonzalez, S., Spinelli, L., & Grave de Peralta, R. (2004). EEG 
source imaging. Clinical Neurophysiology, 115(10), 2195-2222.  
Miederer, I., Ziegler, S. I., Liedtke, C., Spilker, M. E., Miederer, M., Sprenger, T., . . . Boecker, H. 
(2009). Kinetic modelling of [11 C] flumazenil using data-driven methods. European Journal of 
Nuclear Medicine and Molecular Imaging, 36(4), 659-670.  
Miller, G. (2010). Beyond DSM: Seeking a brain-based classification of mental illness. Science, 
327(5972), 1437-1437.  
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2004). Treatments for schizophrenia: A 
critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular 
Psychiatry, 10(1), 79-104.  
Möller, H.-J., Müller, W. E., & Bandelow, B. (2001). Neuroleptika, Pharmakologische Grundlagen, 
klinisches Wissen und therapeutisches Vorgehen. Stuttgart: Wissenschaftliche 
Verlagsgesellschaft. 
Mulert, C., Jäger, L., Propp, S., Karch, S., Störmann, S., Pogarell, O., . . . Hegerl, U. (2005). Sound level 
dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and 
fMRI. Neuroimage, 28(1), 49-58. doi: 10.1016/j.neuroimage.2005.05.041 
Mulert, C., Juckel, G., Augustin, H., & Hegerl, U. (2002). Comparison between the analysis of the 
loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis 
in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in 
major depression. Clinical Neurophysiology, 113(10), 1566-1572. doi: 10.1016/S1388-
2457(02)00252-3 
Mulert, C., Juckel, G., Brunnmeier, M., Karch, S., Leicht, G., Mergl, R., . . . Pogarell, O. (2007). 
Prediction of treatment response in major depression: Integration of concepts. Journal of 
Affective Disorders, 98(3), 215-225. doi: 10.1016/j.jad.2006.07.021 
Murphy, D. L. (1990). Peripheral indices of central serotonin function in humans. Annals of the New York 
Academy of Sciences, 600(1), 282-295.  
Musall, S., von Pföstl, V., Rauch, A., Logothetis, N. K., & Whittingstall, K. (2014). Effects of neural 
synchrony on surface EEG. Cerebral Cortex, 24(4), 1045-1053. doi: 10.1093/cercor/bhs389 
Muthukumaraswamy, S. D., Edden, R. E., Jones, D. K., Swettenham, J. B., & Singh, K. D. (2009). 
Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to 
visual stimulation in humans. Proceedings of the National Academy of Sciences, 106(20), 8356-
8361.  
Näätänen, R., & Picton, T. (1987). The N1 wave of the human electric and magnetic response to sound: A 
review and an analysis of the component structure. Psychophysiology, 24(4), 375-425. doi: 
10.1111/j.1469-8986.1987.tb00311.x 
Nathan, P., Segrave, R., Phan, K., O'Neill, B., & Croft, R. (2006). Direct evidence that acutely enhancing 
serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness 
dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. 
Human Psychopharmacology, 21(1), 47-52. doi: 10.1002/hup.740 
References 
76 
Neukirch, M., Hegerl, U., Kötitz, R., Dorn, H., Gallinat, U., & Herrmann, W. M. (2002). Comparison of 
the amplitude/intensity function of the auditory evoked N1m and N1 components. 
Neuropsychobiology, 45(1), 41-48. doi: 10.1159/000048672 
Neuner, I., Kawohl, W., Arrubla, J., Warbrick, T., Wyss, C., Hitz, K., . . . Shah, J. N. (2014). Cortical 
signal variation in the processing of rising sound pressure levels:  a combined event-related 
potentials and fMRI study. PLoS One, 9(10), e109216. doi: 10.1371/journal.pone.0109216 
Neuner, I., Stoecker, T., Kellermann, T., Ermer, V., Wegener, H.-P., Eickhoff, S. B., . . . Shah, N. J. 
(2010). Electrophysiology meets fMRI: Neural correlates of the startle reflex assessed by 
simultaneous EMG-fMRI data acquisition. Human Brain Mapping, 31(11), 1675-1685. doi: 
10.1002/hbm.20965 
Nichols, T. E., & Holmes, A. P. (2002). Nonparametric permutation tests for functional neuroimaging: a 
primer with examples. Human Brain Mapping, 15(1), 1-25. doi: 10.1002/hbm.1058 
Nishizawa, S., Benkelfat, C., Young, S. N., Leyton, M., Mzengeza, S., de Montigny, C., . . . Diksic, M. 
(1997). Differences between males and females in rates of serotonin synthesis in human brain. 
Proceedings of the National Academy of Sciences, 94(10), 5308-5313.  
Norra, C., Becker, S., Broecheler, A., Kawohl, W., Kunert, H. J., & Buchner, H. (2008). Loudness 
dependence of evoked dipole source activity during acute serotonin challenge in females. Human 
Psychopharmacology-Clinical and Experimental, 23(1), 31-42.  
O'Neill, B. V. (2008). The pharmacology of the loudness dependence of the auditory evoked potential 
(LDAEP).  Doctoral dissertation, Swinburne University of Technology, Melbourne.    
O'Neill, B. V., Croft, R. J., Leung, S., Guille, V., Galloway, M., Phan, K. L., & Nathan, P. J. (2006). 
Dopamine receptor stimulation does not modulate the loudness dependence of the auditory 
evoked potential in humans. Psychopharmacology, 188(1), 92-99. doi: 10.1007/s00213-006-
0501-5 
O'Neill, B. V., Croft, R. J., Leung, S., Oliver, C., Phan, K. L., & Nathan, P. J. (2007). High-dose glycine 
inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. 
Psychopharmacology, 195(1), 85-93. doi: 10.1007/s00213-007-0870-4 
O'Neill, B. V., Croft, R. J., & Nathan, P. J. (2008). The loudness dependence of the auditory evoked 
potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: Rationale, 
evaluation and review of findings. Human Psychopharmacology-Clinical and Experimental, 
23(5), 355-370. doi: 10.1002/hup.940 
O'Neill, B. V., Guille, V., Croft, R. J., Leung, S., Scholes, K. E., Phan, K. L., & Nathan, P. J. (2008). 
Effects of selective and combined serotonin and dopamine depletion on the loudness dependence 
of the auditory evoked potential (LDAEP) in humans. Human Psychopharmacology, 23(4), 301-
312. doi: 10.1002/hup.926 
Ojima, H. (2011). Interplay of excitation and inhibition elicited by tonal stimulation in pyramidal neurons 
of primary auditory cortex. Neuroscience and Biobehavioral Reviews, 35(10), 2084-2093. doi: 
10.1016/j.neubiorev.2010.11.009 
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., . . . Michi, T. (2000). 
Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. 
Life Sciences, 66(25), 2455-2464.  
Oldfield, R. C. (1971). The assessment and analysis of handedness: The edinburgh inventory. 
Neuropsychologia, 9(1), 97-113. doi: 10.1016/0028-3932(71)90067-4 
Oliva, J. L., Leung, S., Croft, R. J., O'Neill, B. V., O'Kane, J., Stout, J. C., . . . Nathan, P. J. (2010). The 
loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and 
noradrenergic neurotransmission. Human Psychopharmacology-Clinical and Experimental, 
25(5), 423-427. doi: 10.1002/hup.1133 
Oliva, J. L., Leung, S., Croft, R. J., O'Neill, B. V., Stout, J. C., & Nathan, P. J. (2011). Evidence for sex 
differences in the loudness dependence of the auditory evoked potential in humans. Human 
Psychopharmacology, 26(2), 172-176. doi: 10.1002/hup.1187 
Orrù, G., Pettersson-Yeo, W., Marquand, A. F., Sartori, G., & Mechelli, A. (2012). Using support vector 
machine to identify imaging biomarkers of neurological and psychiatric disease: A critical 
review. Neuroscience and Biobehavioral Reviews, 36(4), 1140-1152. doi: 
10.1016/j.neubiorev.2012.01.004 
References 
77 
Ostermann, J., Uhl, I., Köhler, E., Juckel, G., & Norra, C. (2012). The loudness dependence of auditory 
evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric 
inpatients. Human Psychopharmacology-Clinical and Experimental, 27(6), 595-604. doi: 
10.1002/hup.2269 
Pantazis, D., & Leahy, R. M. (2010). Statistical inference in MEG distributed source imaging MEG: An 
introduction to methods (pp. 257-284). New York, NY: Oxford university press. 
Park, Y. M. (2014). Relationship between SSRI-induced sexual dysfunction and central serotonergic 
activity based on the loudness dependence of auditory evoked potentials. Psychopharmacology, 
231(3), 551-555.  
Park, Y. M., Kim, D. W., Kim, S., Im, C. H., & Lee, S. H. (2011). The loudness dependence of the 
auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with 
generalized anxiety disorder. Psychopharmacology, 213(2-3), 625-632.  
Park, Y. M., Lee, B. H., Um, T. H., & Kim, S. (2014). Serum BDNF levels in relation to illness severity, 
suicide attempts, and central serotonin activity in patients with major depressive disorder: A pilot 
study. PLoS One, 9(3). doi: 10.1371/journal.pone.0091061 
Park, Y. M., & Lee, S. H. (2013). Clinical usefulness of loudness dependence of auditory evoked 
potentials (LDAEP) in patients with bipolar disorder. Psychiatry Investigation, 10(3), 233-237. 
doi: 10.4306/pi.2013.10.3.233 
Park, Y. M., & Lee, S. H. (2014). Chronotype in relation to bipolarity, suicidal ideation, and auditory 
evoked potentials in patients with major depressive disorder: Preliminary study. Korean Journal 
of Biological Psychiatry, 21(1), 14-20.  
Park, Y. M., Lee, S. H., Kim, S., & Bae, S. M. (2010). The loudness dependence of the auditory evoked 
potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety 
disorder, and healthy controls. Progress in Neuro-Psychopharmacology and Biological 
Psychiatry, 34(2), 313-316. doi: 10.1016/j.pnpbp.2009.12.004 
Parvizi, J., Van Hoesen, G. W., Buckwalter, J., & Damasio, A. (2006). Neural connections of the 
posteromedial cortex in the macaque. Proceedings of the National Academy of Sciences, 103(5), 
1563-1568. doi: 10.1073/pnas.0507729103 
Pascual-Marqui, R. D. (1999). Review of methods for solving the EEG inverse problem. International 
Journal of Bioelectromagnetism, 1(1), 75-86.  
Pascual-Marqui, R. D., Michel, C. M., & Lehmann, D. (1994). Low resolution electromagnetic 
tomography: A new method for localizing electrical activity in the brain. International Journal of 
Psychophysiology, 18(1), 49-65.  
Penhune, V., Zatorre, R., MacDonald, J., & Evans, A. (1996). Interhemispheric anatomical differences in 
human primary auditory cortex: probabilistic mapping and volume measurement from magnetic 
resonance scans. Cerebral Cortex, 6(5), 661-672.  
Perala, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsa, E., Pirkola, S., . . . Lonnqvist, J. (2007). 
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of 
General Psychiatry, 64(1), 19-28. doi: 10.1001/archpsyc.64.1.19 
Picton, T. W., Alain, C., Woods, D. L., John, M. S., Scherg, M., Valdes-Sosa, P., . . . Trujillo, N. J. 
(1999). Intracerebral sources of human auditory-evoked potentials. Audiology and Neuro-
Otology, 4(2), 64-79. doi: 10.1159/000013823 
Picton, T. W., Bentin, S., Berg, P., Donchin, E., Hillyard, S. A., Johnson, R., Jr., . . . Taylor, M. J. (2000). 
Guidelines for using human event-related potentials to study cognition: Recording standards and 
publication criteria. Psychophysiology, 37(2), 127-152.  
Pizzagalli, D., Pascual-Marqui, R. D., Nitschke, J. B., Oakes, T. R., Larson, C. L., Abercrombie, H. C., . . 
. Davidson, R. J. (2001). Anterior cingulate activity as a predictor of degree of treatment response 
in major depression: Evidence from brain electrical tomography analysis. American Journal of 
Psychiatry, 158(3), 405-415. doi: 10.1176/appi.ajp.158.3.405 
Pogarell, O., Tatsch, K., Juckel, G., Hamann, C., Mulert, C., Popperl, G., . . . Hegerl, U. (2004). 
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of 
auditory evoked potentials in patients with obsessive-compulsive disorder. 
Neuropsychopharmacology, 29(10), 1910-1917.  
Prescott, J., Connolly, J. F., & Gruzelier, J. H. (1984). The augmenting/reducing phenomenon in the 
auditory evoked potential. Biological Psychology, 19(1), 31-44.  
References 
78 
Proietti-Cecchini, A., Afra, J., & Schoenen, J. (1997). Intensity dependence of the cortical auditory 
evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: 
Demonstration of a central effect for the 5HT(1B/1D) agonist zolmitriptan (311C90, Zomig (R)). 
Cephalalgia, 17(8), 849-854. doi: 10.1046/j.1468-2982.1997.1708849.x 
Quednow, B. B., Treyer, V., Hasler, F., Dörig, N., Wyss, M. T., Burger, C., . . . Vollenweider, F. X. 
(2012). Assessment of serotonin release capacity in the human brain using dexfenfluramine 
challenge and [18F]altanserin positron emission tomography. Neuroimage, 59(4), 3922-3932. 
doi: 10.1016/j.neuroimage.2011.09.045 
Reite, M., Zimmerman, J. T., Edrich, J., & Zimmerman, J. E. (1982). Auditory evoked magnetic fields: 
response amplitude vs. stimulus intensity. Electroencephalography and Clinical 
Neurophysiology, 54(2), 147-152. doi: 10.1016/0013-4694(82)90156-0 
Reynolds, G. P., Yao, Z., Zhang, X., Sun, J., & Zhang, Z. (2005). Pharmacogenetics of treatment in first-
episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with 
positive and negative symptom response. European Neuropsychopharmacology, 15(2), 143-151.  
Rössler, W., Riecher-Rössler, A., Angst, J., Murray, R., Gamma, A., Eich, D., . . . Gross, V. A. (2007). 
Psychotic experiences in the general population: A twenty-year prospective community study. 
Schizophrenia Research, 92(1-3), 1-14.  
Rössler, W., Salize, H. J., van Os, J., & Riecher-Rössler, A. (2005). Size of burden of schizophrenia and 
psychotic disorders. European Neuropsychopharmacology, 15(4), 399-409. doi: 
10.1016/j.euroneuro.2005.04.009 
Roth, B., & Meltzer, H. (2000). The role of serotonin in schizophrenia. In H. Meltzer (Ed.), 
Psychopharmacology: The Fourth Generation of Progress (pp. 575-583). New York: Raven. 
Roth, W. T., Horvath, T. B., Pfefferbaum, A., & Kopell, B. S. (1980). Event-related potentials in 
schizophrenics. Electroencephalography and Clinical Neurophysiology, 48(2), 127-139.  
Rummel-Kluge, C., Kissling, W., & Leucht, S. (2006). Antidepressants for the negative symptoms of 
schizophrenia. Cochrane Database of Systematic Reviews(3).  
Salisbury, D. F., Kuroki, N., Kasai, K., Shenton, M. E., & McCarley, R. W. (2007). Progressive and 
interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. 
Archives of General Psychiatry, 64(5), 521-529. doi: 10.1001/archpsyc.64.5.521 
Sándor, P. S., Áfra, J., Proietti-Cecchini, A., Albert, A., & Schoenen, J. (1999). Familial influences on 
cortical evoked potentials in migraine. Neuroreport, 10(6), 1235-1238.  
Sauseng, P., Klimesch, W., Gruber, W. R., Hanslmayr, S., Freunberger, R., & Doppelmayr, M. (2007). 
Are event-related potential components generated by phase resetting of brain oscillations? A 
critical discussion. Neuroscience, 146(4), 1435-1444. doi: 10.1016/j.neuroscience.2007.03.014 
Schadow, J., Lenz, D., Thaerig, S., Busch, N. A., Fründ, I., & Herrmann, C. S. (2007). Stimulus intensity 
affects early sensory processing: Sound intensity modulates auditory evoked gamma-band 
activity in human EEG. International Journal of Psychophysiology, 65(2), 152-161. doi: 
10.1016/j.ijpsycho.2007.04.006 
Schechter, G., & Buchsbaum, M. (1973). The effects of attention, stimulus intensity, and individual 
differences on the average evoked response. Psychophysiology, 10(4), 392-400. doi: 
10.1111/j.1469-8986.1973.tb00797.x 
Scherg, M. (1990). Fundamentals of dipole source potential analysis. In F. Grandori, M. Hoke & G. L. 
Romani (Eds.), Auditory evoked electric and magnetic fields. Advances in audiology (Vol. 6, pp. 
40-69). Basel: Karger. 
Scherg, M., & Berg, P. (1991). Use of prior knowledge in brain electromagnetic source analysis. Brain 
Topography, 4(2), 143-150. doi: 10.1007/BF01132771 
Scherg, M., & Picton, T. W. (1991). Separation and identification of event-related potential components 
by brain electric source analysis. Electroencephalography and Clinical Neurophysiology. 
Supplement, 42, 24-37.  
Scherg, M., Vajsar, J., & Picton, T. W. (1989). A source analysis of the late human auditory evoked 
potentials. Journal of Cognitive Neuroscience, 1, 336-355. doi: 10.1162/jocn.1989.1.4.336 
Scherg, M., & Von Cramon, D. (1985). Two bilateral sources of the late AEP as identified by a spatio-
temporal dipole model. Electroencephalography and Clinical Neurophysiology, 62(1), 32-44. 
doi: 10.1016/0168-5597(85)90033-4 
References 
79 
Scherg, M., & Von Cramon, D. (1986). Evoked dipole source potentials of the human auditory cortex. 
Electroencephalography and Clinical Neurophysiology, 65(5), 344-360.  
Scherg, M., & Von Cramon, D. (1990). Dipole source potentials of the auditory cortex in normal subjects 
and on patients with temporal lobe lesions. Advances in Audiology, 6, 165-193.  
Schmidt, F. L., Le, H., & Ilies, R. (2003). Beyond alpha: An empirical examination of the effects of 
different sources of measurement error on reliability estimates for measures of individual-
differences constructs. Psychological Methods, 8(2), 206.  
Schooler, C., Buchsbaum, M. S., & Carpenter Jr, W. T. (1976). Evoked response and kinesthetic 
measures of augmenting/reducing in schizophrenics: Replications and extensions. The Journal of 
Nervous and Mental Disease, 163(4), 221-232.  
Schroeder, C. E., & Foxe, J. (2005). Multisensory contributions to low-level, 'unisensory' processing. 
Current Opinion in Neurobiology, 15(4), 454-458. doi: 10.1016/j.conb.2005.06.008 
Segrave, R., Croft, R. J., Illic, S., Phan, K. L., & Nathan, P. J. (2006). Pindolol does not augment central 
serotonin function increases to citalopram in humans: An auditory evoked potential investigation. 
Pharmacology Biochemistry and Behavior, 85(1), 82-90. doi: 10.1016/j.pbb.2006.07.013 
Seifritz, E., Esposito, F., Hennel, F., Mustovic, H., Neuhoff, J. G., Bilecen, D., . . . Di Salle, F. (2002). 
Spatiotemporal pattern of neural processing in the human auditory cortex. Science, 297(5587), 
1706-1708. doi: 10.1126/science.1074355 
Sepehry, A. A., Potvin, S., Elie, R., & Stip, E. (2007). Selective serotonin reuptake inhibitor (SSRI) add-
on therapy for the negative symptoms of schizophrenia: A meta-analysis. Journal of Clinical 
Psychiatry, 68(4), 604-610.  
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI findings in 
schizophrenia. Schizophrenia Research, 49(1-2), 1-52.  
Silver, H. (2004). Selective serotonin re-uptake inhibitor augmentation in the treatment of negative 
symptoms of schizophrenia. Expert Opinion on Pharmacotherapy, 5(10), 2053-2058.  
Simmons, J. G., Nathan, P. J., Berger, G., & Allen, N. B. (2011). Chronic modulation of serotonergic 
neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked 
potential in healthy participants. Psychopharmacology, 217(1), 101-110.  
Simpson, G. V., & Knight, R. T. (1993). Multiple brain systems generating the rat auditory evoked-
potential. I. characterization of the auditory-cortex response. Brain Research, 602(2), 240-250. 
doi: 10.1016/0006-8993(93)90689-k 
Singh, I., & Rose, N. (2009). Biomarkers in psychiatry. Nature, 460(7252), 202-207.  
Singh, S. P., Singh, V., Kar, N., & Chan, K. (2010). Efficacy of antidepressants in treating the negative 
symptoms of chronic schizophrenia: Meta-analysis. The British Journal of Psychiatry, 197(3), 
174-179.  
Smith, S. M., & Nichols, T. E. (2009). Threshold-free cluster enhancement: addressing problems of 
smoothing, threshold dependence and localisation in cluster inference. Neuroimage, 44(1), 83-98. 
doi: 10.1016/j.neuroimage.2008.03.061 
Smith, S. W. (1997). The scientist and engineer's guide to digital signal processing. San Diego, 
California: California Technical Publ. 
Steiger, A., & Kimura, M. (2010). Wake and sleep EEG provide biomarkers in depression. Journal of 
Psychiatric Research, 44(4), 242-252.  
Stevens, G., Flaxman, S., Brunskill, E., Mascarenhas, M., Mathers, C. D., & Finucane, M. (2013). Global 
and regional hearing impairment prevalence: An analysis of 42 studies in 29 countries. European 
Journal of Public Health, 23(1), 146-152. doi: 10.1093/eurpub/ckr176 
Strobel, A., Debener, S., Schmidt, D., Hunnerkopf, R., Lesch, K. P., & Brocke, B. (2003). Allelic 
variation in serotonin transporter function associated with the intensity dependence of the 
auditory evoked potential. American Journal of Medical Genetics Part B-Neuropsychiatric 
Genetics, 118B(1), 41-47.  
Sun, D., van Erp, T. G., Thompson, P. M., Bearden, C. E., Daley, M., Kushan, L., . . . Cannon, T. D. 
(2009). Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: 
Classification analysis using probabilistic brain atlas and machine learning algorithms. Biological 
Psychiatry, 66(11), 1055-1060.  
References 
80 
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008). Schizophrenia, "just the facts" what we know in 
2008. 2. Epidemiology and etiology. Schizophrenia Research, 102(1-3), 1-18. doi: 
10.1016/j.schres.2008.04.011 
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009). Schizophrenia ,‚just the facts"  4. Clinical 
features and conceptualization. Schizophrenia Research, 110(1), 1-23.  
Taylor, J. G., Ioannides, A. A., & Muller-Gartner, H. W. (1999). Mathematical analysis of lead field 
expansions. IEEE Transactions on Medical Imaging, 18(2), 151-163. doi: 10.1109/42.759120 
Uhl, I., Gorynia, I., Gallinat, J., Mulert, C., Wutzler, A., Heinz, A., & Juckel, G. (2006). Is the loudness 
dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor 
citalopram in healthy subjects? Human Psychopharmacology, 21(7), 463-471.  
Uhl, I., Illes, F., Grassnickel, V., Echterhoff, S., Norra, C., & Juckel, G. (2012). Loudness dependence of 
auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major 
depression: A pilot study. European Archives of Psychiatry and Clinical Neuroscience, 262(6), 
487-492. doi: 10.1007/s00406-012-0297-8 
Uhl, I., Krumova, E. K., Regeniter, S., Bär, K. J., Norra, C., Richter, H., . . . Maier, C. (2011). 
Association between wind-up ratio and central serotonergic function in healthy subjects and 
depressed patients. Neuroscience Letters, 504(2), 176-180.  
Uppenkamp, S., & Roehl, M. (2013). Human auditory neuroimaging of intensity and loudness. Hearing 
Research, 307, 65-73. doi: 10.1016/j.heares.2013.08.005 
Vasama, J. P., Mäkelä, J. P., Tissari, S. O., & Hämäläinen, M. S. (1995). Effects of intensity variation on 
human auditory evoked magnetic fields. Acta Oto-Laryngologica, 115(2), 616-621.  
Velasco, M., & Velasco, F. (1986). Subcortical correlates of the somatic, auditory and visual vertex 
activities. II. Referential EEG responses. Electroencephalography and Clinical Neurophysiology, 
63(1), 62-67. doi: 10.1016/0013-4694(86)90063-5 
Vogt, B. A., Finch, D. M., & Olson, C. R. (1992). Functional heterogeneity in cingulate cortex: the 
anterior executive and posterior evaluative regions. Cerebral Cortex, 2(6), 435-443. doi: 
10.1093/cercor/2.6.435-a 
Waberski, T. D., Gobbele, R., Kawohl, W., Cordes, C., & Buchner, H. (2003). Immediate cortical 
reorganization after local anesthetic block of the thumb: source localization of somatosensory 
evoked potentials in human subjects. Neuroscience Letters, 347(3), 151-154.  
Waldvogel, D., van Gelderen, P., Muellbacher, W., Ziemann, U., Immisch, I., & Hallett, M. (2000). The 
relative metabolic demand of inhibition and excitation. Nature, 406(6799), 995-998. doi: 
10.1038/35023171 
Walpurger, V., Pietrowsky, R., Kirschbaum, C., & Wolf, O. T. (2004). Effects of the menstrual cycle on 
auditory event-related potentials. Hormones and Behavior, 46(5), 600-606.  
Walter, W., Cooper, R., Aldridge, V., McCallum, W., & Winter, A. (1964). Contingent negative 
variation: an electric sign of sensori-motor association and expectancy in the human brain. 
Nature, 203, 380-384.  
Wan, L., Baldridge, R. M., Colby, A. M., & Stanford, M. S. (2009). Enhanced intensity dependence and 
aggression history indicate previous regular ecstasy use in abstinent polydrug users. Progress in 
Neuro-Psychopharmacology and Biological Psychiatry, 33(8), 1484-1490. doi: 
10.1016/j.pnpbp.2009.08.007 
Weidner, R., Boers, F., Mathiak, K., Dammers, J., & Fink, G. R. (2010). The temporal dynamics of the 
Muller-Lyer illusion. Cerebral Cortex, 20(7), 1586-1595. doi: 10.1093/cercor/bhp217 
Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of 
schizophrenia. Archives of General Psychiatry, 44(7), 660-669.  
Winograd-Gurvich, C., Fitzgerald, P. B., Georgiou-Karistianis, N., Bradshaw, J. L., & White, O. B. 
(2006). Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's 
disease. Brain Research Bulletin, 70(4), 312-321.  
Wood, C. C., McCarthy, G., Squires, N. K., Vaughan, H. G., Woods, D. L., & McCallum, W. C. (1984). 
Anatomical and Physiological Substrates of Event-Related Potentials. Annals of the New York 
Academy of Sciences, 425(1), 681-721. doi: 10.1111/j.1749-6632.1984.tb23595.x 
Woodman, G. F. (2012). Homologues of human ERP components in nonhuman primates. In S. J. Luck & 
E. S. Kapperman (Eds.), The oxford handbook of event-related potential components (first ed., 
pp. 611-626). New York, NY: Oxford university press. 
References 
81 
Woods, D. L. (1995). The component structure of the N 1 wave of the human auditory evoked potential. 
Electroencephalography and Clinical Neurophysiology. Supplement, 44, 102-109.  
Woods, D. L., Herron, T. J., Cate, A. D., Yund, E. W., Stecker, G. C., Rinne, T., & Kang, X. (2010). 
Functional properties of human auditory cortical fields. Frontiers in systems neuroscience, 4.  
World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: 
Diagnostic criteria for research. Geneva: World Health Organization. 
Wu, G. K., Tao, H. W., & Zhang, L. I. (2011). From elementary synaptic circuits to information 
processing in primary auditory cortex. Neuroscience and Biobehavioral Reviews, 35(10), 2094-
2104. doi: 10.1016/j.neubiorev.2011.05.004 
Wutzler, A., Winter, C., Kitzrow, W., Uhl, I., Wolf, R. J., Heinz, A., & Juckel, G. (2008). Loudness 
dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: 
Simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary 
auditory cortex. Neuropsychopharmacology, 33(13), 3176-3181. doi: 10.1038/npp.2008.42 
Wyss, C., Boers, F., Kawohl, W., Arrubla, J., Vahedipour, K., Dammers, J., . . . Shah, J. N. (2014). 
Spatiotemporal properties of auditory intensity processing in multisensor MEG. Neuroimage, 
102P2, 465-473. doi: 10.1016/j.neuroimage.2014.08.012 
Wyss, C., Hitz, K., Hengartner, M. P., Theodoridou, A., Obermann, C., Uhl, I., . . . Kawohl, W. (2013). 
The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic 
dysfunction in patients with predominant schizophrenic negative symptoms. PLoS One, 8(7), 
e68650. doi: 10.1371/journal.pone.0068650 
Yamaguchi, S., & Knight, R. T. (1990). Gating of somatosensory input by human prefrontal cortex. Brain 
Research, 521(1-2), 281-288.  
Yasuno, F., Suhara, T., Ichimiya, T., Takano, A., Ando, T., & Okubo, Y. (2004). Decreased 5-HT1A 
receptor binding in amygdala of schizophrenia. Biological Psychiatry, 55(5), 439-444.  
Zacharias, N., Konig, R., & Heil, P. (2012). Stimulation-history effects on the M100 revealed by its 
differential dependence on the stimulus onset interval. Psychophysiology, 49(7), 909-919. doi: 
10.1111/j.1469-8986.2012.01370.x 
Zilles, K., Palomero-Gallagher, N., Grefkes, C., Scheperjans, F., Boy, C., Amunts, K., & Schleicher, A. 
(2002). Architectonics of the human cerebral cortex and transmitter receptor fingerprints: 
Reconciling functional neuroanatomy and neurochemistry. European Neuropsychopharmacology 
12(6), 587-599. doi: 10.1016/S0924-977X(02)00108-6 
 
 
Appendix 
82 
Appendix 
Table 1: Associations between genetic markers (COMT) and LDAEP mean values in left and right 
hemisphere across groups.  
Hemisphere Group Mean 95% CI Wald χ2 (df) Sig 
Left A-allele non-carriers (N=2) 1.612 1.363-1.908 6.746 (1) .009 * 
 A-allele carriers (N=13) 1.148 0.947-1.393   
Right A-allele non-carriers (N=2) 1.413 1.168-1.711 3.697 (1) .055 
 A-allele carriers (N=13) 1.113 0.957-1.294   
Left AA genotype (N=5) 
AG genotype (N=8) 
GG genotype (N=2) 
1.286 
1.062 
1.612 
1.023-1.617 
0.805-1.401 
1.363-1.908 
7.423 (2) .024 * 
Right AA genotype (N=5) 1.211 1.087-1.347 3.584 (2) .158 
 AG genotype (N=8) 
GG genotype (N=2) 
1.052 
1.413 
0.828-1.337 
1.168-1.711 
  
Abbreviations: * P < 0.05.  
 
 
Table 2: Associations between genetic markers (SERT) and LDAEP mean values in left and right 
hemisphere across groups.  
Hemisphere Group Mean 95% CI Wald χ2 (df) Sig 
Left S-allele carriers (N=2) 1.180 0.969-1.436 1.044 (1) .307 
 L-allele carriers (N=13) 1.409 1.066-1.862   
Right S-allele carriers (N=2) 1.198 1.044-1.375 3.553 (1) .059 
 L-allele carriers (N=13) 0.861 0.629 -1.179   
Left SS+SL genotypes (N=13) 1.180 0.969-1.436 1.044 (1) .307 
 LL genotype (N=2) 1.409 1.066-1.862   
Right SS+SL genotypes (N=13) 1.198 1.044-1.375 3.553 (1) .059 
 LL genotype (N=2) 0.861 0.629-1.179   
Abbreviations: S, short variant; L, long variant.  
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